data_2lfo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CG ' ' HE3' ' A' ' 107' ' ' MET . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' C ' ' HG ' ' A' ' 122' ' ' SER . 2.0 tp-100 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.576 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 17' ' ' PHE . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.487 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.57 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.506 HG22 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.689 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.689 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.506 ' SD ' HG22 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' O ' HD21 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.774 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.431 ' HE3' ' CG ' ' A' ' 6' ' ' TRP . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.403 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' HD13 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.478 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB3' HG13 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 21' ' ' LEU . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 17' ' ' PHE . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.425 ' C ' HD21 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.527 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.437 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.575 HD11 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.575 ' N ' HD11 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.455 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.478 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD13 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 17' ' ' PHE . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 24' ' ' PRO . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.51 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.821 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.498 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.467 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.821 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.447 ' C ' ' HG ' ' A' ' 97' ' ' SER . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 96' ' ' PHE . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.4 ' CZ ' HG12 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 9' ' ' TYR . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.587 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.768 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 18' ' ' LEU . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.533 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 24' ' ' PRO . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' CG ' HD12 ' A' ' 34' ' ' ILE . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.449 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB1' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.945 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 24' ' ' PRO . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.648 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.648 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.56 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.945 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.493 ' NH1' ' HB1' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.744 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE1' HD23 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD23 ' CE1' ' A' ' 17' ' ' PHE . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.447 ' HE3' ' O ' ' A' ' 26' ' ' ASP . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.68 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' HD12 ' A' ' 89' ' ' LEU . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.68 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.633 ' CE1' HG12 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.461 HD11 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.461 ' N ' HD11 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 64' ' ' LEU . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.452 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 35.1 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 2.1 t30 -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.452 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.744 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.539 ' N ' ' HD2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB3' ' ND2' ' A' ' 105' ' ' ASN . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.477 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 34' ' ' ILE . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 30' ' ' MET . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.549 HG22 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.757 ' SG ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 119' ' ' ILE . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 117' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.406 ' CG ' ' HE3' ' A' ' 107' ' ' MET . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.95 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 14' ' ' TYR . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.739 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 59' ' ' THR . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CD1' HG12 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.55 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.406 ' HE3' ' CG ' ' A' ' 6' ' ' TRP . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.95 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.428 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' CE1' HD23 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' CE1' ' A' ' 17' ' ' PHE . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 24' ' ' PRO . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 34' ' ' ILE . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.735 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' THR . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.629 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.629 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.735 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' SG ' ' A' ' 91' ' ' CYS . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.495 ' SG ' HG23 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.423 ' C ' ' HG ' ' A' ' 97' ' ' SER . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 13' ' ' ASN . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.54 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 17' ' ' PHE . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.477 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 24' ' ' PRO . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.535 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 30' ' ' MET . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.594 HG22 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.527 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.594 ' SD ' HG22 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 100' ' ' GLN . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 120' ' ' ARG . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.483 ' C ' ' HG ' ' A' ' 122' ' ' SER . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.809 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 15' ' ' GLU . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' HB ' ' CD ' ' A' ' 54' ' ' PRO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.594 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.809 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.594 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.483 ' HG ' ' C ' ' A' ' 7' ' ' GLN . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.504 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.571 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 24' ' ' PRO . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.646 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HD12 ' A' ' 89' ' ' LEU . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.618 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG21 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.739 ' SG ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.448 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.533 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HD13 ' HG2' ' A' ' 19' ' ' LYS . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 73' ' ' MET . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.488 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.688 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.688 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 53' ' ' THR . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.488 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' HD12 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.663 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.486 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 24' ' ' PRO . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 30' ' ' MET . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.536 HG23 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.497 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.536 ' SD ' HG23 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 82' ' ' VAL . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.505 HG23 ' NH2' ' A' ' 121' ' ' ARG . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH2' HG23 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.886 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' GLU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.519 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.64 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.64 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.592 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.548 ' CB ' HG23 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.886 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.493 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.498 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 30' ' ' MET . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.527 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 74' ' ' ASP . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 72' ' ' THR . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' ' 69' ' ' ASP . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.596 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.596 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.451 ' CB ' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.448 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.58 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.58 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HA ' HD11 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.514 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.425 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' HG12 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.471 HG23 ' OD1' ' A' ' 74' ' ' ASP . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' OD1' HG23 ' A' ' 72' ' ' THR . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' N ' HG21 ' A' ' 82' ' ' VAL . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 7.9 mm100 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.411 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.465 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.488 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.401 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.517 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 24' ' ' PRO . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.516 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 30' ' ' MET . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' A' ' 82' ' ' VAL . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.3 t30 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.419 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 14' ' ' TYR . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.91 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' MET . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.569 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.569 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 76' ' ' LYS . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.491 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.91 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TRP . . . . . 0.424 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' HD12 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD12 ' CE2' ' A' ' 17' ' ' PHE . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 30' ' ' MET . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.688 HG23 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.581 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.688 ' SD ' HG23 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' A' ' 82' ' ' VAL . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG23 ' SG ' ' A' ' 80' ' ' CYS . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.44 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.413 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.417 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.474 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' CG ' ' HE3' ' A' ' 107' ' ' MET . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' C ' ' HG ' ' A' ' 122' ' ' SER . 2.0 tp-100 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.576 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 17' ' ' PHE . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.487 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.474 ' HG ' ' N25' ' A' ' 202' ' ' CHO . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.57 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB1' ' O24' ' A' ' 202' ' ' CHO . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.507 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.506 HG22 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HG2' ' C23' ' A' ' 202' ' ' CHO . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.689 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.689 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.506 ' SD ' HG22 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' O ' HD21 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.774 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.411 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.431 ' HE3' ' CG ' ' A' ' 6' ' ' TRP . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.403 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.485 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.506 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.401 ' HB ' HD13 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.478 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.436 ' HB3' HG13 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 21' ' ' LEU . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 17' ' ' PHE . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.41 ' HB2' ' C18' ' A' ' 202' ' ' CHO . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.401 ' HG2' ' C23' ' A' ' 202' ' ' CHO . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.425 ' C ' HD21 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.527 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.437 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.575 HD11 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' N ' HD11 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.471 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.455 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.455 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.436 HG13 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.478 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.648 ' C19' ' O2 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.531 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD13 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.477 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 17' ' ' PHE . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.465 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.534 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 24' ' ' PRO . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.534 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.429 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HA ' ' C23' ' A' ' 202' ' ' CHO . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.544 HD12 ' C24' ' A' ' 202' ' ' CHO . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HD13 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.67 ' HG3' ' C24' ' A' ' 202' ' ' CHO . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.51 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.51 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.821 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.498 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.467 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.631 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.821 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.447 ' C ' ' HG ' ' A' ' 97' ' ' SER . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 96' ' ' PHE . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.444 ' ND1' ' C11' ' A' ' 201' ' ' GCH . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.4 HG12 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.4 ' CZ ' HG12 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.509 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.67 ' C24' ' HG3' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 9' ' ' TYR . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.587 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.588 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.768 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 201' ' ' GCH . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 18' ' ' LEU . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.533 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 24' ' ' PRO . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.623 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.446 ' O ' HG21 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HD2' ' C23' ' A' ' 202' ' ' CHO . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.566 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.509 ' SD ' ' C17' ' A' ' 202' ' ' CHO . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.414 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.42 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.651 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.587 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.768 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.497 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.534 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.618 ' C23' ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.449 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB1' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.945 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.459 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 201' ' ' GCH . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 HD22 ' C23' ' A' ' 202' ' ' CHO . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 24' ' ' PRO . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.468 ' HG3' ' C26' ' A' ' 202' ' ' CHO . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.55 ' HB ' ' C22' ' A' ' 202' ' ' CHO . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.648 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.648 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.56 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.464 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.945 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.493 ' NH1' ' HB1' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.524 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.669 ' C21' ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.429 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.744 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.506 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE1' HD23 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD23 ' CE1' ' A' ' 17' ' ' PHE . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' PRO . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.447 ' HE3' ' O ' ' A' ' 26' ' ' ASP . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG21 ' C1 ' ' A' ' 201' ' ' GCH . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.562 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.68 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' CD2' HD12 ' A' ' 89' ' ' LEU . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.68 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.562 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.483 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.633 ' CE1' HG12 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.461 HD11 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.461 ' N ' HD11 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 64' ' ' LEU . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.633 HG12 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.452 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 35.1 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.404 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 2.1 t30 -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.452 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.744 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.539 ' N ' ' HD2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.429 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.404 ' HB3' ' ND2' ' A' ' 105' ' ' ASN . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.5 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.487 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.409 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.477 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HG ' ' C23' ' A' ' 202' ' ' CHO . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG21 HD11 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 34' ' ' ILE . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 30' ' ' MET . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.549 HG22 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.595 ' HG2' ' C24' ' A' ' 202' ' ' CHO . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.549 ' SD ' HG22 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.757 ' SG ' HG23 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.431 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.401 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.401 ' O ' HD13 ' A' ' 119' ' ' ILE . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 117' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.406 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.519 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.605 ' C23' ' HG ' ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.406 ' CG ' ' HE3' ' A' ' 107' ' ' MET . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.95 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CE2' ' A' ' 14' ' ' TYR . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 24' ' ' PRO . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.739 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.739 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 59' ' ' THR . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CD1' HG12 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.543 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.481 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.55 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.553 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.406 ' HE3' ' CG ' ' A' ' 6' ' ' TRP . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.95 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.508 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.538 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.428 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' CE1' HD23 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.402 HD23 ' CE1' ' A' ' 17' ' ' PHE . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.574 ' HG ' ' C23' ' A' ' 202' ' ' CHO . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 24' ' ' PRO . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 34' ' ' ILE . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.468 HD11 ' C26' ' A' ' 202' ' ' CHO . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.735 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.544 ' HD2' ' C22' ' A' ' 202' ' ' CHO . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 53' ' ' THR . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.629 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.629 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.735 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' NZ ' ' O4 ' ' A' ' 201' ' ' GCH . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' SG ' ' A' ' 91' ' ' CYS . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.465 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.495 ' SG ' HG23 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.423 ' C ' ' HG ' ' A' ' 97' ' ' SER . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 96' ' ' PHE . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.428 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.514 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.637 ' C21' ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 13' ' ' ASN . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.54 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 17' ' ' PHE . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.477 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 24' ' ' PRO . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.535 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 30' ' ' MET . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.594 HG22 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.527 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.527 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.594 ' SD ' HG22 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' OD1' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.874 ' SG ' HG21 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.41 ' CD2' ' HG3' ' A' ' 100' ' ' GLN . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 120' ' ' ARG . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HG2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.535 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.507 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.483 ' C ' ' HG ' ' A' ' 122' ' ' SER . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.809 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.433 ' HG ' ' HA ' ' A' ' 15' ' ' GLU . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 201' ' ' GCH . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.451 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.578 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG22 ' C1 ' ' A' ' 201' ' ' GCH . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' HB ' ' CD ' ' A' ' 54' ' ' PRO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.517 ' CD ' ' HB ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.432 ' HG1' ' C22' ' A' ' 201' ' ' GCH . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.468 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.411 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.495 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.594 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.809 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.594 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.483 ' HG ' ' C ' ' A' ' 7' ' ' GLN . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.529 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.525 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.448 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.504 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.571 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 24' ' ' PRO . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.646 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.404 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' HD2' ' C23' ' A' ' 202' ' ' CHO . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.618 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.407 ' CD2' HD12 ' A' ' 89' ' ' LEU . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.618 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG21 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.739 ' SG ' HG21 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.561 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.448 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.533 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.527 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.518 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.441 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.663 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' HG ' ' C23' ' A' ' 202' ' ' CHO . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HD13 ' HG2' ' A' ' 19' ' ' LYS . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.42 ' HB2' ' C24' ' A' ' 202' ' ' CHO . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB2' ' C18' ' A' ' 202' ' ' CHO . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.439 HD11 ' C26' ' A' ' 202' ' ' CHO . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.406 HG21 ' SD ' ' A' ' 73' ' ' MET . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.558 ' HG2' ' C24' ' A' ' 202' ' ' CHO . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.488 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.688 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.688 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.406 ' SD ' HG21 ' A' ' 53' ' ' THR . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.488 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.565 HD12 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.565 ' N ' HD12 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.473 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.401 ' ND1' ' C11' ' A' ' 201' ' ' GCH . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.436 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.436 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.663 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.53 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.611 ' C21' ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.464 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.486 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.471 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 24' ' ' PRO . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.478 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 30' ' ' MET . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.536 HG23 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.497 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.419 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.536 ' SD ' HG23 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 82' ' ' VAL . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.521 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.453 ' ND1' ' C11' ' A' ' 201' ' ' GCH . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.505 HG23 ' NH2' ' A' ' 121' ' ' ARG . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.432 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.505 ' NH2' HG23 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.521 ' C6 ' ' SG ' ' A' ' 91' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.501 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.886 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.502 ' H ' ' C ' ' A' ' 12' ' ' GLU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 17' ' ' PHE . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.498 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.519 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.545 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.471 ' HA ' ' N25' ' A' ' 202' ' ' CHO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.687 ' HD3' ' N25' ' A' ' 202' ' ' CHO . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.64 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.64 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.592 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.592 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.548 ' CB ' HG23 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.402 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.886 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.402 ' HD3' ' C ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.578 ' C19' ' O2 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.697 ' C24' ' C21' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.547 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.493 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG13 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG12 ' HB3' ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.498 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 30' ' ' MET . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 HD13 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.4 ' CD2' HD13 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.527 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HZ1' ' A' ' 77' ' ' LYS . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.53 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 74' ' ' ASP . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.527 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.419 ' OD1' HG23 ' A' ' 72' ' ' THR . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' HZ1' ' CG ' ' A' ' 69' ' ' ASP . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.596 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.596 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.451 ' CB ' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.448 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.448 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.58 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.514 ' HB3' ' CA ' ' A' ' 201' ' ' GCH . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.58 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.419 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.65 ' C19' ' O2 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.509 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.57 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.511 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.465 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.484 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HA ' HD11 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD23 ' C22' ' A' ' 202' ' ' CHO . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.514 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.425 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HD2' ' C23' ' A' ' 202' ' ' CHO . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD1' HG12 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' C15' ' A' ' 201' ' ' GCH . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.471 HG23 ' OD1' ' A' ' 74' ' ' ASP . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' OD1' HG23 ' A' ' 72' ' ' THR . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.428 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.577 HG12 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' N ' HG21 ' A' ' 82' ' ' VAL . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.431 ' ND1' ' C11' ' A' ' 201' ' ' GCH . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 7.9 mm100 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.411 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.465 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.459 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.553 ' C23' ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.401 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.517 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 24' ' ' PRO . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.516 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.609 HG23 ' C24' ' A' ' 202' ' ' CHO . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.444 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.625 ' HD3' ' C24' ' A' ' 202' ' ' CHO . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.55 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.442 ' SG ' HG23 ' A' ' 82' ' ' VAL . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.3 t30 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.532 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.417 ' CE1' ' C5 ' ' A' ' 201' ' ' GCH . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.672 ' C19' ' O2 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.625 ' C24' ' HD3' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.419 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 14' ' ' TYR . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.91 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.526 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.468 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 30' ' ' MET . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.442 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 HG12 ' C1 ' ' A' ' 201' ' ' GCH . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.569 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.569 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 76' ' ' LYS . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.443 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.569 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.491 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.91 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.616 ' C19' ' O2 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.499 ' O7 ' ' C4 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.428 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.417 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' HD12 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD13 ' C6 ' ' A' ' 202' ' ' CHO . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 24' ' ' PRO . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 30' ' ' MET . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.688 HG23 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.581 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.688 ' SD ' HG23 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.524 ' SG ' HG23 ' A' ' 82' ' ' VAL . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG23 ' SG ' ' A' ' 80' ' ' CYS . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.44 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.509 ' SG ' ' C6 ' ' A' ' 201' ' ' GCH . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.413 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.417 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GCH . . . . . 0.511 ' O1 ' ' C1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' CHO . . . . . 0.505 ' C6 ' HD13 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.639 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.424 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 122' ' ' SER . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.584 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 28' ' ' ILE . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 28' ' ' ILE . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.67 HG23 HD12 ' A' ' 18' ' ' LEU . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.588 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.559 HG21 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 84' ' ' LEU . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.699 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.817 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.636 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.817 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 119' ' ' ILE . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' THR . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.5 ' HB2' HG22 ' A' ' 8' ' ' VAL . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB3' HG12 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 28' ' ' ILE . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.554 HG23 HD12 ' A' ' 18' ' ' LEU . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.605 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 40' ' ' ILE . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 57' ' ' THR . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 52' ' ' LYS . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.419 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.487 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' HD11 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 8' ' ' VAL . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.625 ' HA ' HD13 ' A' ' 118' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 25' ' ' GLU . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' A' ' 84' ' ' LEU . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.837 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 64' ' ' LEU . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.507 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.837 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' SER . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.409 HG23 HG12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.625 HD13 ' HA ' ' A' ' 14' ' ' TYR . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.607 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.598 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 18' ' ' LEU . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG23 HD12 ' A' ' 18' ' ' LEU . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.626 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' HG22 ' A' ' 57' ' ' THR . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HG3' HD13 ' A' ' 34' ' ' ILE . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 52' ' ' LYS . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 89' ' ' LEU . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 120' ' ' ARG . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.446 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.955 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' HD13 ' A' ' 28' ' ' ILE . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 25' ' ' GLU . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 32' ' ' ARG . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.66 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 89' ' ' LEU . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.66 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 97' ' ' SER . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.405 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.955 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.417 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.75 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 28' ' ' ILE . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.623 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.573 ' HA ' HD12 ' A' ' 28' ' ' ILE . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 25' ' ' GLU . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HA ' HG22 ' A' ' 57' ' ' THR . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.668 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.793 HG22 ' HA ' ' A' ' 52' ' ' LYS . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.692 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.797 HG22 ' HB2' ' A' ' 91' ' ' CYS . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.731 ' CE1' HG13 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.797 ' HB2' HG22 ' A' ' 82' ' ' VAL . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 35.1 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.75 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.679 ' HB ' HD11 ' A' ' 37' ' ' ILE . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 28' ' ' ILE . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' HD13 ' A' ' 28' ' ' ILE . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 34' ' ' ILE . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HA ' ' HB ' ' A' ' 34' ' ' ILE . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 30' ' ' MET . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 34' ' ' ILE . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.522 HG21 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 89' ' ' LEU . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 70' ' ' ILE . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.777 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.777 HG22 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.508 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 88' ' ' LYS . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.435 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 110' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.407 HH22 ' CD ' ' A' ' 12' ' ' GLU . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 37' ' ' ILE . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.559 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.958 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.858 HD12 HG23 ' A' ' 28' ' ' ILE . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 28' ' ' ILE . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.858 HG23 HD12 ' A' ' 18' ' ' LEU . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.754 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CD1' HG11 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' LEU . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.566 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 64' ' ' LEU . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.511 HG23 HG12 ' A' ' 119' ' ' ILE . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.958 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 110' ' ' THR . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HG2' HD13 ' A' ' 28' ' ' ILE . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.404 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.74 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 25' ' ' GLU . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 34' ' ' ILE . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.817 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.638 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.638 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.817 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.462 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 119' ' ' ILE . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 110' ' ' THR . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CE2' HD11 ' A' ' 18' ' ' LEU . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.837 HD12 HG23 ' A' ' 28' ' ' ILE . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD21 ' CE1' ' A' ' 17' ' ' PHE . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 28' ' ' ILE . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.44 HD22 ' HD2' ' A' ' 55' ' ' ARG . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.837 HG23 HD12 ' A' ' 18' ' ' LEU . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.551 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 30' ' ' MET . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 34' ' ' ILE . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.692 HG21 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HD2' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.843 HG22 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.843 ' SG ' HG22 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' CD2' ' HG3' ' A' ' 100' ' ' GLN . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.626 HG23 HG13 ' A' ' 119' ' ' ILE . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 117' ' ' THR . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 112' ' ' THR . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.626 HG13 HG23 ' A' ' 110' ' ' THR . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 120' ' ' ARG . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 37' ' ' ILE . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.453 HG21 ' NH2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.816 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.624 HG23 HD12 ' A' ' 18' ' ' LEU . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.585 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 5' ' ' THR . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.522 ' HB ' ' CD ' ' A' ' 54' ' ' PRO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 89' ' ' LEU . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.603 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 17' ' ' PHE . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.816 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 28' ' ' ILE . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 28' ' ' ILE . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HA ' HD12 ' A' ' 28' ' ' ILE . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 18' ' ' LEU . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.63 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 45' ' ' ASP . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.63 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.78 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.454 HD11 HH11 ' A' ' 120' ' ' ARG . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.454 HH11 HD11 ' A' ' 111' ' ' ILE . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.56 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HD2' HD22 ' A' ' 118' ' ' LEU . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 21' ' ' LEU . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 18' ' ' LEU . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.408 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 30' ' ' MET . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.694 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.694 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.418 ' H ' ' HG2' ' A' ' 73' ' ' MET . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' CD1' ' A' ' 84' ' ' LEU . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 92' ' ' LYS . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.691 ' HB3' HG22 ' A' ' 82' ' ' VAL . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.535 ' H ' HG12 ' A' ' 90' ' ' VAL . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 17' ' ' PHE . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.669 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 105' ' ' ASN . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.464 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.665 ' HB ' HD11 ' A' ' 37' ' ' ILE . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 25' ' ' GLU . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 30' ' ' MET . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.665 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 89' ' ' LEU . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.5 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 119' ' ' ILE . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 110' ' ' THR . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.446 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' NH2' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 37' ' ' ILE . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.894 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HD2' HD22 ' A' ' 118' ' ' LEU . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.522 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' THR . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 52' ' ' LYS . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.645 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.599 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.599 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.588 ' HB3' HG22 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 119' ' ' ILE . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.894 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 110' ' ' THR . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 37' ' ' ILE . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.456 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 21' ' ' LEU . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 28' ' ' ILE . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.647 HG23 HD12 ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 30' ' ' MET . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 51' ' ' SER . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 76' ' ' LYS . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' H ' ' CG2' ' A' ' 72' ' ' THR . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.605 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 92' ' ' LYS . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.773 ' HB3' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' H ' HG12 ' A' ' 90' ' ' VAL . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.59 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 119' ' ' ILE . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 110' ' ' THR . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 37' ' ' ILE . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.64 HD12 HG23 ' A' ' 28' ' ' ILE . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.64 HG23 HD12 ' A' ' 18' ' ' LEU . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.536 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.472 HG21 ' SD ' ' A' ' 73' ' ' MET . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.59 ' CD1' HG11 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 76' ' ' LYS . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' HG21 ' A' ' 53' ' ' THR . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 72' ' ' THR . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 64' ' ' LEU . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 57.1 mm-40 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.762 HG23 HG12 ' A' ' 119' ' ' ILE . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.762 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 28' ' ' ILE . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 18' ' ' LEU . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.511 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 30' ' ' MET . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.406 HH12 ' HG3' ' A' ' 24' ' ' PRO . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 2.8 t-20 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 14' ' ' TYR . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.434 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 37' ' ' ILE . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.919 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CE2' HD11 ' A' ' 21' ' ' LEU . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 HG23 ' A' ' 28' ' ' ILE . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 28' ' ' ILE . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 28' ' ' ILE . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 ' HG2' ' A' ' 19' ' ' LYS . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 30' ' ' MET . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.577 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.49 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB2' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.919 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.538 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.755 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 25' ' ' GLU . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.494 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 30' ' ' MET . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.525 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.7 HG21 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.59 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.7 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 110' ' ' THR . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.639 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.3 tp60 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 122' ' ' SER . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.584 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 28' ' ' ILE . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 28' ' ' ILE . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' N25' ' A' ' 202' ' ' CHO . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.67 HG23 HD12 ' A' ' 18' ' ' LEU . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.588 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' H183 ' A' ' 202' ' ' CHO . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.575 HG11 ' H11' ' A' ' 201' ' ' GCH . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.559 HG21 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.833 ' HG2' H232 ' A' ' 202' ' ' CHO . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 84' ' ' LEU . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.699 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.629 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB2' ' H23' ' A' ' 201' ' ' GCH . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' CD1' ' H25' ' A' ' 201' ' ' GCH . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.817 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.636 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.817 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.829 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 119' ' ' ILE . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' THR . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.5 ' HB2' HG22 ' A' ' 8' ' ' VAL . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.829 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.833 H232 ' HG2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB3' HG12 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' H7 ' ' A' ' 202' ' ' CHO . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD11 ' H61' ' A' ' 202' ' ' CHO . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 H151 ' A' ' 202' ' ' CHO . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.71 ' CD2' H222 ' A' ' 202' ' ' CHO . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.554 HG23 HD12 ' A' ' 18' ' ' LEU . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.61 ' HB2' H261 ' A' ' 202' ' ' CHO . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' HB1' H181 ' A' ' 202' ' ' CHO . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' CD1' H262 ' A' ' 202' ' ' CHO . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.605 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 40' ' ' ILE . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.873 HG21 ' H11' ' A' ' 201' ' ' GCH . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 57' ' ' THR . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.808 ' HG2' H232 ' A' ' 202' ' ' CHO . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 52' ' ' LYS . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.419 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.501 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.415 ' SD ' ' H9 ' ' A' ' 202' ' ' CHO . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' H23' ' A' ' 201' ' ' GCH . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.804 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.726 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.487 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.873 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.808 H232 ' HG2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' HD11 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 8' ' ' VAL . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.625 ' HA ' HD13 ' A' ' 118' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.499 HD22 H182 ' A' ' 202' ' ' CHO . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD13 ' H62' ' A' ' 202' ' ' CHO . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD21 H162 ' A' ' 202' ' ' CHO . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 25' ' ' GLU . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB2' H231 ' A' ' 202' ' ' CHO . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 ' C24' ' A' ' 202' ' ' CHO . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' H11' ' A' ' 201' ' ' GCH . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HG3' ' C24' ' A' ' 202' ' ' CHO . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.856 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' A' ' 84' ' ' LEU . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.657 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.544 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.837 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 64' ' ' LEU . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.507 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.837 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.929 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' SER . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.409 HG23 HG12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.625 HD13 ' HA ' ' A' ' 14' ' ' TYR . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' H22' ' A' ' 202' ' ' CHO . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.929 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.75 H212 H121 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.607 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.598 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 H191 ' A' ' 202' ' ' CHO . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD1' ' H61' ' A' ' 202' ' ' CHO . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD11 ' H7 ' ' A' ' 202' ' ' CHO . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG23 HD12 ' A' ' 18' ' ' LEU . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.626 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.869 HG21 ' H11' ' A' ' 201' ' ' GCH . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' HG22 ' A' ' 57' ' ' THR . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.989 ' HD2' H232 ' A' ' 202' ' ' CHO . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG3' H262 ' A' ' 202' ' ' CHO . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 52' ' ' LYS . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.888 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.984 ' SD ' ' H17' ' A' ' 202' ' ' CHO . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD11 ' H25' ' A' ' 201' ' ' GCH . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 89' ' ' LEU . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.765 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.724 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.536 ' CD ' ' H2 ' ' A' ' 201' ' ' GCH . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 120' ' ' ARG . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.888 ' H34' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.989 H232 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.446 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.955 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.558 ' CD2' H192 ' A' ' 202' ' ' CHO . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' HD13 ' A' ' 28' ' ' ILE . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' ' H62' ' A' ' 202' ' ' CHO . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.931 HD21 H232 ' A' ' 202' ' ' CHO . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 25' ' ' GLU . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.673 ' HG3' H261 ' A' ' 202' ' ' CHO . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 32' ' ' ARG . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.833 HD12 H262 ' A' ' 202' ' ' CHO . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.694 HG21 ' H11' ' A' ' 201' ' ' GCH . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.631 ' HB ' H221 ' A' ' 202' ' ' CHO . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD2' H221 ' A' ' 202' ' ' CHO . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.66 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 89' ' ' LEU . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.661 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.751 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.559 ' HG3' H151 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.71 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 97' ' ' SER . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.789 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.589 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.405 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.955 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.789 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.958 ' O24' H211 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.417 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.75 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.633 ' OH ' H121 ' A' ' 202' ' ' CHO . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 H182 ' A' ' 202' ' ' CHO . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.772 HD13 ' H62' ' A' ' 202' ' ' CHO . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.573 ' HA ' HD12 ' A' ' 28' ' ' ILE . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 H222 ' A' ' 202' ' ' CHO . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 25' ' ' GLU . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.924 HG21 ' H11' ' A' ' 201' ' ' GCH . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HA ' HG22 ' A' ' 57' ' ' THR . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.668 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' H221 ' A' ' 202' ' ' CHO . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.793 HG22 ' HA ' ' A' ' 52' ' ' LYS . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.692 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.78 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.452 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.747 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.797 HG22 ' HB2' ' A' ' 91' ' ' CYS . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.731 ' CE1' HG13 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.797 ' HB2' HG22 ' A' ' 82' ' ' VAL . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.759 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 7.5 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.75 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.924 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.824 H212 H121 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.679 ' HB ' HD11 ' A' ' 37' ' ' ILE . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 28' ' ' ILE . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' HD13 ' A' ' 28' ' ' ILE . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.011 ' HG ' H232 ' A' ' 202' ' ' CHO . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB3' H261 ' A' ' 202' ' ' CHO . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.687 ' CB ' H183 ' A' ' 202' ' ' CHO . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' CD1' H262 ' A' ' 202' ' ' CHO . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 34' ' ' ILE . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.808 HG21 ' H11' ' A' ' 201' ' ' GCH . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.522 HG21 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.901 ' HD2' H221 ' A' ' 202' ' ' CHO . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 89' ' ' LEU . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.599 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.59 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.777 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.777 HG22 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.508 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 88' ' ' LYS . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.724 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.435 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 110' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' NH1' ' H22' ' A' ' 202' ' ' CHO . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.407 HH22 ' CD ' ' A' ' 12' ' ' GLU . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.808 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 1.075 ' O24' H211 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 37' ' ' ILE . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.559 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.958 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.675 ' CD2' ' H61' ' A' ' 202' ' ' CHO . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.858 HD12 HG23 ' A' ' 28' ' ' ILE . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD13 H151 ' A' ' 202' ' ' CHO . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 28' ' ' ILE . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.696 HD21 H222 ' A' ' 202' ' ' CHO . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.858 HG23 HD12 ' A' ' 18' ' ' LEU . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.754 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.712 HG21 ' H11' ' A' ' 201' ' ' GCH . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' H231 ' A' ' 202' ' ' CHO . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' ' C24' ' A' ' 202' ' ' CHO . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CD1' HG11 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' LEU . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.574 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.678 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.45 ' HG3' H221 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD11 ' H25' ' A' ' 201' ' ' GCH . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.566 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 64' ' ' LEU . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.9 t-160 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.408 ' OE1' ' H5 ' ' A' ' 201' ' ' GCH . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.511 HG23 HG12 ' A' ' 119' ' ' ILE . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.958 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 110' ' ' THR . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.974 ' H21' ' O3 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.974 ' O3 ' ' H21' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HG2' HD13 ' A' ' 28' ' ' ILE . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD22 ' C22' ' A' ' 201' ' ' GCH . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.74 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.976 ' HG ' H232 ' A' ' 202' ' ' CHO . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 25' ' ' GLU . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.791 ' HB3' H261 ' A' ' 202' ' ' CHO . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' CB ' H183 ' A' ' 202' ' ' CHO . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' H262 ' A' ' 202' ' ' CHO . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.873 HG21 ' H11' ' A' ' 201' ' ' GCH . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.817 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.046 ' HD2' H221 ' A' ' 202' ' ' CHO . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.638 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.813 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.63 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.817 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD11 ' H25' ' A' ' 201' ' ' GCH . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.439 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.462 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.857 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 119' ' ' ILE . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 110' ' ' THR . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.873 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 1.107 ' O24' H211 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CE2' HD11 ' A' ' 18' ' ' LEU . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.837 HD12 HG23 ' A' ' 28' ' ' ILE . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD22 ' C22' ' A' ' 201' ' ' GCH . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 28' ' ' ILE . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.788 HD21 H222 ' A' ' 202' ' ' CHO . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.837 HG23 HD12 ' A' ' 18' ' ' LEU . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.551 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 H232 ' A' ' 202' ' ' CHO . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 34' ' ' ILE . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.896 HG21 ' H11' ' A' ' 201' ' ' GCH . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.692 HG21 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.701 ' HD2' H221 ' A' ' 202' ' ' CHO . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HD2' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.718 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.596 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.843 HG22 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.843 ' SG ' HG22 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.895 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.626 HG23 HG13 ' A' ' 119' ' ' ILE . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 117' ' ' THR . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 112' ' ' THR . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.626 HG13 HG23 ' A' ' 110' ' ' THR . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.542 ' NH1' ' H11' ' A' ' 202' ' ' CHO . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.896 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.903 H232 HD12 ' A' ' 34' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 37' ' ' ILE . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.453 HG21 ' NH2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.816 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.725 ' CE2' ' H61' ' A' ' 202' ' ' CHO . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD22 ' H23' ' A' ' 201' ' ' GCH . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.701 ' CD1' H151 ' A' ' 202' ' ' CHO . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.624 HG23 HD12 ' A' ' 18' ' ' LEU . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.585 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 5' ' ' THR . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.795 HG21 ' H11' ' A' ' 201' ' ' GCH . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' H232 ' A' ' 202' ' ' CHO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' H232 ' A' ' 202' ' ' CHO . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.831 ' HB2' H261 ' A' ' 202' ' ' CHO . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' ND2' ' H33' ' A' ' 201' ' ' GCH . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.755 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.691 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.564 ' HG2' H213 ' A' ' 202' ' ' CHO . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.698 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 89' ' ' LEU . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.602 ' CE1' ' H42' ' A' ' 201' ' ' GCH . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.603 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 17' ' ' PHE . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.816 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.795 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.831 H261 ' HB2' ' A' ' 55' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 28' ' ' ILE . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 28' ' ' ILE . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.764 HD23 ' H23' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.824 ' CD1' H151 ' A' ' 202' ' ' CHO . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HA ' HD12 ' A' ' 28' ' ' ILE . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 18' ' ' LEU . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.757 HG21 ' H11' ' A' ' 201' ' ' GCH . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' H232 ' A' ' 202' ' ' CHO . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' C23' ' A' ' 202' ' ' CHO . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' HG3' H262 ' A' ' 202' ' ' CHO . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.63 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 45' ' ' ASP . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.63 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.811 ' SD ' ' H17' ' A' ' 202' ' ' CHO . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD21 ' H24' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.78 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.708 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.454 HD11 HH11 ' A' ' 120' ' ' ARG . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 H192 ' A' ' 202' ' ' CHO . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.454 HH11 HD11 ' A' ' 111' ' ' ILE . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.56 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.766 ' H21' ' O3 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.824 H151 ' CD1' ' A' ' 23' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.42 ' CE2' H193 ' A' ' 202' ' ' CHO . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HD2' HD22 ' A' ' 118' ' ' LEU . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 21' ' ' LEU . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.489 HD13 H151 ' A' ' 202' ' ' CHO . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' HG ' ' C23' ' A' ' 202' ' ' CHO . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 18' ' ' LEU . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB2' ' C24' ' A' ' 202' ' ' CHO . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 HD11 H261 ' A' ' 202' ' ' CHO . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.851 HG21 ' H11' ' A' ' 201' ' ' GCH . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HG2' ' C24' ' A' ' 202' ' ' CHO . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.694 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.893 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.517 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.438 ' SD ' ' H14' ' A' ' 202' ' ' CHO . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' H29' ' A' ' 201' ' ' GCH . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' CD1' ' A' ' 84' ' ' LEU . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 92' ' ' LYS . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.877 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.535 ' H ' HG12 ' A' ' 90' ' ' VAL . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.847 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 17' ' ' PHE . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.669 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 105' ' ' ASN . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.893 ' H34' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 1.117 ' O24' H211 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.464 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.665 ' HB ' HD11 ' A' ' 37' ' ' ILE . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' CD2' H192 ' A' ' 202' ' ' CHO . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD13 ' H62' ' A' ' 202' ' ' CHO . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 HD13 H152 ' A' ' 202' ' ' CHO . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.841 HD11 H222 ' A' ' 202' ' ' CHO . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 25' ' ' GLU . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.739 HD12 H232 ' A' ' 202' ' ' CHO . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.665 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' H11' ' A' ' 201' ' ' GCH . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' H221 ' A' ' 202' ' ' CHO . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.59 ' HG2' H262 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.639 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 89' ' ' LEU . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.5 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.523 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.823 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.843 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.56 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 119' ' ' ILE . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CD1' ' H19' ' A' ' 201' ' ' GCH . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 110' ' ' THR . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.446 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' NH2' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.843 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.881 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 37' ' ' ILE . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.894 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.692 ' HE2' ' H5 ' ' A' ' 202' ' ' CHO . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD21 H182 ' A' ' 202' ' ' CHO . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' CD1' ' H62' ' A' ' 202' ' ' CHO . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 H152 ' A' ' 202' ' ' CHO . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD21 H162 ' A' ' 202' ' ' CHO . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.522 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.829 ' HB2' H232 ' A' ' 202' ' ' CHO . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HB3' H262 ' A' ' 202' ' ' CHO . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG21 ' H11' ' A' ' 201' ' ' GCH . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' THR . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.593 ' HA ' ' HN ' ' A' ' 202' ' ' CHO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.728 ' HD3' ' N25' ' A' ' 202' ' ' CHO . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 52' ' ' LYS . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.645 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.588 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' H26' ' A' ' 201' ' ' GCH . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.599 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.599 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.588 ' HB3' HG22 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.768 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.1 t-160 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 119' ' ' ILE . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CD1' ' H23' ' A' ' 201' ' ' GCH . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.894 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 110' ' ' THR . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.768 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.896 ' C24' H211 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 37' ' ' ILE . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CE2' H192 ' A' ' 202' ' ' CHO . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 28' ' ' ILE . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.748 HD13 ' H62' ' A' ' 202' ' ' CHO . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.614 HD21 H222 ' A' ' 202' ' ' CHO . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.647 HG23 HD12 ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.706 HD12 H232 ' A' ' 202' ' ' CHO . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.865 HG21 ' H11' ' A' ' 201' ' ' GCH . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.845 ' HD2' H221 ' A' ' 202' ' ' CHO . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 51' ' ' SER . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.7 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' H ' ' CG2' ' A' ' 72' ' ' THR . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD11 ' H26' ' A' ' 201' ' ' GCH . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.605 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 92' ' ' LYS . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.773 ' HB3' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' H ' HG12 ' A' ' 90' ' ' VAL . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.833 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.523 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.59 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 119' ' ' ILE . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.708 ' CD1' ' H22' ' A' ' 201' ' ' GCH . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 110' ' ' THR . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.865 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.845 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 37' ' ' ILE . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.64 HD12 HG23 ' A' ' 28' ' ' ILE . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 H151 ' A' ' 202' ' ' CHO . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.903 HD21 H222 ' A' ' 202' ' ' CHO . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.64 HG23 HD12 ' A' ' 18' ' ' LEU . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.536 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB1' H181 ' A' ' 202' ' ' CHO . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.949 HG21 ' H11' ' A' ' 201' ' ' GCH . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.472 HG21 ' SD ' ' A' ' 73' ' ' MET . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.747 ' HD2' H231 ' A' ' 202' ' ' CHO . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.59 ' CD1' HG11 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.657 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 76' ' ' LYS . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' HG21 ' A' ' 53' ' ' THR . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 72' ' ' THR . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 64' ' ' LEU . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.871 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 7.9 mm100 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.411 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.762 HG23 HG12 ' A' ' 119' ' ' ILE . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.762 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.949 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.903 H222 HD21 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.719 ' CD2' H192 ' A' ' 202' ' ' CHO . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 28' ' ' ILE . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD13 ' H62' ' A' ' 202' ' ' CHO . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 18' ' ' LEU . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.511 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.638 HD13 ' HN ' ' A' ' 202' ' ' CHO . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' H11' ' A' ' 201' ' ' GCH . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.759 ' HB3' H262 ' A' ' 202' ' ' CHO . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.406 HH12 ' HG3' ' A' ' 24' ' ' PRO . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' OD1' ' H33' ' A' ' 201' ' ' GCH . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.52 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.523 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD11 ' H26' ' A' ' 201' ' ' GCH . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 2.8 t-20 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.853 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.733 ' CE1' ' H3 ' ' A' ' 201' ' ' GCH . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.564 ' HB3' ' H23' ' A' ' 201' ' ' GCH . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 14' ' ' TYR . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.853 ' H6 ' ' SG ' ' A' ' 91' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.927 ' H62' HD13 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.434 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 37' ' ' ILE . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.919 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CE2' HD11 ' A' ' 21' ' ' LEU . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 HG23 ' A' ' 28' ' ' ILE . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 28' ' ' ILE . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 28' ' ' ILE . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.763 HD21 H222 ' A' ' 202' ' ' CHO . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 ' HG2' ' A' ' 19' ' ' LYS . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' H183 ' A' ' 202' ' ' CHO . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.568 HD12 H232 ' A' ' 202' ' ' CHO . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.732 HG11 ' H11' ' A' ' 201' ' ' GCH . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.81 ' HD2' H221 ' A' ' 202' ' ' CHO . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.577 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.623 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.443 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' OD2' ' H25' ' A' ' 201' ' ' GCH . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' H26' ' A' ' 201' ' ' GCH . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.635 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.49 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB2' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB3' ' H23' ' A' ' 201' ' ' GCH . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.919 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.768 ' O2 ' ' H19' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.81 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.538 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.822 HD13 ' H62' ' A' ' 202' ' ' CHO . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 H152 ' A' ' 202' ' ' CHO . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.755 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 H222 ' A' ' 202' ' ' CHO . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 25' ' ' GLU . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.494 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 H232 ' A' ' 202' ' ' CHO . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.525 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.903 HG21 ' H11' ' A' ' 201' ' ' GCH . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.7 HG21 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.848 ' HD2' H221 ' A' ' 202' ' ' CHO . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.784 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.755 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.7 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.718 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.85 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.615 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 110' ' ' THR . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CZ ' ' H22' ' A' ' 202' ' ' CHO . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GCH . . . . . 0.903 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' CHO . . . . . 0.848 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.639 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.424 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 122' ' ' SER . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.584 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 28' ' ' ILE . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 28' ' ' ILE . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.67 HG23 HD12 ' A' ' 18' ' ' LEU . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.588 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.442 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.559 HG21 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 84' ' ' LEU . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.699 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.817 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.636 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.817 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 119' ' ' ILE . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' THR . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.5 ' HB2' HG22 ' A' ' 8' ' ' VAL . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB3' HG12 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 HG23 ' A' ' 28' ' ' ILE . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.554 HG23 HD12 ' A' ' 18' ' ' LEU . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.605 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 40' ' ' ILE . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 57' ' ' THR . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' THR . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 52' ' ' LYS . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.456 HD22 ' C ' ' A' ' 59' ' ' THR . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.419 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.487 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' HD11 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 8' ' ' VAL . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.625 ' HA ' HD13 ' A' ' 118' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 25' ' ' GLU . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' A' ' 84' ' ' LEU . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.837 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 64' ' ' LEU . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.507 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.837 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' SER . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.409 HG23 HG12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.625 HD13 ' HA ' ' A' ' 14' ' ' TYR . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.477 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.607 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.598 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 18' ' ' LEU . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.493 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG23 HD12 ' A' ' 18' ' ' LEU . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.626 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' HG22 ' A' ' 57' ' ' THR . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.487 ' HG3' HD13 ' A' ' 34' ' ' ILE . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 52' ' ' LYS . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.574 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 89' ' ' LEU . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 120' ' ' ARG . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.446 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.955 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' HD13 ' A' ' 28' ' ' ILE . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 25' ' ' GLU . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 32' ' ' ARG . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.66 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 89' ' ' LEU . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.66 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 97' ' ' SER . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.405 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.955 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.417 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.75 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.519 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.56 HD12 HG23 ' A' ' 28' ' ' ILE . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.623 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.573 ' HA ' HD12 ' A' ' 28' ' ' ILE . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 25' ' ' GLU . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HA ' HG22 ' A' ' 57' ' ' THR . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.668 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.793 HG22 ' HA ' ' A' ' 52' ' ' LYS . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.692 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.692 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.797 HG22 ' HB2' ' A' ' 91' ' ' CYS . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.731 ' CE1' HG13 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.797 ' HB2' HG22 ' A' ' 82' ' ' VAL . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 35.1 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 2.1 t30 -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.75 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.427 ' HB3' ' ND2' ' A' ' 105' ' ' ASN . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.679 ' HB ' HD11 ' A' ' 37' ' ' ILE . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.407 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 28' ' ' ILE . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' HD13 ' A' ' 28' ' ' ILE . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.499 ' O ' HG13 ' A' ' 34' ' ' ILE . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' HA ' ' HB ' ' A' ' 34' ' ' ILE . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 30' ' ' MET . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 34' ' ' ILE . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.522 HG21 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 89' ' ' LEU . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 70' ' ' ILE . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.777 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.777 HG22 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.508 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 88' ' ' LYS . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.435 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 110' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.407 HH22 ' CD ' ' A' ' 12' ' ' GLU . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 37' ' ' ILE . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.559 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.958 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.858 HD12 HG23 ' A' ' 28' ' ' ILE . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 28' ' ' ILE . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.858 HG23 HD12 ' A' ' 18' ' ' LEU . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.754 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CD1' HG11 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' LEU . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.566 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 64' ' ' LEU . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.511 HG23 HG12 ' A' ' 119' ' ' ILE . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.958 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 110' ' ' THR . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.442 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HG2' HD13 ' A' ' 28' ' ' ILE . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.404 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.469 HD21 ' CZ ' ' A' ' 17' ' ' PHE . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.74 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 25' ' ' GLU . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.427 ' O ' HG13 ' A' ' 34' ' ' ILE . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 30' ' ' MET . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.817 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.638 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.638 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.817 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.462 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 119' ' ' ILE . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 110' ' ' THR . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CE2' HD11 ' A' ' 18' ' ' LEU . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.837 HD12 HG23 ' A' ' 28' ' ' ILE . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.614 HD21 ' CE1' ' A' ' 17' ' ' PHE . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 28' ' ' ILE . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.44 HD22 ' HD2' ' A' ' 55' ' ' ARG . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.837 HG23 HD12 ' A' ' 18' ' ' LEU . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.551 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 30' ' ' MET . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 34' ' ' ILE . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.692 HG21 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HD2' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.532 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.843 HG22 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.843 ' SG ' HG22 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' CD2' ' HG3' ' A' ' 100' ' ' GLN . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.422 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.626 HG23 HG13 ' A' ' 119' ' ' ILE . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 117' ' ' THR . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 112' ' ' THR . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.626 HG13 HG23 ' A' ' 110' ' ' THR . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.436 HH11 ' HD3' ' A' ' 120' ' ' ARG . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 37' ' ' ILE . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.453 HG21 ' NH2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.816 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 113' ' ' PHE . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.624 HG23 HD12 ' A' ' 18' ' ' LEU . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.585 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 5' ' ' THR . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.522 ' HB ' ' CD ' ' A' ' 54' ' ' PRO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.522 ' CD ' ' HB ' ' A' ' 53' ' ' THR . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 89' ' ' LEU . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.603 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 17' ' ' PHE . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.816 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 28' ' ' ILE . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 28' ' ' ILE . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HA ' HD12 ' A' ' 28' ' ' ILE . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 18' ' ' LEU . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.63 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 45' ' ' ASP . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.63 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.78 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.454 HD11 HH11 ' A' ' 120' ' ' ARG . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.454 HH11 HD11 ' A' ' 111' ' ' ILE . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.56 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HD2' HD22 ' A' ' 118' ' ' LEU . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 21' ' ' LEU . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 18' ' ' LEU . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.408 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 30' ' ' MET . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.694 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.694 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.418 ' H ' ' HG2' ' A' ' 73' ' ' MET . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.603 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' CD1' ' A' ' 84' ' ' LEU . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 92' ' ' LYS . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.691 ' HB3' HG22 ' A' ' 82' ' ' VAL . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.535 ' H ' HG12 ' A' ' 90' ' ' VAL . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 17' ' ' PHE . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.669 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 105' ' ' ASN . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.464 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.665 ' HB ' HD11 ' A' ' 37' ' ' ILE . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.479 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 25' ' ' GLU . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 30' ' ' MET . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.665 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 89' ' ' LEU . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.5 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 76' ' ' LYS . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 119' ' ' ILE . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 110' ' ' THR . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.446 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.489 ' NH2' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 37' ' ' ILE . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.894 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.482 ' HD2' HD22 ' A' ' 118' ' ' LEU . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.522 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' THR . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.447 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 52' ' ' LYS . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.645 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.599 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.599 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.588 ' HB3' HG22 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 119' ' ' ILE . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.894 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 110' ' ' THR . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 37' ' ' ILE . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.456 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' CE2' HD11 ' A' ' 21' ' ' LEU . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 28' ' ' ILE . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.582 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.647 HG23 HD12 ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 30' ' ' MET . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 51' ' ' SER . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' CG2' ' H ' ' A' ' 76' ' ' LYS . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' H ' ' CG2' ' A' ' 72' ' ' THR . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.605 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 92' ' ' LYS . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.773 ' HB3' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' H ' HG12 ' A' ' 90' ' ' VAL . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 88' ' ' LYS . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.59 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 119' ' ' ILE . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 110' ' ' THR . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 37' ' ' ILE . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.64 HD12 HG23 ' A' ' 28' ' ' ILE . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.64 HG23 HD12 ' A' ' 18' ' ' LEU . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.536 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.472 HG21 ' SD ' ' A' ' 73' ' ' MET . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.59 ' CD1' HG11 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 76' ' ' LYS . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' HG21 ' A' ' 53' ' ' THR . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 72' ' ' THR . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 64' ' ' LEU . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 7.9 mm100 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.411 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.762 HG23 HG12 ' A' ' 119' ' ' ILE . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.762 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 28' ' ' ILE . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.428 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 18' ' ' LEU . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.511 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 30' ' ' MET . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 53' ' ' THR . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.406 HH12 ' HG3' ' A' ' 24' ' ' PRO . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.3 t30 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 91' ' ' CYS . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 14' ' ' TYR . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.434 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 37' ' ' ILE . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.919 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CE2' HD11 ' A' ' 21' ' ' LEU . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 HG23 ' A' ' 28' ' ' ILE . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 28' ' ' ILE . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 28' ' ' ILE . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 ' HG2' ' A' ' 19' ' ' LYS . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 30' ' ' MET . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.577 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 76' ' ' LYS . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.49 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB2' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.919 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.538 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.755 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 25' ' ' GLU . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.494 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 30' ' ' MET . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.525 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.7 HG21 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.59 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.7 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 110' ' ' THR . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 8' ' ' VAL . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.926 0 N-CA-C 110.197 -0.297 . . . . 10.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 23.5 m-85 -74.51 -26.66 60.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.934 0.346 . . . . 10.0 111.934 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.469 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -61.39 102.5 0.24 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 120.899 0.381 . . . . 10.0 111.1 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.4 -155.35 24.85 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 111.563 -0.615 . . . . 10.0 111.563 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.639 ' HB ' HD11 ' A' ' 37' ' ' ILE . 24.5 p -127.95 120.31 27.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.811 0.338 . . . . 10.0 110.268 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.424 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 6.8 m95 -115.76 125.21 52.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.068 0.461 . . . . 10.0 111.741 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -92.92 125.06 37.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 122' ' ' SER . 74.1 t -91.23 138.68 19.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -149.22 116.0 5.95 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.685 -0.487 . . . . 10.0 109.685 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.64 154.05 0.93 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.1 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -128.55 29.35 5.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.843 0.312 . . . . 10.0 111.843 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -97.49 139.46 33.38 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 25.82 47.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 O-C-N 125.413 1.696 . . . . 10.0 112.977 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.584 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.4 t80 -96.81 -58.99 1.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.074 -0.512 . . . . 10.0 110.741 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -58.45 -25.65 62.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.69 -0.686 . . . . 10.0 111.829 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -89.33 -30.26 18.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.611 -0.268 . . . . 10.0 111.461 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.441 ' O ' HD12 ' A' ' 21' ' ' LEU . 21.7 t80 -67.32 -36.64 81.88 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.125 -0.694 . . . . 10.0 109.125 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.67 HD12 HG23 ' A' ' 28' ' ' ILE . 39.8 mt -58.03 -33.14 68.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.521 -0.763 . . . . 10.0 110.345 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -71.05 -20.63 62.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.927 -0.579 . . . . 10.0 110.874 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.89 -24.23 33.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.853 0.358 . . . . 10.0 111.553 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mp -83.34 -0.49 49.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.203 -0.453 . . . . 10.0 109.897 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.49 33.97 3.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.164 -0.926 . . . . 10.0 110.182 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.12 162.35 54.72 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.5 -0.773 . . . . 10.0 110.271 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.479 ' O ' HG13 ' A' ' 28' ' ' ILE . 10.7 Cg_exo -68.52 129.21 18.52 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.806 2.337 . . . . 10.0 112.396 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.625 ' HA ' HD12 ' A' ' 28' ' ' ILE . 33.2 mp0 -54.53 -28.34 44.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 10.0 111.464 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.13 -56.71 8.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.452 -0.34 . . . . 10.0 110.334 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.476 ' HG ' ' N25' ' A' ' 202' ' ' CHO . 1.4 tp -59.28 -31.32 69.01 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.88 0.371 . . . . 10.0 110.885 -178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.67 HG23 HD12 ' A' ' 18' ' ' LEU . 98.5 mt -61.59 -22.46 28.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 115.715 -0.675 . . . . 10.0 111.411 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -83.22 -24.67 32.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.996 0.427 . . . . 10.0 110.735 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.588 ' O ' HG13 ' A' ' 34' ' ' ILE . 3.2 mpp? -91.99 -33.46 14.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.519 -0.309 . . . . 10.0 110.664 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB1' H183 ' A' ' 202' ' ' CHO . . . -60.95 -26.44 67.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 10.0 111.544 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -62.7 -19.98 64.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.406 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -109.59 -34.13 6.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.114 0.483 . . . . 10.0 110.021 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 30' ' ' MET . 3.4 mt -74.23 106.96 4.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.658 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -113.57 87.15 11.33 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.668 -0.697 . . . . 10.0 109.463 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.19 152.97 78.78 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.553 2.168 . . . . 10.0 112.446 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -90.41 141.29 14.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.681 -0.691 . . . . 10.0 110.16 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -95.35 104.38 15.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.668 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -88.07 119.78 28.78 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.562 -0.532 . . . . 10.0 109.562 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.46 129.83 64.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.38 0.609 . . . . 10.0 111.076 -179.134 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.442 ' CG ' ' HB ' ' A' ' 48' ' ' VAL . 10.9 pt20 -119.27 141.2 49.16 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.623 -0.88 . . . . 10.0 108.623 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 2.0 tt0 -126.02 150.9 47.75 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.191 0.52 . . . . 10.0 111.399 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -144.59 89.72 2.02 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.55 -99.51 1.48 Allowed Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 110.701 -0.96 . . . . 10.0 110.701 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.83 -6.74 11.02 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.578 -0.526 . . . . 10.0 109.578 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -91.6 128.63 37.51 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.941 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.516 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.6 m-85 -117.13 148.57 41.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 10.0 110.865 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 41' ' ' GLN . 93.2 t -134.38 104.47 5.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 108.789 -0.819 . . . . 10.0 108.789 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.575 HG11 ' H11' ' A' ' 201' ' ' GCH . 41.3 t -99.06 124.93 52.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.906 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.5 m -110.01 121.09 44.43 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.279 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -102.93 124.73 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.349 -0.387 . . . . 10.0 110.482 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.531 ' HA ' HG22 ' A' ' 57' ' ' THR . 2.8 mptm? -93.53 124.6 37.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.05 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.559 HG21 ' SD ' ' A' ' 73' ' ' MET . 2.3 p -140.84 150.14 58.68 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.214 -0.448 . . . . 10.0 110.557 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.833 ' HG2' H232 ' A' ' 202' ' ' CHO . 51.5 Cg_exo -61.09 -5.84 5.52 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.628 2.885 . . . . 10.0 113.803 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -110.13 -44.13 3.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -171.25 140.88 1.53 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.956 0.408 . . . . 10.0 110.767 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -90.56 113.3 25.27 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.322 -0.399 . . . . 10.0 110.254 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.3 m -97.42 156.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.545 -0.462 . . . . 10.0 110.973 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.4 m -129.65 130.33 45.43 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.78 -0.646 . . . . 10.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.699 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.2 m-80 -114.21 130.94 56.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.887 -0.783 . . . . 10.0 108.887 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.14 143.25 51.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.909 -0.316 . . . . 10.0 110.944 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 27.1 p90 -163.56 164.82 24.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 10.0 111.157 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.5 m -118.19 135.05 54.48 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.052 -0.522 . . . . 10.0 109.606 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' A' ' 84' ' ' LEU . 43.7 mt -56.87 119.37 6.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.084 0.469 . . . . 10.0 111.865 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.44 7.37 63.55 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.876 -0.678 . . . . 10.0 112.01 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.0 mtpp -132.1 140.02 48.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.143 0.497 . . . . 10.0 111.272 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -79.04 121.29 24.77 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.63 142.48 51.02 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.038 0.446 . . . . 10.0 111.892 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -77.0 129.27 35.89 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.225 -0.898 . . . . 10.0 109.609 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.699 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -131.12 169.62 21.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.895 -0.593 . . . . 10.0 109.811 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.2 m -127.32 133.11 50.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.702 0.63 . . . . 10.0 112.702 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.629 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 12.9 t -90.45 170.06 10.53 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.777 -0.647 . . . . 10.0 109.646 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.559 ' SD ' HG21 ' A' ' 53' ' ' THR . 4.1 tpp -64.99 -27.71 69.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.354 0.597 . . . . 10.0 111.187 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' HB2' ' H23' ' A' ' 201' ' ' GCH . 1.1 m-20 -73.89 -5.01 38.47 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.311 -0.859 . . . . 10.0 112.081 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 79.58 20.75 68.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.457 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -98.01 131.98 43.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.864 -0.421 . . . . 10.0 109.864 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -83.91 114.59 21.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.235 -0.439 . . . . 10.0 109.986 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' CD1' ' H25' ' A' ' 201' ' ' GCH . 20.0 mt -125.99 157.99 36.43 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.602 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -125.25 118.83 26.85 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.429 -0.582 . . . . 10.0 109.429 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 3.0 t -114.38 124.85 52.99 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 120.763 -0.375 . . . . 10.0 110.778 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 m -87.85 89.98 8.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.244 -0.65 . . . . 10.0 109.244 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.817 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -89.26 142.96 12.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.942 -178.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -158.35 144.5 17.15 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.472 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.636 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.8 tm? -86.07 140.37 30.31 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.321 -0.992 . . . . 10.0 108.321 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.636 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -152.87 111.59 3.75 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.056 -0.975 . . . . 10.0 110.888 -178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 59.81 32.0 21.08 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.924 -0.58 . . . . 10.0 111.68 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.34 5.02 87.58 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.719 -0.753 . . . . 10.0 112.574 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.443 ' O ' HD22 ' A' ' 84' ' ' LEU . 25.9 mmtp -115.64 137.24 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.129 -0.323 . . . . 10.0 110.129 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.5 tp -90.04 120.81 31.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.6 t -109.32 123.3 65.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.063 -0.517 . . . . 10.0 111.035 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.817 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -125.99 72.16 1.28 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 10.0 109.137 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 34.2 ttpt -93.44 142.68 27.06 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.867 -0.606 . . . . 10.0 111.08 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.1 m -108.44 -171.33 1.84 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.243 -0.889 . . . . 10.0 109.241 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -82.25 -19.36 39.78 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.921 0.391 . . . . 10.0 111.415 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -126.44 -20.08 4.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 10.0 111.689 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -129.49 -179.5 5.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.652 -0.249 . . . . 10.0 110.855 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 24.2 t -158.61 130.28 6.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 120.914 0.388 . . . . 10.0 111.07 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.829 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.2 t-160 -109.48 121.85 46.12 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -106.11 131.01 53.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.118 -0.492 . . . . 10.0 111.671 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 35.7 mt-30 -132.98 110.39 10.23 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.828 -0.434 . . . . 10.0 109.828 178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.426 ' OE1' ' HE3' ' A' ' 103' ' ' LYS . 20.7 tt0 -116.55 122.64 45.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.26 -0.427 . . . . 10.0 111.373 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 70.4 t -101.59 126.04 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.389 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' OE1' ' A' ' 101' ' ' GLU . 91.1 mttt -121.04 70.35 0.91 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.957 -0.565 . . . . 10.0 110.211 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.61 -105.68 2.95 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.768 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -101.98 6.26 41.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.736 0.303 . . . . 10.0 111.527 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -126.07 146.35 49.95 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.719 0.295 . . . . 10.0 111.193 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.1 ttp -130.59 114.69 15.76 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.027 0.442 . . . . 10.0 110.418 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.47 119.25 51.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 4.3 pt-20 -115.57 143.52 45.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.295 0.569 . . . . 10.0 110.972 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.454 HG23 HG12 ' A' ' 119' ' ' ILE . 1.1 m -129.09 107.44 9.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.402 -0.817 . . . . 10.0 109.627 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.2 mt -110.26 159.17 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.272 -0.422 . . . . 10.0 110.624 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.9 m -147.56 108.82 4.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.72 0.295 . . . . 10.0 110.271 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -142.11 145.24 34.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.992 -0.549 . . . . 10.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 62.65 23.31 64.98 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.494 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.8 12.91 83.69 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.993 -0.623 . . . . 10.0 113.002 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.35 126.75 75.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.834 0.349 . . . . 10.0 110.635 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.7 m -93.95 89.01 5.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.072 -0.513 . . . . 10.0 110.517 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.406 ' HG ' ' HG3' ' A' ' 120' ' ' ARG . 9.5 tp -79.11 111.4 15.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.449 0.642 . . . . 10.0 110.528 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.454 HG12 HG23 ' A' ' 110' ' ' THR . 2.6 mt -99.55 107.76 21.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.189 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 23.7 mtp180 -112.76 136.6 52.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.304 0.573 . . . . 10.0 111.56 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -110.75 125.33 53.41 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 109.154 -0.684 . . . . 10.0 109.154 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.5 ' HB2' HG22 ' A' ' 8' ' ' VAL . 32.5 t -121.08 150.97 40.4 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 121.647 0.737 . . . . 10.0 111.394 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.18 143.26 50.68 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.601 -1.181 . . . . 10.0 107.813 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -66.36 152.87 44.13 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.387 -0.525 . . . . 10.0 110.348 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.247 0.921 0 CA-C-O 118.23 -0.891 . . . . 10.0 110.923 179.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.829 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.833 H232 ' HG2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.51 0.195 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 23.0 m-85 -81.36 -26.51 35.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.407 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.83 108.26 0.98 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.159 -0.473 . . . . 10.0 110.916 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.34 -154.45 24.72 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.895 -0.669 . . . . 10.0 112.177 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -132.8 119.34 20.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.939 -0.393 . . . . 10.0 109.939 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.8 m95 -113.63 124.86 53.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.233 0.539 . . . . 10.0 112.04 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -90.63 112.84 24.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.623 -1.251 . . . . 10.0 107.623 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.8 p -85.55 140.96 15.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 113.06 0.763 . . . . 10.0 113.06 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -140.25 126.18 19.53 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.21 -0.905 . . . . 10.0 108.995 178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -169.18 168.58 9.79 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 122.098 -0.376 . . . . 10.0 111.622 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -155.75 39.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 10.0 110.541 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.487 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.1 mp0 -126.71 132.82 51.04 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 115.764 -0.653 . . . . 10.0 109.709 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.514 ' HB3' HG12 ' A' ' 116' ' ' VAL . 60.6 m-20 37.75 41.63 0.34 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.936 -1.484 . . . . 10.0 112.288 -177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -83.71 -64.43 1.17 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.175 -0.466 . . . . 10.0 111.049 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.2 pt-20 -61.48 -38.38 87.07 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.476 -0.783 . . . . 10.0 111.977 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.24 -26.75 65.85 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.703 0.287 . . . . 10.0 111.333 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -76.76 -30.8 56.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' H7 ' ' A' ' 202' ' ' CHO . 13.2 mt -64.91 -34.85 79.38 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 177.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -71.84 -21.65 61.65 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 115.656 -0.702 . . . . 10.0 110.485 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.65 -5.47 59.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.818 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 HD11 ' H61' ' A' ' 202' ' ' CHO . 16.0 mt -104.03 12.94 33.52 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.303 -0.408 . . . . 10.0 110.223 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 54.56 33.43 19.01 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.538 -0.756 . . . . 10.0 110.69 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.791 HD13 H151 ' A' ' 202' ' ' CHO . 92.9 mt -79.75 164.06 55.26 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.84 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.3 Cg_exo -72.56 128.41 13.48 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.348 2.032 . . . . 10.0 111.491 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.19 -36.99 64.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.826 -0.624 . . . . 10.0 111.506 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.1 -33.33 74.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.183 -0.462 . . . . 10.0 111.233 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.71 ' CD2' H222 ' A' ' 202' ' ' CHO . 1.6 tp -84.84 -33.84 22.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.25 -0.432 . . . . 10.0 110.91 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.554 HG23 HD12 ' A' ' 18' ' ' LEU . 98.0 mt -59.86 -34.46 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.379 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -71.59 -25.63 62.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.464 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.61 ' HB2' H261 ' A' ' 202' ' ' CHO . 11.1 mmt -90.3 -34.67 15.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.96 0.41 . . . . 10.0 110.108 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.609 ' HB1' H181 ' A' ' 202' ' ' CHO . . . -57.67 -26.64 61.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 10.0 111.152 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -54.42 -28.35 43.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.937 -0.574 . . . . 10.0 111.754 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -106.69 -4.6 19.31 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.817 0.341 . . . . 10.0 111.483 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 ' CD1' H262 ' A' ' 202' ' ' CHO . 4.8 mt -101.42 117.46 46.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.063 0.459 . . . . 10.0 111.739 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 mptt -128.22 84.44 63.24 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.611 -0.722 . . . . 10.0 109.524 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.5 162.44 39.02 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.959 2.439 . . . . 10.0 112.976 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.35 139.63 17.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.836 -0.62 . . . . 10.0 109.391 179.359 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.4 t -92.26 110.48 22.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.708 0.29 . . . . 10.0 110.921 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -91.31 132.65 36.02 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.198 -0.455 . . . . 10.0 110.498 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.605 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -143.81 131.02 17.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.509 0.671 . . . . 10.0 110.902 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.7 140.83 52.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.609 -0.723 . . . . 10.0 109.22 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.09 159.06 25.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.478 0.656 . . . . 10.0 112.354 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 29.7 ttpt -150.91 73.25 1.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.635 -1.166 . . . . 10.0 107.936 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.39 -126.08 7.82 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.158 -0.777 . . . . 10.0 111.158 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -86.06 -10.5 54.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.545 -0.539 . . . . 10.0 109.545 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -94.27 135.17 35.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.57 -0.741 . . . . 10.0 110.741 -179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.605 ' HD2' HD11 ' A' ' 40' ' ' ILE . 21.3 m-85 -127.82 146.96 50.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.407 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.93 103.74 11.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.104 -0.702 . . . . 10.0 109.104 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.873 HG21 ' H11' ' A' ' 201' ' ' GCH . 6.4 t -98.18 136.56 28.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.315 -0.857 . . . . 10.0 110.166 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.8 m -121.83 119.33 31.32 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.366 0.603 . . . . 10.0 111.72 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.6 m -102.07 107.66 18.84 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 10.0 108.726 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HA ' HG22 ' A' ' 57' ' ' THR . 31.0 mtpt -90.48 124.29 34.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.573 -0.74 . . . . 10.0 110.744 -178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 11.4 p -130.69 156.41 79.86 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 10.0 110.18 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.808 ' HG2' H232 ' A' ' 202' ' ' CHO . 2.9 Cg_exo -77.32 37.46 0.6 Allowed 'Trans proline' 0 CA--C 1.528 0.19 0 C-N-CA 123.36 2.707 . . . . 10.0 112.171 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -159.51 -50.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 10.0 111.403 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -148.27 109.66 4.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.572 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 52' ' ' LYS . 23.5 p -82.16 115.84 21.45 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.343 -0.614 . . . . 10.0 109.343 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.3 m -111.63 137.44 44.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 120.385 -0.526 . . . . 10.0 112.108 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.456 ' C ' HD22 ' A' ' 60' ' ' ASN . 1.5 t -110.89 136.06 50.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.359 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -125.31 128.12 47.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 -179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.25 148.57 44.83 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.704 -0.398 . . . . 10.0 110.387 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.419 ' CD2' HG11 ' A' ' 82' ' ' VAL . 42.5 p90 -159.65 161.86 35.05 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 120.565 -0.454 . . . . 10.0 111.931 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.8 m -120.21 124.37 45.54 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.937 -0.764 . . . . 10.0 108.937 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -54.07 117.13 2.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.416 0.524 . . . . 10.0 112.416 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.86 -8.2 61.25 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.574 -0.739 . . . . 10.0 113.336 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -120.61 157.28 29.88 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.858 0.329 . . . . 10.0 110.764 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -80.97 119.09 23.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 10.0 109.727 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.46 127.98 54.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.175 0.512 . . . . 10.0 111.562 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -76.82 121.76 23.83 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -127.75 162.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 116.336 -0.393 . . . . 10.0 110.619 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.3 m -122.61 128.53 50.8 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.963 -0.695 . . . . 10.0 111.801 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.501 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 5.0 t -84.95 163.53 18.88 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.563 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.415 ' SD ' ' H9 ' ' A' ' 202' ' ' CHO . 19.6 ptp -76.73 -2.92 35.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.28 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -14.32 35.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.32 0.581 . . . . 10.0 109.833 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 41.16 5.27 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.725 -0.671 . . . . 10.0 114.061 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.46 150.13 49.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.141 -0.318 . . . . 10.0 110.141 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -96.68 107.45 19.9 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 10.0 110.494 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.478 HD11 ' H23' ' A' ' 201' ' ' GCH . 28.9 mt -121.47 164.43 17.18 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.51 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -140.95 125.11 17.34 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.767 -0.373 . . . . 10.0 110.064 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.1 t -108.11 146.89 31.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.411 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.8 t -112.69 33.78 4.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.543 0.687 . . . . 10.0 109.81 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.647 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 0.4 OUTLIER -41.89 135.78 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.441 -1.254 . . . . 10.0 112.978 -179.562 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -145.77 159.08 43.7 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.172 -0.922 . . . . 10.0 110.24 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -84.92 138.57 32.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.731 -0.841 . . . . 10.0 108.731 178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.587 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -157.8 116.72 3.2 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.955 -1.02 . . . . 10.0 110.153 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 62.24 30.36 17.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.55 -0.75 . . . . 10.0 111.347 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.17 10.72 86.0 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.846 -0.692 . . . . 10.0 112.885 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 142.24 51.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.544 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.0 OUTLIER -86.21 124.96 33.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.123 0.487 . . . . 10.0 110.142 -179.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 30.1 t -108.92 107.51 23.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.692 -0.685 . . . . 10.0 111.545 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.804 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 48.6 t -109.49 80.78 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.09 -0.707 . . . . 10.0 109.09 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 97' ' ' SER . 21.8 ttpp -97.64 143.25 28.5 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.183 0.516 . . . . 10.0 110.778 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -159.1 0.69 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.444 -0.798 . . . . 10.0 110.351 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.63 -39.33 20.41 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.995 0.426 . . . . 10.0 110.506 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -119.36 -8.76 10.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.906 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 112' ' ' THR . 8.6 m-85 -130.28 -176.45 3.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.662 -0.415 . . . . 10.0 111.467 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 92' ' ' LYS . 16.4 t -158.98 131.97 7.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.034 -0.53 . . . . 10.0 110.763 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.726 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -112.34 111.15 21.81 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.691 -0.855 . . . . 10.0 108.691 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.83 131.98 44.53 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 10.0 110.033 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -139.77 116.5 10.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.85 -0.426 . . . . 10.0 109.85 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -124.7 135.55 53.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.891 0.377 . . . . 10.0 111.85 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.6 t -105.26 116.37 48.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.119 -0.491 . . . . 10.0 109.793 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -118.66 98.54 6.28 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.006 -0.543 . . . . 10.0 109.884 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.37 -99.57 0.59 Allowed Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 116.029 -0.532 . . . . 10.0 112.832 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -119.05 12.65 12.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.361 0.6 . . . . 10.0 110.49 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -128.11 131.02 49.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.231 -0.441 . . . . 10.0 110.736 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -110.52 118.65 36.82 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 178.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.7 119.59 59.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.188 -0.46 . . . . 10.0 109.98 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -123.32 146.18 48.13 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.697 0.761 . . . . 10.0 111.528 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 m -131.1 109.46 10.48 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.604 -0.726 . . . . 10.0 109.17 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -107.21 163.9 5.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.904 -0.589 . . . . 10.0 110.442 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 96' ' ' PHE . 25.8 m -154.78 110.71 3.17 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.07 -0.345 . . . . 10.0 110.07 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -147.72 147.87 30.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.858 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.02 18.7 64.95 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 121.339 -0.458 . . . . 10.0 112.389 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.34 12.85 72.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.781 -0.723 . . . . 10.0 112.546 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.514 HG12 ' HB3' ' A' ' 13' ' ' ASN . 2.4 t -126.0 131.44 71.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.985 0.421 . . . . 10.0 111.151 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 58.5 m -95.89 89.75 5.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.9 tp -77.11 109.52 11.02 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.328 0.585 . . . . 10.0 110.096 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.9 mt -92.8 116.24 33.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.474 -0.784 . . . . 10.0 109.96 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -122.17 148.6 44.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.325 0.583 . . . . 10.0 111.243 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.487 HH22 ' CD ' ' A' ' 12' ' ' GLU . 3.5 mtm180 -131.31 125.98 34.16 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.872 -0.788 . . . . 10.0 108.872 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.0 OUTLIER -119.31 143.34 47.42 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.367 0.604 . . . . 10.0 111.732 -178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -113.71 141.03 47.75 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.195 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ttp180 -73.91 145.16 44.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.792 -0.448 . . . . 10.0 109.792 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.9 t . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.896 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.873 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.808 H232 ' HG2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 120.651 0.263 . . . . 10.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 19.3 m-85 -77.98 -32.6 51.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.723 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.51 121.81 11.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.807 0.337 . . . . 10.0 110.854 179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.27 -151.41 22.87 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.334 -0.706 . . . . 10.0 111.334 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.528 ' HB ' HD11 ' A' ' 37' ' ' ILE . 6.6 p -132.46 118.96 19.98 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.921 0.391 . . . . 10.0 110.785 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -116.28 124.85 51.19 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.852 -0.613 . . . . 10.0 111.054 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -97.73 110.64 23.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.822 -0.626 . . . . 10.0 109.802 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 8' ' ' VAL . 3.5 m -76.58 140.24 17.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 10.0 112.107 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.03 114.24 4.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 10.0 109.501 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -170.39 164.6 8.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.961 -0.563 . . . . 10.0 109.804 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -140.12 37.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.575 0.226 . . . . 10.0 111.42 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 119' ' ' ILE . 21.9 mm-40 -108.05 122.26 46.51 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 121.245 0.545 . . . . 10.0 110.615 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 39.67 43.74 1.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.487 -1.688 . . . . 10.0 111.56 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.625 ' HA ' HD13 ' A' ' 118' ' ' LEU . 42.5 t80 -79.78 -64.62 1.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.162 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 1.3 pt-20 -59.56 -37.36 78.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.622 -0.717 . . . . 10.0 111.677 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' N ' ' HG3' ' A' ' 15' ' ' GLU . 26.7 tt0 -67.98 -35.06 77.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.085 -0.507 . . . . 10.0 111.231 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 27.3 t80 -69.69 -35.45 75.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.168 -0.469 . . . . 10.0 110.268 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.499 HD22 H182 ' A' ' 202' ' ' CHO . 15.4 mt -59.87 -35.49 74.91 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 10.0 109.954 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 15' ' ' GLU . 67.8 mttt -70.9 -26.6 63.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.707 . . . . 10.0 110.268 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.32 -11.93 59.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.6 . . . . 10.0 110.551 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.744 HD13 ' H62' ' A' ' 202' ' ' CHO . 21.3 mt -100.31 6.71 44.62 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.54 -0.754 . . . . 10.0 109.409 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.27 30.46 17.54 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 114.956 -1.02 . . . . 10.0 110.663 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 75.5 mt -77.29 158.91 78.81 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.47 -0.787 . . . . 10.0 109.979 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' O ' HG13 ' A' ' 28' ' ' ILE . 31.8 Cg_endo -65.55 122.49 10.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.665 2.243 . . . . 10.0 112.241 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.8 mp0 -53.92 -36.81 63.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.785 -0.643 . . . . 10.0 110.889 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -60.41 -40.21 90.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.476 -0.784 . . . . 10.0 110.826 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.487 HD21 H162 ' A' ' 202' ' ' CHO . 0.7 OUTLIER -75.0 -37.77 61.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.574 -0.285 . . . . 10.0 110.376 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 25' ' ' GLU . 91.7 mt -54.68 -32.43 25.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -68.62 -37.76 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 10.0 112.115 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.441 ' CE ' ' HA ' ' A' ' 27' ' ' LEU . 7.9 ptt? -91.6 -31.71 15.79 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.54 -0.464 . . . . 10.0 111.223 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' HB2' H231 ' A' ' 202' ' ' CHO . . . -60.83 -26.9 67.68 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.805 -0.634 . . . . 10.0 111.671 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 32' ' ' ARG . 10.6 ptm180 -62.14 -17.3 57.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.34 -0.391 . . . . 10.0 111.664 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -115.07 -1.23 13.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.27 0.557 . . . . 10.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.717 HD12 ' C24' ' A' ' 202' ' ' CHO . 1.8 mt -105.12 112.06 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 CA-C-O 121.224 0.535 . . . . 10.0 110.439 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.68 86.64 35.55 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 115.597 -0.729 . . . . 10.0 110.393 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.48 162.23 42.76 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.729 2.286 . . . . 10.0 111.834 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.54 139.73 17.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.028 0.442 . . . . 10.0 110.126 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.5 t -95.55 111.95 26.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.583 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.77 129.14 35.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.466 . . . . 10.0 109.934 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.443 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -129.01 130.35 68.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.378 0.609 . . . . 10.0 111.129 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -115.52 119.28 35.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.031 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 1.7 tt0 -108.78 145.43 35.2 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.942 0.401 . . . . 10.0 110.489 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -147.17 96.37 2.71 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.949 -0.76 . . . . 10.0 108.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.95 -97.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.524 -1.03 . . . . 10.0 110.524 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -120.76 -10.78 9.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.642 0.258 . . . . 10.0 110.578 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -93.15 133.64 36.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.045 0.45 . . . . 10.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.469 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.9 m-85 -119.98 147.93 44.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.769 -0.651 . . . . 10.0 111.04 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.4 t -129.91 100.64 5.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.181 -0.918 . . . . 10.0 108.76 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' H11' ' A' ' 201' ' ' GCH . 47.8 t -93.09 131.66 39.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.387 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -111.36 111.5 22.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.949 -0.569 . . . . 10.0 110.879 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.5 m -97.74 103.88 15.86 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.234 -0.439 . . . . 10.0 109.912 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -89.7 126.56 35.7 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.195 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 7.4 p -136.22 166.3 29.02 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HG3' ' C24' ' A' ' 202' ' ' CHO . 52.4 Cg_endo -64.56 -33.86 54.73 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 123.027 2.485 . . . . 10.0 112.236 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 52.7 mtp85 -77.19 -60.66 2.27 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.354 -0.839 . . . . 10.0 111.523 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -163.3 138.17 6.36 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.755 0.312 . . . . 10.0 110.751 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 59.0 m -84.05 121.38 27.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.278 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.14 143.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.993 -0.549 . . . . 10.0 111.353 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 140.64 37.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.747 -0.661 . . . . 10.0 111.146 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.856 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -129.94 121.96 27.62 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.28 147.25 45.91 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 120.853 -0.339 . . . . 10.0 110.788 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CD1' HG11 ' A' ' 82' ' ' VAL . 26.4 p90 -162.56 166.45 24.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.064 -0.254 . . . . 10.0 110.819 -179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 m -123.03 130.95 53.45 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.467 -0.333 . . . . 10.0 110.289 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' A' ' 84' ' ' LEU . 41.2 mt -61.25 118.17 6.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.813 0.339 . . . . 10.0 111.367 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 99.44 2.62 56.58 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.691 -0.686 . . . . 10.0 111.61 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -133.94 164.85 26.36 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.195 0.521 . . . . 10.0 111.201 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' CD ' ' HD2' ' A' ' 79' ' ' LYS . 23.7 tt0 -98.43 127.98 44.6 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.076 -0.966 . . . . 10.0 108.448 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 147.6 50.24 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.96 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.09 116.83 23.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.121 -0.945 . . . . 10.0 109.454 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.657 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.3 pp -124.09 161.99 26.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.886 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -117.75 144.57 45.18 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.732 -0.387 . . . . 10.0 111.797 -178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.544 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 10.2 t -101.34 166.21 10.87 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.532 -0.304 . . . . 10.0 110.248 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 12.4 tpp -64.13 -21.29 66.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 10.0 111.388 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.91 -29.14 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.065 -0.516 . . . . 10.0 111.472 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.9 14.88 12.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.584 -0.817 . . . . 10.0 112.949 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -104.59 152.95 21.81 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -99.97 127.04 46.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 10.0 110.564 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.26 153.07 49.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.988 -0.551 . . . . 10.0 109.554 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 19.1 pttt -118.12 115.38 24.7 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 4.5 t -106.44 128.79 54.33 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.209 -0.451 . . . . 10.0 111.312 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -99.66 95.19 6.79 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.896 -0.779 . . . . 10.0 108.896 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.837 ' HB ' ' SG ' ' A' ' 91' ' ' CYS . 14.1 p -106.09 148.48 10.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.845 -177.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -154.29 153.69 32.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.725 -0.67 . . . . 10.0 109.616 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' A' ' 64' ' ' LEU . 3.5 tm? -83.0 138.16 33.86 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.552 -0.907 . . . . 10.0 108.552 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.507 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -150.55 107.52 3.56 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.137 -0.938 . . . . 10.0 111.012 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 61.37 26.35 16.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.918 -0.583 . . . . 10.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 90.88 8.16 65.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.42 -0.895 . . . . 10.0 112.486 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 mptt -119.77 149.42 42.07 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.528 -0.545 . . . . 10.0 109.528 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -98.66 120.75 39.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.329 0.585 . . . . 10.0 110.302 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 21.9 t -106.14 96.57 4.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.384 -0.825 . . . . 10.0 111.934 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.837 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -105.56 101.06 10.6 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -117.21 144.77 44.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.255 0.55 . . . . 10.0 111.651 -178.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -105.14 -163.47 0.96 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.237 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -85.18 -32.16 22.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.863 0.363 . . . . 10.0 110.958 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -122.27 -12.76 8.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.205 -0.452 . . . . 10.0 111.634 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -130.02 171.51 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.802 -0.359 . . . . 10.0 110.291 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -151.4 133.22 14.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.75 0.309 . . . . 10.0 110.51 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.929 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.7 t-160 -105.02 117.11 33.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.993 -0.743 . . . . 10.0 108.993 179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 18.4 tt0 -96.3 127.32 42.2 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.204 -179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 24.9 mt-30 -135.73 110.52 8.71 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.351 0.407 . . . . 10.0 110.588 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -119.09 116.08 25.63 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.226 -0.443 . . . . 10.0 111.184 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.2 122.09 48.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-O 121.001 0.429 . . . . 10.0 110.501 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -128.9 102.0 6.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.694 -0.685 . . . . 10.0 109.904 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.77 -107.64 2.16 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 116.096 -0.502 . . . . 10.0 112.508 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -114.78 20.52 15.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.036 0.446 . . . . 10.0 110.643 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -132.21 146.97 52.38 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.046 -0.524 . . . . 10.0 110.703 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.419 ' HB3' ' HB3' ' A' ' 122' ' ' SER . 32.1 ttp -125.36 120.35 30.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.163 0.506 . . . . 10.0 110.185 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.477 HG13 ' CZ ' ' A' ' 121' ' ' ARG . 88.0 t -101.43 110.97 29.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.551 -0.749 . . . . 10.0 109.373 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 5.2 pt-20 -125.72 137.1 53.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.745 0.783 . . . . 10.0 111.434 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.409 HG23 HG12 ' A' ' 119' ' ' ILE . 1.0 OUTLIER -131.32 120.56 23.32 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.275 -0.875 . . . . 10.0 109.348 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.71 166.91 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.88 0.371 . . . . 10.0 111.154 -178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.6 m -152.01 110.29 3.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.04 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.64 144.42 31.89 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.679 -0.489 . . . . 10.0 109.679 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.03 20.26 66.69 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.26 11.57 82.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 121.265 -0.493 . . . . 10.0 112.641 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.9 131.36 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 117.061 0.43 . . . . 10.0 110.747 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.1 m -95.43 91.16 6.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.334 -0.394 . . . . 10.0 111.204 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.625 HD13 ' HA ' ' A' ' 14' ' ' TYR . 14.2 tp -79.61 115.38 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.091 0.472 . . . . 10.0 109.916 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 12' ' ' GLU . 2.3 mt -95.66 116.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.928 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 ' NH1' ' H22' ' A' ' 202' ' ' CHO . 18.9 mtm180 -119.11 133.98 55.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.114 0.483 . . . . 10.0 110.652 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.477 ' CZ ' HG13 ' A' ' 108' ' ' VAL . 2.0 mmp_? -114.41 136.3 53.15 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.775 -1.194 . . . . 10.0 107.775 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 107' ' ' MET . 1.0 OUTLIER -125.95 144.96 50.48 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.017 -0.673 . . . . 10.0 112.024 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -123.28 140.1 53.37 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.965 -1.016 . . . . 10.0 109.068 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -80.67 151.55 28.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.834 0.349 . . . . 10.0 110.277 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.429 -0.796 . . . . 10.0 109.971 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.929 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.75 H212 H121 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.5 -27.1 62.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.757 -0.202 . . . . 10.0 110.662 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.522 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 3.4 t -57.24 120.99 9.06 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 123.371 0.419 . . . . 10.0 110.359 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 159.91 -149.1 18.45 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 111.208 -0.757 . . . . 10.0 111.208 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.615 ' HB ' HD11 ' A' ' 37' ' ' ILE . 4.2 p -138.16 117.95 13.2 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -116.24 128.33 55.5 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.184 0.516 . . . . 10.0 111.482 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -91.54 104.29 16.8 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.62 -0.881 . . . . 10.0 108.62 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.5 p -78.06 145.36 9.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.359 -0.837 . . . . 10.0 112.624 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -153.47 135.29 14.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.472 -0.785 . . . . 10.0 109.241 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 177.49 159.06 0.41 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.818 0.342 . . . . 10.0 110.957 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -141.59 40.88 1.72 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.103 -0.499 . . . . 10.0 110.763 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -122.71 142.0 51.17 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 116.187 -0.46 . . . . 10.0 110.598 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.607 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 51.2 m-20 26.63 53.56 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 O-C-N 125.635 1.834 . . . . 10.0 112.921 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.598 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 34.0 t80 -100.97 -62.81 1.2 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.474 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -64.74 -31.03 72.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.073 -0.512 . . . . 10.0 110.815 -179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -75.26 -28.38 59.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.026 -0.534 . . . . 10.0 110.583 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.785 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.6 OUTLIER -76.17 -32.54 59.09 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD21 H191 ' A' ' 202' ' ' CHO . 40.3 mt -61.13 -42.4 98.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.98 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttt -69.81 -15.63 63.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.729 -0.669 . . . . 10.0 110.153 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -87.41 4.42 43.24 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.211 0.529 . . . . 10.0 111.532 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.628 ' CD1' ' H61' ' A' ' 202' ' ' CHO . 8.7 mt -124.84 16.96 8.66 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.714 -0.675 . . . . 10.0 109.793 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 55.63 35.92 26.19 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.023 -0.99 . . . . 10.0 110.781 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.48 HD11 ' H7 ' ' A' ' 202' ' ' CHO . 88.5 mt -78.32 163.31 62.64 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.662 -0.699 . . . . 10.0 111.083 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.493 ' O ' HG12 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -66.89 117.94 5.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.54 2.16 . . . . 10.0 112.473 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 54.3 mm-40 -46.96 -30.43 2.57 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.441 0.696 . . . . 10.0 112.303 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -72.47 -44.91 61.65 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 110.336 -0.246 . . . . 10.0 110.336 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.543 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -64.9 -28.12 69.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.81 -178.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG23 HD12 ' A' ' 18' ' ' LEU . 7.0 mm -60.58 -26.08 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.96 -0.564 . . . . 10.0 110.177 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -76.97 -34.5 57.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.505 -0.77 . . . . 10.0 110.653 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.626 ' O ' HG13 ' A' ' 34' ' ' ILE . 2.1 mpp? -85.23 -52.98 5.53 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.934 -0.576 . . . . 10.0 110.537 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.13 -34.42 30.82 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.863 0.69 . . . . 10.0 112.863 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -60.31 -15.28 23.92 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.503 0.557 . . . . 10.0 112.503 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -122.91 1.09 9.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.162 0.506 . . . . 10.0 111.121 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 ' O ' ' A' ' 30' ' ' MET . 56.7 mt -92.85 100.87 11.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.114 0.483 . . . . 10.0 110.669 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -122.91 83.81 50.18 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.456 -0.793 . . . . 10.0 109.952 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -83.4 -171.04 1.0 Allowed 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.167 1.911 . . . . 10.0 111.595 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.615 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -97.2 143.46 12.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 109.75 -0.463 . . . . 10.0 109.75 178.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.53 111.19 27.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 120.674 0.273 . . . . 10.0 110.345 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -91.04 129.9 37.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.163 -0.471 . . . . 10.0 109.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.89 123.02 12.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.54 0.686 . . . . 10.0 110.295 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -125.23 131.67 53.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.044 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.522 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 10.2 pt20 -116.28 170.41 8.55 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.361 0.6 . . . . 10.0 110.533 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -150.74 76.16 1.24 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.74 -93.05 1.84 Allowed Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.874 -0.89 . . . . 10.0 110.874 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.39 -19.86 11.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 10.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -82.81 129.84 35.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.871 -0.604 . . . . 10.0 111.058 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -117.53 149.46 40.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.917 -0.583 . . . . 10.0 110.572 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.2 t -135.81 104.2 4.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.843 -0.799 . . . . 10.0 108.843 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.869 HG21 ' H11' ' A' ' 201' ' ' GCH . 3.8 t -95.77 135.08 30.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.721 -0.672 . . . . 10.0 110.71 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 89.5 m -122.03 112.48 18.31 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 10.0 110.588 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -97.53 123.21 41.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 10.0 110.018 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.692 ' HA ' HG22 ' A' ' 57' ' ' THR . 13.1 mtpp -87.15 127.48 35.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 10.0 111.036 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.7 p -133.51 158.15 76.3 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 10.0 110.658 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.989 ' HD2' H232 ' A' ' 202' ' ' CHO . 51.2 Cg_exo -59.7 -6.67 4.75 Favored 'Trans proline' 0 N--CA 1.476 0.496 0 C-N-CA 123.431 2.754 . . . . 10.0 113.313 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.613 ' HG3' H262 ' A' ' 202' ' ' CHO . 5.1 mtt180 -108.81 -65.96 1.09 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.709 0.29 . . . . 10.0 110.577 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -160.6 147.29 15.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.242 -0.435 . . . . 10.0 110.191 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.692 HG22 ' HA ' ' A' ' 52' ' ' LYS . 1.5 p -73.73 128.77 36.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.404 -0.362 . . . . 10.0 110.879 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.45 143.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.82 -0.437 . . . . 10.0 109.82 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 m -111.62 128.31 56.01 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.134 -0.485 . . . . 10.0 111.67 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.574 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 51.8 m-80 -123.1 122.67 39.04 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.12 146.15 47.98 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.745 -0.382 . . . . 10.0 111.361 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.403 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 26.8 p90 -156.47 173.58 16.7 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.42 -0.354 . . . . 10.0 110.66 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -127.29 133.33 50.17 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.261 -0.644 . . . . 10.0 109.261 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.2 mt -56.29 109.51 0.61 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.055 0.455 . . . . 10.0 112.123 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.24 -4.27 60.38 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.473 -0.785 . . . . 10.0 113.785 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -122.97 159.91 27.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.546 0.673 . . . . 10.0 111.727 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -80.01 139.26 37.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.517 -0.765 . . . . 10.0 110.033 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . . . -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.913 0.387 . . . . 10.0 110.942 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -83.86 103.68 13.33 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.888 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.5 pp -107.24 168.84 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.934 -0.576 . . . . 10.0 109.709 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.7 m -139.59 129.17 24.41 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.1 -0.64 . . . . 10.0 111.661 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.656 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 11.2 t -78.05 161.51 27.4 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.28 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.984 ' SD ' ' H17' ' A' ' 202' ' ' CHO . 14.9 ptp -69.67 -12.39 61.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.442 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -80.11 -16.85 54.09 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.327 0.584 . . . . 10.0 110.771 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.32 11.6 47.97 Favored Glycine 0 C--N 1.329 0.149 0 C-N-CA 120.672 -0.775 . . . . 10.0 112.774 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -93.77 137.97 32.45 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 10.0 109.403 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 4.0 mptt -90.01 124.93 35.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.166 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.411 HD11 ' H25' ' A' ' 201' ' ' GCH . 7.8 mt -136.79 149.93 48.05 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.766 -0.652 . . . . 10.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.79 113.45 14.12 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.262 -0.644 . . . . 10.0 109.262 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 43.9 t -115.4 139.85 49.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.089 0.471 . . . . 10.0 111.812 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 m -99.2 78.41 2.23 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 t -70.37 137.23 24.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.38 -0.827 . . . . 10.0 111.349 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -145.74 148.05 32.58 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.871 -0.604 . . . . 10.0 110.715 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.7 tp -94.19 108.68 20.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.063 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -114.48 115.73 27.72 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.352 -0.385 . . . . 10.0 111.127 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 59.39 33.7 22.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.822 -0.626 . . . . 10.0 111.293 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.59 7.94 86.78 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 121.136 -0.554 . . . . 10.0 112.171 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 19.8 ttmt -116.4 128.26 55.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.712 0.292 . . . . 10.0 110.851 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 89' ' ' LEU . 8.8 tp -82.47 121.48 26.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.67 -0.493 . . . . 10.0 109.67 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.2 t -116.34 134.85 58.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.827 -0.624 . . . . 10.0 111.884 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.765 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 41.5 t -132.99 72.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 26.3 ttpp -96.36 140.55 30.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.851 -0.613 . . . . 10.0 111.272 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.02 -171.3 1.84 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.17 -0.923 . . . . 10.0 109.16 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -22.55 42.35 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.02 0.438 . . . . 10.0 110.31 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -116.1 -35.7 4.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.977 -0.556 . . . . 10.0 111.722 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -112.58 175.31 5.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.499 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -153.93 102.94 2.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.295 -0.411 . . . . 10.0 111.411 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.724 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -92.03 125.85 36.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.332 -0.988 . . . . 10.0 108.332 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.55 132.63 45.67 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.255 -0.578 . . . . 10.0 112.445 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.536 ' CD ' ' H2 ' ' A' ' 201' ' ' GCH . 35.8 mt-30 -120.28 143.89 48.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.354 -0.61 . . . . 10.0 109.354 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 107' ' ' MET . 70.1 tt0 -139.04 131.13 28.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.909 0.385 . . . . 10.0 111.624 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 44.8 t -101.85 117.13 46.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.034 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -114.25 84.97 2.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 10.0 109.938 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.86 -92.18 0.81 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.91 -0.662 . . . . 10.0 112.262 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -118.07 2.39 12.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.18 0.514 . . . . 10.0 110.433 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -112.51 151.95 29.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.845 -0.616 . . . . 10.0 110.581 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 9.4 tmm? -135.02 101.41 4.87 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.375 -0.602 . . . . 10.0 109.375 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.2 p -103.86 122.53 56.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.008 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -121.88 150.26 42.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.648 0.737 . . . . 10.0 111.039 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -127.65 121.66 31.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.116 -0.947 . . . . 10.0 110.264 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.423 HD11 ' NH1' ' A' ' 120' ' ' ARG . 1.2 mt -118.09 164.12 14.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.787 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 19.4 m -152.48 107.74 3.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.577 0.227 . . . . 10.0 111.549 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.669 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 40.0 m-85 -142.48 148.86 38.39 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.1 -1.074 . . . . 10.0 108.1 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.57 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.59 12.11 55.4 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.431 -0.89 . . . . 10.0 112.569 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.86 11.83 72.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.323 -0.465 . . . . 10.0 112.528 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 16.1 t -116.27 136.52 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 O-C-N 122.526 -0.397 . . . . 10.0 110.474 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 19.5 m -101.85 91.62 4.46 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.128 0.49 . . . . 10.0 110.713 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.785 ' HB2' ' CD2' ' A' ' 17' ' ' PHE . 1.1 tp -73.43 108.15 6.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.231 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.8 mt -101.71 108.85 24.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.516 -0.766 . . . . 10.0 110.615 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 120' ' ' ARG . 13.2 mtp-105 -120.28 151.39 39.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 10.0 111.039 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -126.45 138.46 53.53 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.758 -0.83 . . . . 10.0 108.758 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -128.79 142.81 50.87 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 120.292 -0.563 . . . . 10.0 111.62 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 mmtt -115.21 132.1 56.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.422 -0.808 . . . . 10.0 109.323 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -65.21 153.19 41.69 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.002 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.25 1.123 0 O-C-N 124.342 1.026 . . . . 10.0 111.57 178.73 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.888 ' H34' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.989 H232 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.136 -0.32 . . . . 10.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 13.2 m-85 -78.05 -31.41 50.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.494 -0.321 . . . . 10.0 110.747 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.23 104.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.719 0.637 . . . . 10.0 110.501 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.83 -155.31 26.37 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.08 -0.581 . . . . 10.0 112.294 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.426 ' HB ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -131.17 119.77 22.35 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.875 0.369 . . . . 10.0 110.119 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.446 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.9 m95 -116.96 127.43 54.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.405 0.621 . . . . 10.0 112.297 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -94.47 130.15 40.95 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.025 -0.988 . . . . 10.0 108.652 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.4 t -95.37 145.47 8.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 113.877 1.065 . . . . 10.0 113.877 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.42 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 34.3 p90 -150.42 124.4 9.31 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 114.928 -1.033 . . . . 10.0 108.835 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' NH1' ' A' ' 120' ' ' ARG . . . 177.12 133.53 0.06 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.043 0.449 . . . . 10.0 111.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -112.38 59.67 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.259 0.552 . . . . 10.0 110.3 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 14' ' ' TYR . 3.0 tp10 -100.46 -145.11 0.34 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.731 0.777 . . . . 10.0 109.878 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.955 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.1 p30 -73.07 31.35 0.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.08 -1.418 . . . . 10.0 111.794 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.476 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 71.1 t80 -59.55 -63.47 1.29 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.719 0.295 . . . . 10.0 111.678 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -62.19 -24.6 67.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.308 -0.406 . . . . 10.0 111.776 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -79.24 -35.84 40.92 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.934 0.397 . . . . 10.0 110.977 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.558 ' CD2' H192 ' A' ' 202' ' ' CHO . 14.5 t80 -70.54 -33.99 71.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.953 -0.567 . . . . 10.0 109.764 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 12.1 mt -60.93 -35.84 77.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.972 -0.558 . . . . 10.0 110.304 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.477 ' HG2' HD13 ' A' ' 28' ' ' ILE . 12.8 mttt -69.4 -31.29 69.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.224 -0.443 . . . . 10.0 110.048 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.76 -28.59 63.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.255 0.55 . . . . 10.0 110.116 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.502 ' CD1' ' H62' ' A' ' 202' ' ' CHO . 32.3 mt -82.59 5.15 21.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.6 -0.727 . . . . 10.0 109.933 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.79 33.34 20.1 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.673 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.0 mt -81.11 157.87 70.52 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.73 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 28' ' ' ILE . 9.6 Cg_endo -63.84 125.63 15.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.006 1.804 . . . . 10.0 112.952 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.2 mt-10 -55.28 -35.23 64.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.597 -0.729 . . . . 10.0 111.188 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.28 -40.06 95.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.908 -0.587 . . . . 10.0 110.413 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.931 HD21 H232 ' A' ' 202' ' ' CHO . 1.4 tp -74.35 -35.26 63.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.255 -0.43 . . . . 10.0 110.608 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 25' ' ' GLU . 90.6 mt -59.29 -36.2 62.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.993 -0.548 . . . . 10.0 111.258 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -64.95 -36.65 85.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.106 -0.497 . . . . 10.0 111.57 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.673 ' HG3' H261 ' A' ' 202' ' ' CHO . 10.6 ptp -87.92 -38.43 15.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.823 0.344 . . . . 10.0 110.694 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.0 -32.14 71.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.835 -0.62 . . . . 10.0 111.767 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 32' ' ' ARG . 9.1 ptt180 -65.8 -23.11 66.63 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.501 -0.318 . . . . 10.0 111.321 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -98.54 -14.59 19.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.87 0.367 . . . . 10.0 110.825 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.833 HD12 H262 ' A' ' 202' ' ' CHO . 1.4 mt -85.35 134.96 25.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.033 -0.53 . . . . 10.0 111.165 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.51 86.68 29.23 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.655 -0.702 . . . . 10.0 109.673 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -79.23 177.93 8.04 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.788 2.326 . . . . 10.0 112.077 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -123.52 139.11 51.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 116.261 -0.427 . . . . 10.0 109.919 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 68.1 t -92.65 108.44 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.926 0.393 . . . . 10.0 110.535 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -88.75 125.23 34.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.031 -0.531 . . . . 10.0 109.975 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.53 129.93 41.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.458 0.647 . . . . 10.0 111.14 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -137.11 137.7 39.54 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.633 -0.506 . . . . 10.0 109.633 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.86 -165.83 1.4 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.511 0.672 . . . . 10.0 111.963 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -176.71 90.14 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.68 -1.146 . . . . 10.0 108.939 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.4 -88.94 1.51 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.781 -0.723 . . . . 10.0 111.589 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.9 -14.67 3.96 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.573 0.225 . . . . 10.0 111.091 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -87.42 124.29 33.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.297 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.413 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 4.6 m-85 -113.24 149.6 33.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.071 0.462 . . . . 10.0 111.113 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 t -132.83 103.33 5.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.393 -0.822 . . . . 10.0 109.072 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.694 HG21 ' H11' ' A' ' 201' ' ' GCH . 14.6 t -99.53 131.67 46.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.038 -0.528 . . . . 10.0 110.353 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 54.6 m -117.14 109.86 17.45 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.067 -0.515 . . . . 10.0 111.087 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.36 119.6 24.37 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 57' ' ' THR . 53.5 mtpt -94.76 123.16 38.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.095 -0.502 . . . . 10.0 111.834 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.631 ' HB ' H221 ' A' ' 202' ' ' CHO . 2.6 p -136.24 146.36 55.89 Favored Pre-proline 0 N--CA 1.448 -0.531 0 CA-C-N 115.518 -0.765 . . . . 10.0 110.046 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HD2' H221 ' A' ' 202' ' ' CHO . 85.4 Cg_exo -52.28 -22.05 14.72 Favored 'Trans proline' 0 N--CA 1.473 0.323 0 C-N-CA 123.72 2.946 . . . . 10.0 113.186 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -92.53 -65.69 0.98 Allowed 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.713 0.292 . . . . 10.0 111.739 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -151.47 139.29 19.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.315 . . . . 10.0 111.504 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -85.83 122.83 30.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.842 179.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.25 147.83 6.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.987 -0.375 . . . . 10.0 109.987 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.29 128.6 55.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.052 0.453 . . . . 10.0 111.787 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.66 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 30.2 m-80 -123.14 126.57 47.28 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.596 -0.891 . . . . 10.0 108.596 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 148.24 49.11 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.03 -0.268 . . . . 10.0 111.034 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.413 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 29.6 p90 -158.46 169.67 23.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.897 0.38 . . . . 10.0 111.151 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 6.4 m -123.4 131.02 53.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.935 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 89' ' ' LEU . 69.0 mt -58.91 108.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.98 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 7.3 55.49 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.683 -0.69 . . . . 10.0 112.725 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 36.2 mtpt -136.65 158.41 44.51 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.923 0.392 . . . . 10.0 110.659 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -87.8 142.07 28.1 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.171 -0.677 . . . . 10.0 109.171 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.17 146.55 38.91 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.043 0.449 . . . . 10.0 110.862 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.97 120.71 26.06 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.459 -0.791 . . . . 10.0 109.574 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.661 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.7 pp -124.44 160.71 28.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.022 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -133.24 127.52 33.89 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.103 -0.639 . . . . 10.0 111.979 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.751 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 9.0 t -86.96 165.31 15.96 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.775 -0.648 . . . . 10.0 110.29 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.559 ' HG3' H151 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -69.97 -17.14 63.29 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.759 0.314 . . . . 10.0 111.74 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -78.13 -16.42 57.97 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.174 0.511 . . . . 10.0 110.578 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.05 36.67 6.59 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.444 -0.884 . . . . 10.0 113.048 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -111.19 127.92 55.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.452 -0.573 . . . . 10.0 109.452 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' LYS . 26.8 mmtt -86.52 108.19 18.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.103 0.478 . . . . 10.0 110.138 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.9 mt -126.66 148.2 49.85 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.322 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.6 mtmt -122.55 113.83 19.83 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.744 -0.836 . . . . 10.0 108.744 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 52.0 t -108.73 143.16 38.23 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.243 -0.583 . . . . 10.0 111.775 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.4 m -100.69 80.41 2.18 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.7 t -77.79 140.43 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.246 -0.888 . . . . 10.0 111.243 -178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -153.78 150.32 28.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.603 -0.726 . . . . 10.0 110.284 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tp -91.81 105.47 17.74 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.511 0.507 . . . . 10.0 109.955 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -117.31 123.23 46.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.89 -0.595 . . . . 10.0 110.153 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 61.84 28.01 17.12 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.038 -0.528 . . . . 10.0 111.162 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.74 5.45 89.41 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.919 -0.657 . . . . 10.0 112.96 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -117.89 159.88 22.36 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.6 tp -99.99 124.48 45.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.145 0.498 . . . . 10.0 110.188 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.8 t -111.57 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.85 -0.614 . . . . 10.0 111.058 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.71 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 44.4 t -123.84 87.95 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' HB3' ' A' ' 97' ' ' SER . 25.5 ttpp -100.12 142.92 30.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.24 0.543 . . . . 10.0 111.387 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.0 -163.64 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.218 -0.901 . . . . 10.0 109.236 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -87.52 -31.24 20.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.923 0.392 . . . . 10.0 110.712 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -122.36 -6.79 8.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.187 -0.461 . . . . 10.0 111.305 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -135.16 177.52 7.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.692 0.282 . . . . 10.0 110.508 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HB3' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -155.58 133.08 11.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.273 -0.422 . . . . 10.0 111.236 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.789 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -111.67 121.1 44.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.89 -0.781 . . . . 10.0 108.89 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -109.91 127.44 54.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.235 -0.438 . . . . 10.0 110.707 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.589 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 36.5 mt-30 -129.24 112.76 14.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.876 0.37 . . . . 10.0 110.846 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.07 130.01 56.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.285 0.565 . . . . 10.0 111.465 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.7 t -104.34 120.63 54.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt -125.47 86.65 2.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.39 -0.368 . . . . 10.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.92 -112.02 4.01 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.882 -0.599 . . . . 10.0 112.435 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -94.66 8.92 40.77 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.362 0.265 . . . . 10.0 111.514 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -129.31 153.31 47.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.168 0.509 . . . . 10.0 111.848 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.405 ' HB2' ' CE3' ' A' ' 6' ' ' TRP . 5.4 tmm? -133.41 106.28 7.4 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.358 -0.837 . . . . 10.0 108.994 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 m -101.95 119.49 50.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.105 -0.498 . . . . 10.0 110.392 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 120' ' ' ARG . 6.7 pt-20 -119.15 149.86 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.323 0.582 . . . . 10.0 111.362 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.3 115.5 15.01 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.249 -0.887 . . . . 10.0 109.536 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.7 OUTLIER -115.94 165.8 10.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.189 -0.46 . . . . 10.0 110.252 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 75.6 m -151.98 109.71 3.64 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.591 -0.522 . . . . 10.0 109.591 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.504 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 12.5 m-85 -145.64 145.35 30.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.548 -0.296 . . . . 10.0 110.374 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.45 59.1 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 121.213 -0.517 . . . . 10.0 113.192 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.86 11.14 77.48 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.937 -0.649 . . . . 10.0 112.946 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -125.68 126.72 70.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 10.0 110.459 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 0.8 OUTLIER -98.17 80.87 2.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.424 0.631 . . . . 10.0 111.002 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.955 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 22.1 tp -62.84 114.24 3.52 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.364 -0.834 . . . . 10.0 111.146 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.09 110.8 27.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.562 -0.745 . . . . 10.0 109.437 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -109.35 149.26 29.75 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 121.503 0.668 . . . . 10.0 112.779 -177.386 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.8 mtm180 -126.95 127.57 45.05 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.833 -1.076 . . . . 10.0 108.786 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.96 151.02 49.63 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.29 0.567 . . . . 10.0 112.011 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 17.3 mmtt -121.31 146.36 46.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.324 -0.853 . . . . 10.0 109.379 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -79.8 146.38 32.32 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.833 0.349 . . . . 10.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.249 1.067 0 CA-C-O 119.024 -0.512 . . . . 10.0 110.223 179.582 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.789 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.958 H211 ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -67.66 -30.43 69.97 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 110.043 -0.355 . . . . 10.0 110.043 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.76 100.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.406 . . . . 10.0 110.387 179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.09 -150.02 11.31 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.701 -0.762 . . . . 10.0 112.819 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -130.24 121.02 25.37 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 110.381 -0.229 . . . . 10.0 110.381 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.417 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 9.0 m95 -118.75 128.2 54.26 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.404 0.52 . . . . 10.0 112.404 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.57 112.26 24.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.406 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG22 ' HB2' ' A' ' 122' ' ' SER . 52.9 t -78.1 148.35 6.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.133 -0.485 . . . . 10.0 110.357 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 45.3 p90 -149.19 27.1 0.86 Allowed 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.108 0.41 . . . . 10.0 112.108 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.6 143.44 28.28 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.126 0.417 . . . . 10.0 112.126 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -133.45 46.63 2.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.939 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.4 -86.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.184 0.992 . . . . 10.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.75 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 1.6 p30 -117.43 27.88 8.81 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.716 -1.584 . . . . 10.0 110.013 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.633 ' OH ' H121 ' A' ' 202' ' ' CHO . 55.4 t80 -57.87 -58.6 7.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.352 -0.84 . . . . 10.0 111.933 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -64.18 -23.29 67.26 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.853 0.316 . . . . 10.0 111.853 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.35 -40.87 29.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.087 0.47 . . . . 10.0 110.527 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 24.4 t80 -65.75 -33.92 76.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.953 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.61 HD22 H182 ' A' ' 202' ' ' CHO . 16.6 mt -58.36 -37.35 75.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 10.0 111.08 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.5 mttt -71.48 -24.2 61.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.5 . . . . 10.0 110.898 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -80.53 -9.2 59.78 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.116 0.484 . . . . 10.0 110.988 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.772 HD13 ' H62' ' A' ' 202' ' ' CHO . 14.6 mt -101.63 8.25 41.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.029 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 64.07 26.11 13.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.5 -0.773 . . . . 10.0 111.026 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 82.8 mt -75.87 163.43 66.99 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.815 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HB2' ' OD1' ' A' ' 26' ' ' ASP . 18.8 Cg_endo -78.52 123.87 6.15 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.686 1.59 . . . . 10.0 111.696 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.573 ' HA ' HD12 ' A' ' 28' ' ' ILE . 35.8 mt-10 -60.11 -24.37 64.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.377 -0.374 . . . . 10.0 111.768 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD1' ' HB2' ' A' ' 24' ' ' PRO . 1.3 p-10 -65.45 -34.3 77.96 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.2 -0.667 . . . . 10.0 109.2 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 H222 ' A' ' 202' ' ' CHO . 1.7 tp -84.09 -34.45 24.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.739 -0.664 . . . . 10.0 109.67 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.573 HD12 ' HA ' ' A' ' 25' ' ' GLU . 98.6 mt -59.13 -34.61 53.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.789 -0.641 . . . . 10.0 111.283 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -67.16 -26.77 66.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.209 -0.45 . . . . 10.0 110.58 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.452 ' O ' HG13 ' A' ' 34' ' ' ILE . 36.1 mtt -88.73 -43.09 11.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.121 0.486 . . . . 10.0 109.945 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.71 -28.45 65.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.387 -0.824 . . . . 10.0 112.493 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -64.22 -12.66 42.88 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.726 0.269 . . . . 10.0 111.726 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -114.55 -20.81 10.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.127 0.489 . . . . 10.0 110.595 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 30' ' ' MET . 45.0 mt -80.2 122.51 35.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.005 -0.543 . . . . 10.0 111.655 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 pttt -117.16 86.08 20.05 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.305 -0.628 . . . . 10.0 109.305 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.49 164.1 26.46 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.913 2.409 . . . . 10.0 113.133 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -99.31 142.08 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.6 178.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -102.48 108.69 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.81 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -85.68 130.29 34.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.902 -0.59 . . . . 10.0 109.663 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.98 127.42 12.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.396 0.617 . . . . 10.0 111.417 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -127.77 146.67 50.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 10.0 110.752 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -129.78 168.34 16.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.917 0.389 . . . . 10.0 110.836 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -149.14 72.38 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.7 -91.62 1.5 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.988 -0.845 . . . . 10.0 110.988 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -117.46 -19.01 9.66 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 121.144 -0.223 . . . . 10.0 110.97 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -85.49 138.27 32.33 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.127 0.489 . . . . 10.0 110.361 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -124.39 147.14 48.45 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.61 -0.723 . . . . 10.0 110.555 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.8 t -132.15 101.16 4.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.617 -0.883 . . . . 10.0 108.617 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.924 HG21 ' H11' ' A' ' 201' ' ' GCH . 4.3 t -94.85 126.26 47.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.671 -0.695 . . . . 10.0 110.396 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 29.0 m -108.81 106.98 17.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.915 -0.584 . . . . 10.0 111.474 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.7 m -89.0 98.3 11.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.884 -0.784 . . . . 10.0 108.884 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HA ' HG22 ' A' ' 57' ' ' THR . 43.8 mtmt -88.87 116.81 27.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.671 -0.695 . . . . 10.0 111.169 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.668 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.2 p -127.82 161.8 53.35 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.144 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HD2' H221 ' A' ' 202' ' ' CHO . 17.4 Cg_exo -68.59 -1.46 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.065 2.51 . . . . 10.0 112.878 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 9.4 mmt85 -116.43 -59.16 2.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 10.0 111.876 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -145.11 123.76 12.53 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.067 -0.515 . . . . 10.0 110.938 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.793 HG22 ' HA ' ' A' ' 52' ' ' LYS . 39.7 p -89.97 101.67 14.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.259 -0.645 . . . . 10.0 109.259 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.44 156.24 3.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 119.872 -0.731 . . . . 10.0 111.804 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -120.24 134.57 55.23 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.601 -0.727 . . . . 10.0 109.935 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.692 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.8 m-80 -125.26 122.88 38.22 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.469 -0.938 . . . . 10.0 108.469 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.11 147.7 46.48 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.913 -0.315 . . . . 10.0 111.564 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.5 176.82 11.61 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.805 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 27.1 m -127.17 133.85 50.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.598 -0.519 . . . . 10.0 109.598 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 33.5 mt -56.61 111.51 1.02 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 112.451 0.537 . . . . 10.0 112.451 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.13 60.42 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.624 -0.798 . . . . 10.0 113.251 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -132.13 139.52 48.47 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.111 0.481 . . . . 10.0 111.296 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -66.79 136.69 55.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.371 -0.831 . . . . 10.0 109.591 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.31 141.24 37.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.958 0.409 . . . . 10.0 111.294 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -84.62 118.09 24.15 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.518 -0.765 . . . . 10.0 109.201 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.78 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.1 pp -119.69 168.48 11.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.996 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -124.57 126.02 45.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.192 0.52 . . . . 10.0 111.959 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.452 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 8.2 t -82.34 164.81 20.83 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.945 -0.571 . . . . 10.0 110.002 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.668 ' SD ' HG21 ' A' ' 53' ' ' THR . 10.9 ttm -72.54 -13.8 61.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.191 0.52 . . . . 10.0 110.73 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.17 -27.11 59.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.472 -0.786 . . . . 10.0 109.931 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.71 54.96 0.96 Allowed Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.811 -0.631 . . . . 10.0 112.006 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -148.62 142.88 26.14 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 10.0 109.831 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -88.59 119.59 29.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.067 -0.515 . . . . 10.0 109.937 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.4 mt -125.17 151.25 46.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.026 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -106.7 115.19 29.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.949 -0.389 . . . . 10.0 109.949 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.747 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -112.63 108.54 17.64 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.802 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.9 m -83.02 74.5 9.96 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.411 0.624 . . . . 10.0 110.169 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.797 HG22 ' HB2' ' A' ' 91' ' ' CYS . 2.8 t -79.5 122.61 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.399 0.619 . . . . 10.0 109.362 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.731 ' CE1' HG13 ' A' ' 90' ' ' VAL . 11.9 p-80 -135.51 149.0 49.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.665 -0.698 . . . . 10.0 110.089 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.472 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.9 tm? -80.7 136.72 36.22 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 107.477 -1.305 . . . . 10.0 107.477 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.472 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -144.53 103.08 3.91 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.01 -0.995 . . . . 10.0 111.27 -177.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 59.84 32.89 21.51 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.806 -0.633 . . . . 10.0 111.916 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 88.2 3.1 79.47 Favored Glycine 0 C--N 1.324 -0.116 0 C-N-CA 120.917 -0.658 . . . . 10.0 112.591 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -114.94 130.87 57.0 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.191 -0.3 . . . . 10.0 110.191 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.4 tp -86.33 129.5 34.83 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.416 -0.587 . . . . 10.0 109.416 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.731 HG13 ' CE1' ' A' ' 83' ' ' HIS . 1.1 p -143.63 143.35 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 114.362 1.245 . . . . 10.0 114.362 -177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.797 ' HB2' HG22 ' A' ' 82' ' ' VAL . 38.8 t -132.84 91.48 2.9 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -94.66 143.81 26.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.231 0.539 . . . . 10.0 110.716 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.6 t -118.77 178.96 4.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.057 -0.72 . . . . 10.0 109.057 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -77.74 -18.95 55.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.841 0.353 . . . . 10.0 110.914 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -127.01 -14.88 5.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.433 -0.349 . . . . 10.0 111.675 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -132.99 174.2 10.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.505 -0.316 . . . . 10.0 111.003 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.12 126.13 5.89 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.256 -0.429 . . . . 10.0 110.257 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.759 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 4.9 t60 -104.11 128.99 51.8 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.075 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 6.2 tt0 -114.18 132.0 56.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.374 -0.376 . . . . 10.0 110.841 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.453 ' HG3' ' CG ' ' A' ' 109' ' ' GLU . 35.1 tt0 -138.61 105.42 5.38 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.677 0.61 . . . . 10.0 109.62 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -118.65 131.71 56.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.741 0.305 . . . . 10.0 111.329 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 73.7 t -106.41 118.72 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.398 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -120.22 96.57 5.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.094 -0.503 . . . . 10.0 109.931 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.23 -101.4 1.05 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.071 -0.585 . . . . 10.0 112.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 124' ' ' ARG . 2.1 t30 -119.02 14.8 13.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.133 0.492 . . . . 10.0 110.163 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -124.86 138.59 54.25 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.338 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 66.9 ttp -123.67 119.15 28.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.9 m -112.99 134.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.288 0.566 . . . . 10.0 110.825 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' CG ' ' HG3' ' A' ' 100' ' ' GLN . 29.3 mt-10 -120.97 150.39 41.19 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.411 0.624 . . . . 10.0 111.191 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.78 99.26 3.75 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.725 -1.125 . . . . 10.0 109.068 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.0 OUTLIER -109.67 168.9 3.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.357 -0.609 . . . . 10.0 109.357 -178.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.2 m -150.33 106.91 3.51 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.819 -0.437 . . . . 10.0 109.819 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.423 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 17.9 m-85 -142.11 145.71 34.58 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.787 -0.449 . . . . 10.0 109.787 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 61.51 23.34 62.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 121.01 -0.614 . . . . 10.0 112.483 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.07 12.34 81.13 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.778 -0.725 . . . . 10.0 112.475 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.1 119.35 55.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.034 0.445 . . . . 10.0 111.11 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.582 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 2.2 t -91.21 71.39 6.22 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.95 0.881 . . . . 10.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.75 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 19.0 tp -56.4 116.12 2.89 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 114.704 -1.135 . . . . 10.0 111.409 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.0 mt -101.99 123.89 55.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.209 -0.905 . . . . 10.0 108.713 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -123.43 144.91 49.2 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 122.274 1.035 . . . . 10.0 112.69 -177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.527 ' HD2' ' N ' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -117.87 125.38 50.4 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.019 -1.9 . . . . 10.0 108.423 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.482 ' HB2' HG22 ' A' ' 8' ' ' VAL . 20.9 t -129.31 152.6 48.7 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.422 0.63 . . . . 10.0 111.252 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 22.0 mmtt -122.76 137.09 55.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.149 -0.932 . . . . 10.0 109.812 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' HB3' ' ND2' ' A' ' 105' ' ' ASN . 14.5 ttp180 -69.3 144.06 53.66 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.153 -0.314 . . . . 10.0 110.153 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.13 -0.938 . . . . 10.0 109.959 -179.272 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.924 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.824 H212 H121 ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.732 -0.099 . . . . 10.0 110.732 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.584 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 52.4 m-85 -76.05 -30.69 58.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.524 -0.307 . . . . 10.0 110.562 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.34 122.34 13.01 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.141 -0.481 . . . . 10.0 111.159 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.95 -151.28 23.3 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.034 -0.603 . . . . 10.0 111.867 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.679 ' HB ' HD11 ' A' ' 37' ' ' ILE . 17.6 p -134.24 116.62 15.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.175 -0.305 . . . . 10.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.9 m95 -113.55 130.41 56.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.197 0.522 . . . . 10.0 112.234 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -95.24 108.97 21.14 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 9.9 p -83.03 142.55 13.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 113.033 0.753 . . . . 10.0 113.033 -177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -142.04 135.68 29.46 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.195 -0.911 . . . . 10.0 108.659 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -167.63 149.05 5.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.731 0.3 . . . . 10.0 111.441 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -133.32 24.3 4.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.543 0.687 . . . . 10.0 109.492 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.407 ' CD ' HH22 ' A' ' 121' ' ' ARG . 6.7 mp0 -117.39 150.26 39.16 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.03 -0.987 . . . . 10.0 110.304 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.426 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 43.2 m-20 15.57 58.39 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 O-C-N 125.706 1.879 . . . . 10.0 113.494 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.487 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 44.4 t80 -104.19 -61.17 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.08 -0.509 . . . . 10.0 111.156 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.94 -29.96 71.08 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.71 -0.396 . . . . 10.0 110.777 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -74.59 -31.97 62.21 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.989 0.423 . . . . 10.0 110.493 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -70.72 -36.29 73.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.022 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 28' ' ' ILE . 16.1 mt -61.28 -37.13 82.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.07 -0.513 . . . . 10.0 110.84 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.414 ' HG2' HD13 ' A' ' 28' ' ' ILE . 13.4 mttt -70.19 -28.93 65.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.46 -0.336 . . . . 10.0 110.194 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.76 -16.53 60.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 10.0 111.161 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 18' ' ' LEU . 14.5 mt -94.65 9.53 38.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.011 -0.54 . . . . 10.0 110.278 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 60.71 31.84 20.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.404 -0.816 . . . . 10.0 110.963 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.42 159.83 68.93 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.727 -0.669 . . . . 10.0 110.538 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.22 134.22 26.51 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.954 2.436 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -56.81 -34.64 67.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.063 -0.517 . . . . 10.0 112.191 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -67.67 -34.56 77.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.911 0.386 . . . . 10.0 110.377 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.011 ' HG ' H232 ' A' ' 202' ' ' CHO . 0.8 OUTLIER -72.75 -39.17 67.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 10.0 110.017 179.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 18' ' ' LEU . 87.5 mt -63.16 -26.78 41.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.148 -0.933 . . . . 10.0 111.243 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 53.5 mttp -77.18 -14.71 59.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.69 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.58 ' HB3' H261 ' A' ' 202' ' ' CHO . 24.0 mtt -97.5 -43.12 7.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.317 0.58 . . . . 10.0 109.74 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.687 ' CB ' H183 ' A' ' 202' ' ' CHO . . . -60.62 -25.18 66.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.063 -0.971 . . . . 10.0 112.627 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 0.2 OUTLIER -49.09 -31.65 8.32 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.474 0.546 . . . . 10.0 112.474 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.54 11.18 12.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.678 0.275 . . . . 10.0 111.657 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' CD1' H262 ' A' ' 202' ' ' CHO . 2.3 mt -101.5 119.25 49.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 10.0 111.636 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' VAL . 4.2 pttp -126.48 85.31 60.52 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.652 178.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 34' ' ' ILE . 6.3 Cg_exo -71.58 157.34 56.23 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.887 2.391 . . . . 10.0 112.308 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -85.57 137.97 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.01 -0.541 . . . . 10.0 109.645 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -98.0 107.59 20.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.11 -0.496 . . . . 10.0 110.951 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -87.09 126.06 34.53 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.379 -0.6 . . . . 10.0 109.379 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.24 131.0 44.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 121.656 0.741 . . . . 10.0 111.354 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -127.53 135.93 51.02 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.314 -0.857 . . . . 10.0 109.507 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -120.67 162.69 19.26 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.489 0.661 . . . . 10.0 111.409 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -143.27 77.88 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.922 -1.036 . . . . 10.0 108.228 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.43 -95.8 1.47 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.744 -0.741 . . . . 10.0 111.529 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -108.59 -23.32 11.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.719 0.295 . . . . 10.0 110.759 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -87.2 131.81 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.055 0.455 . . . . 10.0 110.883 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -120.13 153.2 36.51 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.65 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.21 104.4 4.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.779 -0.823 . . . . 10.0 108.779 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.808 HG21 ' H11' ' A' ' 201' ' ' GCH . 79.3 t -94.23 131.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.075 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.0 m -111.05 114.21 27.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.267 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.8 m -105.39 107.08 17.88 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.25 0.547 . . . . 10.0 110.093 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -88.7 124.34 34.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.309 -0.86 . . . . 10.0 111.148 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.522 HG21 ' SD ' ' A' ' 73' ' ' MET . 12.6 p -122.98 160.6 48.72 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.133 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.901 ' HD2' H221 ' A' ' 202' ' ' CHO . 25.0 Cg_exo -68.69 1.31 3.87 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.34 2.693 . . . . 10.0 112.816 178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -121.09 -61.0 1.59 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.708 0.29 . . . . 10.0 111.536 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.34 127.41 10.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.913 0.387 . . . . 10.0 110.871 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 58.3 m -80.01 131.44 35.8 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.042 -0.527 . . . . 10.0 110.903 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.4 m -115.15 149.28 17.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 10.0 110.774 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.2 m -115.19 126.38 54.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.781 -0.645 . . . . 10.0 110.59 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 0.8 OUTLIER -117.89 125.2 50.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.856 -0.794 . . . . 10.0 108.856 179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.11 149.73 40.54 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.294 -0.261 . . . . 10.0 110.294 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -163.22 150.95 13.23 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 120.612 -0.435 . . . . 10.0 111.337 -178.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 4.8 m -109.63 132.27 54.29 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.6 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 89' ' ' LEU . 46.8 mt -58.58 114.34 2.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.29 -0.413 . . . . 10.0 111.939 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.25 -1.0 58.8 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.67 -0.695 . . . . 10.0 112.768 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 54.5 mtpt -118.85 172.37 7.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.15 0.5 . . . . 10.0 111.103 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -92.92 129.07 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.848 . . . . 10.0 109.375 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.03 131.12 55.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.453 0.538 . . . . 10.0 112.453 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -93.61 82.26 4.36 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.599 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -96.78 170.96 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.618 -1.174 . . . . 10.0 112.504 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -130.27 138.46 50.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.932 -0.576 . . . . 10.0 111.509 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.59 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 15.1 t -97.21 166.36 11.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.3 -0.409 . . . . 10.0 111.612 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.522 ' SD ' HG21 ' A' ' 53' ' ' THR . 3.4 mtt -63.25 -27.61 69.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.554 -0.748 . . . . 10.0 112.235 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -27.24 64.82 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.907 0.384 . . . . 10.0 111.443 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 104.6 27.6 6.01 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.31 -0.948 . . . . 10.0 112.754 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -113.04 142.9 45.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.967 -0.383 . . . . 10.0 109.967 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -93.83 115.75 28.17 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.839 -0.619 . . . . 10.0 109.951 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.54 146.8 52.4 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.98 0.419 . . . . 10.0 110.254 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -108.1 112.07 24.42 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.333 0.587 . . . . 10.0 109.91 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.777 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -101.71 122.78 44.56 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.576 -0.738 . . . . 10.0 110.066 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.44 95.1 9.79 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.946 -0.57 . . . . 10.0 109.667 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.777 HG22 ' SG ' ' A' ' 80' ' ' CYS . 0.5 OUTLIER -92.11 146.41 6.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.894 -0.593 . . . . 10.0 111.149 -178.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -159.41 147.29 17.4 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.474 -0.785 . . . . 10.0 110.16 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.508 HD13 ' N ' ' A' ' 85' ' ' ALA . 3.4 tm? -86.44 138.61 31.63 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.508 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -155.58 113.73 3.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.122 -0.945 . . . . 10.0 110.342 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.6 m-80 63.66 27.2 14.78 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.308 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.39 85.92 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.505 -0.855 . . . . 10.0 112.365 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.45 ' HD2' HG22 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -121.62 141.82 50.73 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.55 126.15 35.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.059 0.457 . . . . 10.0 110.39 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.45 HG22 ' HD2' ' A' ' 88' ' ' LYS . 4.6 t -113.65 116.16 51.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.539 -0.755 . . . . 10.0 110.983 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 6.8 t -118.23 79.94 1.45 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -101.12 144.26 30.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.268 0.556 . . . . 10.0 111.266 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.92 -161.2 0.8 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.396 -0.82 . . . . 10.0 109.215 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.55 -30.58 19.19 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.313 0.578 . . . . 10.0 110.62 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -113.52 -20.67 11.17 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.671 -0.695 . . . . 10.0 112.13 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.92 169.27 16.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.925 0.393 . . . . 10.0 111.725 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.82 122.67 8.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.926 -0.579 . . . . 10.0 111.112 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.724 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.9 t-160 -109.67 120.72 43.36 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.93 129.47 56.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.988 0.423 . . . . 10.0 110.393 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -132.79 113.17 12.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.244 -0.434 . . . . 10.0 109.884 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -115.24 123.75 49.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.503 -0.317 . . . . 10.0 111.414 -178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 75.8 t -100.3 121.07 50.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.1 -0.5 . . . . 10.0 109.874 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -121.14 99.22 6.37 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.069 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 71.16 -102.64 1.11 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.164 -0.541 . . . . 10.0 112.051 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 33.8 p-10 -121.95 19.84 10.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.392 0.615 . . . . 10.0 109.857 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -131.92 127.62 36.78 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.085 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.1 ttm -108.59 118.16 36.06 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.939 -0.573 . . . . 10.0 110.42 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 47.4 t -110.69 105.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.29 -0.633 . . . . 10.0 109.29 179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -112.47 151.6 29.72 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.534 0.683 . . . . 10.0 111.113 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.435 HG23 HG13 ' A' ' 119' ' ' ILE . 90.0 m -138.29 117.71 12.87 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.466 -0.788 . . . . 10.0 109.259 178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -114.47 157.58 15.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.004 -0.544 . . . . 10.0 110.611 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 11.0 m -141.97 108.24 5.26 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -142.37 142.04 32.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.697 -0.482 . . . . 10.0 109.697 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.7 17.25 64.6 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.519 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 87.07 8.43 75.52 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.294 -0.479 . . . . 10.0 112.578 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 112' ' ' THR . 11.8 t -116.79 131.39 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.038 0.447 . . . . 10.0 110.942 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.8 m -98.4 91.2 5.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.653 -0.703 . . . . 10.0 110.382 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.8 tp -83.77 109.1 17.24 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.365 0.602 . . . . 10.0 111.447 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.435 HG13 HG23 ' A' ' 110' ' ' THR . 2.5 mp -89.95 122.51 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 115.235 -0.893 . . . . 10.0 110.018 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' NH1' ' H22' ' A' ' 202' ' ' CHO . 24.4 mtm180 -126.56 146.95 49.94 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.276 0.56 . . . . 10.0 111.644 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.407 HH22 ' CD ' ' A' ' 12' ' ' GLU . 2.6 mtm180 -125.52 128.58 48.21 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.8 OUTLIER -122.81 116.17 23.24 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.467 0.651 . . . . 10.0 111.131 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -87.96 138.11 31.74 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.319 -0.855 . . . . 10.0 110.12 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.5 ttp180 -75.66 144.61 41.55 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.679 -0.677 . . . . 10.0 110.522 -179.24 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.808 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 1.075 H211 ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.847 -0.427 . . . . 10.0 109.847 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 12.8 m-85 -68.04 -31.7 71.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.159 0.287 . . . . 10.0 110.99 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.34 103.29 0.49 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.176 -0.465 . . . . 10.0 110.206 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.63 -157.76 27.43 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.013 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 37' ' ' ILE . 12.0 p -126.97 118.16 23.96 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.746 0.308 . . . . 10.0 110.771 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -113.97 128.59 56.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.021 0.439 . . . . 10.0 111.906 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.9 tp60 -98.77 102.01 13.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 7.4 p -73.92 144.96 11.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.5 -0.773 . . . . 10.0 112.792 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.559 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 5.4 p90 -152.88 137.84 17.19 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 114.859 -1.064 . . . . 10.0 109.101 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -178.18 159.6 1.29 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.099 0.476 . . . . 10.0 111.806 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -134.17 56.31 1.85 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.589 -0.732 . . . . 10.0 109.264 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.2 -151.41 0.45 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.926 0.869 . . . . 10.0 111.805 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.958 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.2 p30 -69.08 38.06 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.517 -1.674 . . . . 10.0 112.879 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.636 ' CE2' HD11 ' A' ' 18' ' ' LEU . 70.4 t80 -67.78 -60.9 2.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.858 0.361 . . . . 10.0 111.668 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.55 -16.35 15.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.606 0.595 . . . . 10.0 112.606 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -41.26 9.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.994 0.426 . . . . 10.0 110.603 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.675 ' CD2' ' H61' ' A' ' 202' ' ' CHO . 9.7 t80 -64.61 -39.39 93.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.826 -0.625 . . . . 10.0 111.887 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.858 HD12 HG23 ' A' ' 28' ' ' ILE . 11.5 mt -55.25 -37.68 67.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.21 0.528 . . . . 10.0 111.364 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -69.61 -22.65 63.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.624 -0.716 . . . . 10.0 111.998 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.45 -17.02 46.76 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.03 0.443 . . . . 10.0 111.47 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 18' ' ' LEU . 5.3 mt -92.86 6.16 48.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.056 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.78 35.84 13.55 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.483 0.659 . . . . 10.0 110.604 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.559 HD13 H151 ' A' ' 202' ' ' CHO . 86.4 mt -80.51 158.63 71.06 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.496 -0.775 . . . . 10.0 110.612 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.1 Cg_exo -70.29 126.26 12.76 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.093 1.862 . . . . 10.0 111.439 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.616 ' HA ' HD12 ' A' ' 28' ' ' ILE . 13.5 tp10 -50.68 -36.82 37.71 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 123.643 0.589 . . . . 10.0 111.196 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.08 -54.72 41.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.596 -0.729 . . . . 10.0 110.576 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.696 HD21 H222 ' A' ' 202' ' ' CHO . 0.9 OUTLIER -62.45 -30.97 71.63 Favored 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.795 -179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.858 HG23 HD12 ' A' ' 18' ' ' LEU . 92.8 mt -63.94 -23.84 34.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.401 -0.363 . . . . 10.0 110.901 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 49.5 mttm -84.37 -28.42 27.0 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.127 0.489 . . . . 10.0 109.884 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.754 ' O ' HG13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -84.92 -53.03 5.58 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.841 -0.618 . . . . 10.0 111.001 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.54 -20.83 58.38 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.713 0.634 . . . . 10.0 112.713 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -77.52 -13.77 59.83 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.165 0.507 . . . . 10.0 110.584 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -110.31 -33.56 6.6 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.845 -0.616 . . . . 10.0 109.787 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 30' ' ' MET . 7.2 mt -74.53 113.01 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.805 -0.634 . . . . 10.0 109.98 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -120.69 79.53 31.02 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.64 -178.85 4.86 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.967 2.445 . . . . 10.0 110.716 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -101.36 140.57 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.855 -0.338 . . . . 10.0 110.189 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -91.26 104.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.936 0.398 . . . . 10.0 110.099 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -86.77 126.9 34.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.555 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.97 129.63 44.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.246 0.546 . . . . 10.0 110.232 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -124.32 147.19 48.33 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.385 -0.598 . . . . 10.0 109.385 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -130.11 165.41 22.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.315 0.579 . . . . 10.0 110.696 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -152.74 81.77 1.22 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.43 -108.65 3.05 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 110.11 -1.196 . . . . 10.0 110.11 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.53 -6.12 16.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.034 0.445 . . . . 10.0 109.97 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -92.25 129.09 38.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.182 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 61' ' ' SER . 3.9 m-85 -116.78 149.53 39.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.816 0.341 . . . . 10.0 111.139 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.5 t -133.99 102.83 4.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.498 -0.774 . . . . 10.0 109.127 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.712 HG21 ' H11' ' A' ' 201' ' ' GCH . 65.5 t -89.15 132.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.697 -0.683 . . . . 10.0 110.31 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 99.0 m -119.63 107.39 13.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.855 -0.611 . . . . 10.0 110.911 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -105.14 116.95 32.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.145 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -90.7 126.81 36.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.82 -0.627 . . . . 10.0 110.092 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' H231 ' A' ' 202' ' ' CHO . 7.7 p -134.05 161.94 60.69 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.665 -0.243 . . . . 10.0 111.362 -178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' ' C24' ' A' ' 202' ' ' CHO . 59.2 Cg_exo -57.83 -29.41 85.99 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.158 2.572 . . . . 10.0 111.7 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -75.87 -66.06 0.83 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.896 -1.047 . . . . 10.0 110.118 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -172.51 144.65 1.5 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.461 -0.791 . . . . 10.0 109.362 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -70.14 129.49 39.55 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.445 -0.343 . . . . 10.0 110.208 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.2 m -106.0 158.28 6.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.542 -0.299 . . . . 10.0 110.353 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 t -126.71 133.66 50.85 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 121.333 0.587 . . . . 10.0 110.44 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -124.61 118.14 25.86 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -123.09 142.34 50.98 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.326 -0.55 . . . . 10.0 111.226 -178.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CD1' HG11 ' A' ' 82' ' ' VAL . 12.9 p90 -156.97 171.07 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 10.0 110.987 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 m -120.57 129.92 53.98 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.856 -0.611 . . . . 10.0 109.431 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 84' ' ' LEU . 36.4 mt -60.08 129.68 42.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.911 0.386 . . . . 10.0 111.255 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.96 3.84 79.3 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.836 -0.62 . . . . 10.0 112.05 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -133.8 165.88 23.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 120.944 0.402 . . . . 10.0 110.507 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -102.91 127.03 50.29 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.45 143.64 49.93 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.817 0.342 . . . . 10.0 110.848 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -78.36 124.54 28.23 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.465 -0.788 . . . . 10.0 109.779 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.574 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.1 pp -129.25 166.62 26.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.51 -0.768 . . . . 10.0 108.954 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 m -125.99 130.52 51.36 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 119.504 -0.878 . . . . 10.0 113.173 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.678 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 10.2 t -85.84 153.2 22.42 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.644 -0.872 . . . . 10.0 108.644 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.45 ' HG3' H221 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -67.57 -10.7 54.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.615 0.245 . . . . 10.0 111.227 -179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.562 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 3.2 t70 -73.09 -28.6 62.38 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.354 0.597 . . . . 10.0 109.632 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.27 29.6 4.46 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.75 -0.659 . . . . 10.0 112.7 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.562 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 12.6 mttp -118.5 144.9 45.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.54 0.209 . . . . 10.0 110.58 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -93.64 112.72 24.65 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.593 -0.521 . . . . 10.0 109.593 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD11 ' H25' ' A' ' 201' ' ' GCH . 19.6 mt -117.5 155.15 30.22 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.031 -0.531 . . . . 10.0 110.784 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -113.31 112.39 23.61 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.04 -0.726 . . . . 10.0 109.04 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.477 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 48.8 t -91.25 110.2 21.49 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.328 -0.549 . . . . 10.0 111.892 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.16 79.74 2.61 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.566 ' CG2' ' HG ' ' A' ' 89' ' ' LEU . 12.7 p -103.5 156.1 5.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 114.996 -1.002 . . . . 10.0 112.514 -176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -158.09 151.51 23.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.221 -0.899 . . . . 10.0 108.897 178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 64' ' ' LEU . 11.1 tp -90.66 103.81 16.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.905 0.383 . . . . 10.0 110.421 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.27 117.26 31.36 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.009 -0.541 . . . . 10.0 110.143 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 64.65 23.08 12.74 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.941 -0.572 . . . . 10.0 111.527 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.78 11.14 71.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.516 -0.849 . . . . 10.0 111.708 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -120.47 142.73 48.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.972 -0.381 . . . . 10.0 109.972 179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 1.4 tp -90.19 126.32 35.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.063 0.459 . . . . 10.0 110.002 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 4.7 t -120.36 99.89 8.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.305 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 44.0 t -100.37 98.81 9.41 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.396 -1.335 . . . . 10.0 107.396 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -106.0 137.92 43.07 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.036 -0.529 . . . . 10.0 112.023 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.52 -168.33 1.71 Allowed 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.345 -0.843 . . . . 10.0 108.877 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -83.28 -25.05 31.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.988 0.423 . . . . 10.0 111.516 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -125.09 -15.24 6.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.826 0.346 . . . . 10.0 111.254 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -128.99 -178.86 4.8 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.981 -0.288 . . . . 10.0 110.658 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.8 t -160.97 135.13 7.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.96 0.41 . . . . 10.0 110.407 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.9 t-160 -105.51 121.93 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -108.44 132.66 53.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.965 -0.562 . . . . 10.0 110.921 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.408 ' OE1' ' H5 ' ' A' ' 201' ' ' GCH . 3.1 pt20 -142.03 113.36 7.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 10.0 109.895 178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -112.98 128.25 56.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.104 -0.498 . . . . 10.0 111.477 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -101.69 118.75 48.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.176 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -118.23 87.33 2.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.111 -0.495 . . . . 10.0 110.321 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.2 -93.28 0.77 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.888 -0.596 . . . . 10.0 112.656 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -117.74 8.29 12.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 10.0 110.986 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -127.1 131.75 50.77 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.957 0.408 . . . . 10.0 111.727 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 53.2 ttp -113.93 109.19 18.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.011 -0.737 . . . . 10.0 109.011 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.5 t -102.29 114.72 42.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.599 -0.273 . . . . 10.0 110.327 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pm0 -108.26 144.19 36.07 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.767 0.794 . . . . 10.0 111.693 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.511 HG23 HG12 ' A' ' 119' ' ' ILE . 1.8 m -129.1 109.74 11.43 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.789 -1.096 . . . . 10.0 109.166 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 117' ' ' THR . 1.1 mt -114.48 160.89 13.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.547 -0.297 . . . . 10.0 110.691 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 17.6 m -148.81 108.56 4.02 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.364 -0.235 . . . . 10.0 110.364 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 27.0 m-85 -140.07 145.45 37.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.283 -0.636 . . . . 10.0 109.283 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.45 17.65 48.17 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 121.248 -0.501 . . . . 10.0 113.029 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.67 4.64 72.71 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.946 -0.645 . . . . 10.0 112.549 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.439 ' HB ' ' CD1' ' A' ' 17' ' ' PHE . 1.6 t -115.79 121.13 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 121.274 0.559 . . . . 10.0 110.664 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 0.0 OUTLIER -94.47 82.08 3.99 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.336 -0.847 . . . . 10.0 110.876 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.958 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 28.6 tp -68.02 111.74 4.6 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.939 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.511 HG12 HG23 ' A' ' 110' ' ' THR . 5.3 mt -102.0 128.75 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 10.0 110.364 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.44 ' CZ ' HG21 ' A' ' 8' ' ' VAL . 11.0 mtp85 -137.34 170.36 16.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.045 0.45 . . . . 10.0 111.267 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -140.13 131.19 26.29 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 178.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 4.4 m -119.17 119.65 34.77 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.655 -0.702 . . . . 10.0 111.372 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.412 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 22.2 pttt -97.1 137.4 36.22 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.801 -0.636 . . . . 10.0 109.63 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.8 ttp180 -72.6 145.31 47.44 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.982 0.42 . . . . 10.0 110.24 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.272 -0.871 . . . . 10.0 110.172 -179.498 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.974 ' H21' ' O3 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.974 ' O3 ' ' H21' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 110.44 -0.207 . . . . 10.0 110.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -78.45 -30.41 47.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.307 -0.406 . . . . 10.0 111.466 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.64 117.76 3.38 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 123.292 0.37 . . . . 10.0 110.991 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.81 -147.4 15.32 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.421 -0.895 . . . . 10.0 112.484 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -138.99 117.32 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.706 0.289 . . . . 10.0 110.485 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -116.51 128.0 55.05 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.862 0.363 . . . . 10.0 111.511 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -90.59 110.73 21.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.3 OUTLIER -82.45 147.88 5.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.573 -0.74 . . . . 10.0 111.968 -178.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -152.57 148.5 27.43 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -172.75 170.08 4.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.644 0.259 . . . . 10.0 111.461 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.37 24.76 1.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 10.0 109.819 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -127.02 146.53 50.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.81 -1.087 . . . . 10.0 110.523 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.442 ' HB3' ' CG1' ' A' ' 116' ' ' VAL . 50.6 m-20 20.97 49.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 O-C-N 125.636 1.835 . . . . 10.0 114.086 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 51.6 t80 -94.47 -61.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.864 0.364 . . . . 10.0 110.367 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.94 -32.24 72.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.917 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.08 -32.79 63.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.212 -0.449 . . . . 10.0 110.789 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.469 ' CZ ' HD21 ' A' ' 21' ' ' LEU . 20.0 t80 -70.38 -33.94 72.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.199 -0.455 . . . . 10.0 109.779 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 20.4 mt -61.86 -40.11 94.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.951 -0.568 . . . . 10.0 110.163 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.639 ' HG2' HD13 ' A' ' 28' ' ' ILE . 24.1 mttt -69.94 -21.08 63.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.291 -0.413 . . . . 10.0 110.313 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -82.67 -15.9 50.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.239 -0.437 . . . . 10.0 110.825 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD22 ' C22' ' A' ' 201' ' ' GCH . 14.5 mt -97.03 8.49 44.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.155 0.502 . . . . 10.0 110.171 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.82 35.72 10.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.066 -0.97 . . . . 10.0 110.738 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 87.7 mt -84.54 162.07 51.9 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 10.0 110.108 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' O ' HG13 ' A' ' 28' ' ' ILE . 3.0 Cg_exo -72.63 129.38 14.53 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.223 1.949 . . . . 10.0 112.005 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.74 ' HA ' HD12 ' A' ' 28' ' ' ILE . 1.6 mm-40 -55.49 -35.49 65.6 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.83 0.452 . . . . 10.0 111.138 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -63.24 -40.64 98.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.994 -0.548 . . . . 10.0 110.253 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.976 ' HG ' H232 ' A' ' 202' ' ' CHO . 4.1 tp -74.56 -33.25 62.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 10.0 110.293 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.74 HD12 ' HA ' ' A' ' 25' ' ' GLU . 89.0 mt -62.56 -31.94 53.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.882 -1.053 . . . . 10.0 110.939 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -73.83 -14.79 61.15 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 10.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.791 ' HB3' H261 ' A' ' 202' ' ' CHO . 40.5 mtt -93.47 -47.72 6.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 10.0 110.233 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' CB ' H183 ' A' ' 202' ' ' CHO . . . -56.61 -28.82 61.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.314 -0.857 . . . . 10.0 112.819 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -56.4 -21.33 24.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.373 0.508 . . . . 10.0 112.373 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -123.17 18.26 9.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.146 0.498 . . . . 10.0 110.547 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.853 ' CD1' H262 ' A' ' 202' ' ' CHO . 1.0 OUTLIER -113.0 135.77 51.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 10.0 110.777 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -118.91 84.98 27.47 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.033 -0.531 . . . . 10.0 110.439 179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.28 143.06 69.13 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.388 2.058 . . . . 10.0 111.139 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.503 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -93.19 139.3 18.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.012 0.434 . . . . 10.0 110.281 179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -96.75 106.64 18.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.894 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -91.25 122.95 34.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.434 -0.58 . . . . 10.0 109.434 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -132.91 130.43 58.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.59 0.709 . . . . 10.0 111.612 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -121.23 138.34 54.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.374 -0.83 . . . . 10.0 109.34 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -124.84 157.09 36.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.53 0.681 . . . . 10.0 111.587 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -148.52 80.98 1.46 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.915 -1.039 . . . . 10.0 108.241 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.5 -105.13 1.96 Allowed Glycine 0 N--CA 1.446 -0.654 0 N-CA-C 110.636 -0.985 . . . . 10.0 110.636 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -102.27 -20.46 14.63 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.774 0.321 . . . . 10.0 110.444 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.58 132.45 34.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 10.0 110.687 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.401 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.5 m-85 -122.86 152.67 40.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.805 -0.634 . . . . 10.0 110.649 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.5 t -134.33 104.83 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.152 -0.685 . . . . 10.0 109.152 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.873 HG21 ' H11' ' A' ' 201' ' ' GCH . 57.7 t -98.02 126.7 50.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.478 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 59.4 m -110.7 117.52 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.846 -0.615 . . . . 10.0 110.547 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -100.71 99.9 10.51 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.208 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.8 mmmm -85.55 117.56 24.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.474 -0.784 . . . . 10.0 110.565 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.817 HG21 ' SD ' ' A' ' 73' ' ' MET . 7.4 p -131.38 164.3 43.46 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 116.264 -0.425 . . . . 10.0 111.086 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.046 ' HD2' H221 ' A' ' 202' ' ' CHO . 3.0 Cg_exo -76.35 27.65 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.836 2.358 . . . . 10.0 112.467 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp85 -146.52 -59.56 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.79 0.328 . . . . 10.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -151.37 128.81 11.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.331 -0.395 . . . . 10.0 110.663 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.0 t -92.75 114.75 27.39 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.133 -0.691 . . . . 10.0 109.133 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.67 143.08 14.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 10.0 112.434 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -106.21 116.66 32.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.855 -1.066 . . . . 10.0 109.691 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.638 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -114.28 119.29 36.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -118.05 146.15 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.242 -0.286 . . . . 10.0 111.324 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -155.67 168.87 25.78 Favored 'General case' 0 CA--C 1.524 -0.035 0 CA-C-O 120.735 0.302 . . . . 10.0 111.306 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 2.7 m -122.73 133.69 54.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 10.0 109.701 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.25 115.27 2.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.104 0.478 . . . . 10.0 112.025 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.68 4.84 65.25 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.622 -0.717 . . . . 10.0 113.203 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 58.2 mttm -133.06 150.89 52.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.37 0.605 . . . . 10.0 111.48 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 27.8 tt0 -76.8 132.35 39.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.237 -0.892 . . . . 10.0 109.998 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.43 127.91 40.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.743 0.306 . . . . 10.0 110.974 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.412 ' OD1' ' HB3' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -77.76 115.32 17.42 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.172 -0.677 . . . . 10.0 109.172 178.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.813 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.3 pp -117.69 175.49 3.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.864 -0.607 . . . . 10.0 110.482 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 m -138.68 130.46 27.82 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.291 -0.563 . . . . 10.0 112.389 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.63 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 9.9 t -81.93 164.36 21.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.863 -0.608 . . . . 10.0 109.785 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.817 ' SD ' HG21 ' A' ' 53' ' ' THR . 12.5 ptp -69.69 -13.31 62.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.429 . . . . 10.0 112.079 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -77.29 -42.12 38.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.946 0.403 . . . . 10.0 109.999 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.87 17.94 2.46 Favored Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.881 -0.676 . . . . 10.0 112.751 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -97.32 131.19 44.25 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.177 -0.305 . . . . 10.0 110.177 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -85.73 109.85 18.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.562 HD11 ' H25' ' A' ' 201' ' ' GCH . 16.5 mt -121.86 156.35 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.787 -0.642 . . . . 10.0 110.301 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HD2' ' CD ' ' A' ' 67' ' ' GLU . 12.5 pttt -125.24 125.09 43.03 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.054 -0.721 . . . . 10.0 109.054 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.439 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -117.12 123.16 46.09 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.48 -0.488 . . . . 10.0 111.485 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.9 m -95.11 78.42 3.53 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.391 -0.966 . . . . 10.0 108.391 177.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.462 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -80.71 136.01 24.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.357 -0.838 . . . . 10.0 111.83 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -140.95 148.0 39.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.127 -0.488 . . . . 10.0 110.606 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.8 tp -90.76 106.72 18.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.958 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -116.51 119.22 34.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.979 -0.555 . . . . 10.0 111.058 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 59.9 30.79 20.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.549 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.87 -5.78 84.34 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.731 -0.747 . . . . 10.0 112.793 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.417 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.3 mptt -107.25 151.01 26.01 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 7.3 tp -96.78 126.23 41.79 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.106 0.479 . . . . 10.0 109.894 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.21 142.12 44.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.19 0.519 . . . . 10.0 112.023 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.442 ' SG ' HG22 ' A' ' 82' ' ' VAL . 6.8 t -142.98 99.82 3.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.532 -0.914 . . . . 10.0 108.532 177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.5 ttpt -112.61 143.82 43.15 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.113 -0.494 . . . . 10.0 111.197 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.3 -169.2 1.43 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.507 -0.769 . . . . 10.0 109.243 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -84.44 -27.83 27.27 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 10.0 110.177 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -113.81 -19.82 11.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.899 -0.591 . . . . 10.0 111.943 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -129.65 174.58 9.55 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.755 -0.378 . . . . 10.0 111.056 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -158.48 126.93 5.36 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.346 -0.388 . . . . 10.0 110.405 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.857 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -113.0 116.48 30.02 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -105.56 130.58 53.58 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.021 -0.536 . . . . 10.0 111.422 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -130.51 118.39 21.02 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -128.01 127.57 43.44 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.822 -0.351 . . . . 10.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 54.0 t -103.99 129.52 56.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.194 -0.457 . . . . 10.0 110.439 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -130.31 98.06 4.6 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.124 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 72.16 -103.91 1.4 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.027 -0.606 . . . . 10.0 112.167 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.63 17.18 13.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.303 0.573 . . . . 10.0 110.07 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -132.41 141.34 48.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.751 -0.659 . . . . 10.0 110.732 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.8 ttm -118.68 138.68 52.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.398 -0.593 . . . . 10.0 109.398 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.08 111.56 28.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.188 -0.671 . . . . 10.0 109.188 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -118.41 140.42 49.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.529 0.681 . . . . 10.0 111.309 -179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.406 HG23 HG12 ' A' ' 119' ' ' ILE . 1.2 m -126.08 116.31 21.2 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.176 -0.92 . . . . 10.0 109.558 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.89 167.84 8.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.693 0.282 . . . . 10.0 110.694 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.3 m -153.95 113.8 3.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.093 -0.336 . . . . 10.0 110.093 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -146.43 144.96 30.05 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.553 -0.536 . . . . 10.0 109.553 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.63 20.39 65.98 Favored Glycine 0 C--O 1.23 -0.133 0 C-N-CA 120.586 -0.816 . . . . 10.0 111.993 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.55 12.74 82.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 121.054 -0.593 . . . . 10.0 112.565 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 13' ' ' ASN . 11.2 t -120.61 122.55 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 O-C-N 122.587 -0.36 . . . . 10.0 110.723 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 89.0 m -91.62 91.76 8.16 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.952 0.406 . . . . 10.0 110.165 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.4 tp -75.73 109.46 9.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.213 0.53 . . . . 10.0 109.921 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.406 HG12 HG23 ' A' ' 110' ' ' THR . 2.8 mt -98.77 122.02 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.553 -0.749 . . . . 10.0 109.652 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 14.7 ptt180 -143.09 158.62 43.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.994 0.426 . . . . 10.0 111.57 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.49 145.49 47.22 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 115.782 -0.645 . . . . 10.0 109.454 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -127.2 126.84 43.5 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.305 0.574 . . . . 10.0 111.168 -179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -107.81 138.73 43.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.122 -0.49 . . . . 10.0 110.697 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -74.03 159.88 32.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.245 -0.883 . . . . 10.0 111.403 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.873 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 1.107 H211 ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.463 -0.199 . . . . 10.0 110.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -85.93 -31.2 22.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 110.024 -0.361 . . . . 10.0 110.024 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.07 103.95 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.036 -0.529 . . . . 10.0 110.977 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.15 -154.11 22.64 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.197 -0.525 . . . . 10.0 112.248 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.8 p -127.82 120.03 26.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.879 0.371 . . . . 10.0 110.684 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.496 ' O ' HG12 ' A' ' 37' ' ' ILE . 6.3 m95 -119.9 130.17 54.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -103.42 114.09 28.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.822 -0.436 . . . . 10.0 109.822 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 41.2 t -75.06 131.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.579 -0.737 . . . . 10.0 111.457 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.4 85.82 1.98 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.594 0.711 . . . . 10.0 110.094 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 121' ' ' ARG . . . -145.36 156.6 43.88 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.928 -0.483 . . . . 10.0 110.745 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -136.3 52.97 1.95 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.077 -0.511 . . . . 10.0 111.495 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -85.65 -143.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.523 -0.917 . . . . 10.0 108.523 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.99 73.37 1.67 Allowed 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' CE2' HD11 ' A' ' 18' ' ' LEU . 67.8 t80 -94.29 -62.18 1.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.982 -1.008 . . . . 10.0 113.229 -176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -56.01 -39.59 72.12 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.223 0.453 . . . . 10.0 112.223 -177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -68.59 -30.67 69.47 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.731 0.301 . . . . 10.0 110.61 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 21' ' ' LEU . 18.1 t80 -68.45 -39.11 81.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.956 -0.566 . . . . 10.0 109.632 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.837 HD12 HG23 ' A' ' 28' ' ' ILE . 11.9 mt -62.79 -35.49 80.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.065 -0.516 . . . . 10.0 109.884 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.563 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.9 mttt -74.06 -14.55 61.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.86 -0.609 . . . . 10.0 110.092 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.413 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -91.13 -7.33 51.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.149 -0.478 . . . . 10.0 111.562 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.653 HD22 ' C22' ' A' ' 201' ' ' GCH . 6.5 mt -107.79 12.1 27.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.305 0.574 . . . . 10.0 109.747 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.24 35.28 18.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.849 -1.068 . . . . 10.0 111.031 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 9.9 mt -83.2 163.48 50.24 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.294 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.475 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.4 Cg_exo -72.16 119.21 6.02 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.2 1.933 . . . . 10.0 110.584 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.806 ' HA ' HD12 ' A' ' 28' ' ' ILE . 41.3 mt-10 -55.36 -27.84 49.95 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.63 0.581 . . . . 10.0 111.226 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -65.42 -43.99 88.81 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.771 -0.649 . . . . 10.0 109.921 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.788 HD21 H222 ' A' ' 202' ' ' CHO . 1.4 tp -74.6 -31.77 62.13 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.131 0.491 . . . . 10.0 109.914 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.837 HG23 HD12 ' A' ' 18' ' ' LEU . 97.3 mt -57.78 -36.03 53.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 10.0 110.272 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 24.3 mtmt -62.44 -41.97 99.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.675 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.551 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.5 mtt -74.85 -34.82 62.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.35 0.595 . . . . 10.0 110.41 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -62.28 -22.53 66.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.487 -0.778 . . . . 10.0 111.974 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 28' ' ' ILE . 47.7 mtp180 -68.85 -10.32 56.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.951 0.405 . . . . 10.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -116.07 -36.32 4.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.012 -0.54 . . . . 10.0 110.504 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.903 HD12 H232 ' A' ' 202' ' ' CHO . 5.5 mt -66.76 126.29 25.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.515 . . . . 10.0 111.748 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -122.89 81.34 49.96 Favored Pre-proline 0 C--N 1.321 -0.643 0 N-CA-C 108.776 -0.824 . . . . 10.0 108.776 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' HD3' HG22 ' A' ' 34' ' ' ILE . 54.6 Cg_endo -71.86 163.81 37.66 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.366 2.044 . . . . 10.0 113.266 -178.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 6' ' ' TRP . 0.0 OUTLIER -106.19 142.14 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.557 -0.747 . . . . 10.0 109.948 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.09 113.47 35.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 10.0 110.249 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -91.02 123.8 34.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 10.0 109.822 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.8 130.3 61.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.45 0.643 . . . . 10.0 111.227 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -135.76 143.89 45.52 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.651 -0.704 . . . . 10.0 109.712 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -127.2 -168.03 1.82 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 10.0 112.078 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -161.13 37.57 0.14 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.297 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.51 -72.59 0.21 Allowed Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 10.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -122.04 -34.72 3.29 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 10.0 110.024 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -81.98 123.14 28.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.766 -0.652 . . . . 10.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -112.81 149.76 32.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.726 -0.67 . . . . 10.0 110.873 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.69 104.75 8.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.415 -0.811 . . . . 10.0 108.884 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.896 HG21 ' H11' ' A' ' 201' ' ' GCH . 43.4 t -97.67 119.95 46.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.762 -0.654 . . . . 10.0 110.401 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 92.0 m -101.21 114.26 28.06 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.731 -0.668 . . . . 10.0 110.826 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 57' ' ' THR . 1.6 m -97.64 96.45 8.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.019 -0.537 . . . . 10.0 109.782 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mmtt -87.11 120.13 28.06 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.478 -0.783 . . . . 10.0 110.511 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.692 HG21 ' SD ' ' A' ' 73' ' ' MET . 6.3 p -134.48 162.63 56.53 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.059 -0.519 . . . . 10.0 110.328 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.701 ' HD2' H221 ' A' ' 202' ' ' CHO . 4.3 Cg_exo -77.63 14.62 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.018 2.479 . . . . 10.0 112.317 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.44 ' HD2' HD22 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -130.35 -57.44 1.07 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.211 -0.45 . . . . 10.0 111.183 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -152.48 121.79 6.75 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.353 -0.385 . . . . 10.0 110.496 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 51' ' ' SER . 2.3 t -92.37 120.11 32.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.41 -0.589 . . . . 10.0 109.41 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -110.49 152.92 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.378 0.608 . . . . 10.0 112.635 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.9 m -109.34 117.64 34.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.913 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.532 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 39.7 m-80 -110.85 116.68 31.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.22 144.87 47.51 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.788 -0.365 . . . . 10.0 111.527 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -156.46 173.76 16.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.914 0.388 . . . . 10.0 111.303 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.2 m -123.72 135.04 53.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.863 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.23 111.73 1.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.096 0.474 . . . . 10.0 112.224 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.61 9.62 56.31 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.755 -0.736 . . . . 10.0 113.496 178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -139.56 153.05 47.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.276 0.538 . . . . 10.0 111.467 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -77.87 132.2 37.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.383 -0.826 . . . . 10.0 110.021 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.52 152.58 44.82 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.087 0.47 . . . . 10.0 111.172 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.48 97.4 9.76 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.745 . . . . 10.0 109.724 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.718 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.2 pp -103.72 169.64 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.285 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 m -140.55 130.19 24.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 10.0 111.061 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.596 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 14.2 t -85.54 162.82 18.73 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.998 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.692 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.1 ptp -70.96 -11.53 61.02 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.323 0.49 . . . . 10.0 112.323 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.67 -1.18 53.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.052 0.453 . . . . 10.0 110.666 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.28 20.76 56.45 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.11 -0.567 . . . . 10.0 113.048 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -104.39 129.07 52.35 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.083 0.468 . . . . 10.0 110.743 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.64 107.59 19.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.629 -0.714 . . . . 10.0 109.265 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -123.43 146.73 47.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.198 0.523 . . . . 10.0 110.732 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -102.71 117.18 34.09 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.981 -0.554 . . . . 10.0 109.749 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.409 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 1.8 t -113.86 118.31 33.87 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.908 0.385 . . . . 10.0 110.445 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.9 m -90.41 91.54 8.51 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.843 HG22 ' SG ' ' A' ' 91' ' ' CYS . 1.9 t -91.15 148.36 4.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.818 -0.628 . . . . 10.0 112.2 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -158.41 146.58 18.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.752 -0.658 . . . . 10.0 110.21 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -93.41 114.14 26.48 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.94 -0.573 . . . . 10.0 110.127 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.25 117.15 22.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.979 -0.555 . . . . 10.0 110.877 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 63.09 29.96 16.2 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.808 -0.633 . . . . 10.0 111.071 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.58 3.06 89.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 10.0 111.998 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -108.84 146.57 33.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.324 -0.25 . . . . 10.0 110.324 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.466 ' HA ' HD12 ' A' ' 89' ' ' LEU . 8.4 tp -98.0 118.67 35.11 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.184 -0.672 . . . . 10.0 109.184 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.88 129.67 73.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.285 -0.416 . . . . 10.0 111.99 -177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.843 ' SG ' HG22 ' A' ' 82' ' ' VAL . 1.5 t -135.03 85.06 2.14 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.006 -0.738 . . . . 10.0 109.006 177.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.8 ttmt -101.76 143.75 31.3 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.756 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -172.36 2.05 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.566 -0.743 . . . . 10.0 109.233 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -85.56 -21.07 28.71 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.93 0.395 . . . . 10.0 110.323 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -114.87 -23.67 9.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 10.0 111.375 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -132.67 -176.17 4.01 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.679 0.276 . . . . 10.0 110.684 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.554 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 28.8 t -164.64 122.7 1.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.302 -0.408 . . . . 10.0 110.652 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.895 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -100.13 121.33 41.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.047 -0.723 . . . . 10.0 109.047 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -105.73 132.53 51.74 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.907 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.444 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 45.5 mt-30 -140.83 131.99 26.42 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.158 0.286 . . . . 10.0 110.666 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -143.96 131.82 21.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.512 -0.313 . . . . 10.0 110.568 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 74.3 t -103.17 117.4 48.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.01 0.434 . . . . 10.0 109.976 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.2 tttt -112.79 83.17 1.77 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.9 -93.62 1.29 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.712 -0.676 . . . . 10.0 111.599 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -122.46 7.42 9.55 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.964 0.411 . . . . 10.0 109.99 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -120.29 120.23 35.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.981 0.42 . . . . 10.0 110.827 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.2 ttp -101.56 107.77 19.14 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.145 0.498 . . . . 10.0 110.18 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 p -95.19 117.62 39.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.099 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -124.63 156.01 38.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.557 0.694 . . . . 10.0 111.321 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.626 HG23 HG13 ' A' ' 119' ' ' ILE . 96.5 m -144.39 120.66 10.88 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.624 -0.716 . . . . 10.0 109.811 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.1 mt -120.39 165.84 15.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.173 -0.467 . . . . 10.0 110.345 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 117' ' ' THR . 20.3 m -150.18 110.92 4.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.089 -0.338 . . . . 10.0 110.089 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -143.43 145.04 32.3 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.525 -0.546 . . . . 10.0 109.525 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 64.66 16.37 61.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 10.0 112.379 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.7 11.85 70.23 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.89 -0.671 . . . . 10.0 112.936 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.22 126.99 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 117.218 0.509 . . . . 10.0 110.678 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 112' ' ' THR . 1.4 m -93.22 93.71 8.39 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.737 -0.665 . . . . 10.0 109.539 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 23.2 tp -90.57 103.38 16.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.172 0.51 . . . . 10.0 111.452 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.626 HG13 HG23 ' A' ' 110' ' ' THR . 3.1 mp -86.98 126.74 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.107 -0.701 . . . . 10.0 109.107 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.542 ' NH1' ' H11' ' A' ' 202' ' ' CHO . 17.5 mtm180 -132.82 158.36 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.587 0.708 . . . . 10.0 111.886 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.426 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -130.26 133.07 46.24 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.159 -1.052 . . . . 10.0 108.159 177.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.1 t -123.59 114.93 20.69 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.346 0.593 . . . . 10.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 138.39 31.55 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.585 -0.734 . . . . 10.0 109.169 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -65.42 155.33 35.81 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.466 -0.334 . . . . 10.0 110.283 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.181 -0.918 . . . . 10.0 110.811 178.441 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.896 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.903 H232 HD12 ' A' ' 34' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 120.601 0.239 . . . . 10.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.496 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 5.9 m-85 -69.23 -25.39 64.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.498 -0.319 . . . . 10.0 110.927 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -60.41 106.53 0.55 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.094 -0.503 . . . . 10.0 110.279 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 170.56 -148.13 11.21 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.588 -0.815 . . . . 10.0 113.146 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 37' ' ' ILE . 8.6 p -135.65 120.84 18.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.786 0.327 . . . . 10.0 111.001 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -119.97 125.9 49.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.047 -0.524 . . . . 10.0 111.45 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -96.27 113.12 24.68 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.453 HG21 ' NH2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -79.65 144.64 10.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 112.674 0.62 . . . . 10.0 112.674 -179.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -157.7 132.89 8.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.772 -1.104 . . . . 10.0 108.946 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.94 169.83 2.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.21 -0.293 . . . . 10.0 110.21 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.61 56.65 1.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.158 0.504 . . . . 10.0 110.884 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -110.71 -149.72 0.45 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.893 -0.594 . . . . 10.0 110.028 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.816 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -66.89 54.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.999 1.32 . . . . 10.0 112.386 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.483 ' CE1' ' HA ' ' A' ' 32' ' ' ARG . 43.5 t80 -75.38 -66.35 0.78 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.715 -0.221 . . . . 10.0 111.535 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 18' ' ' LEU . 9.5 pt-20 -66.59 -30.82 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.664 -0.243 . . . . 10.0 111.583 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -68.05 -31.22 70.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 10.0 110.735 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.725 ' CE2' ' H61' ' A' ' 202' ' ' CHO . 13.0 t80 -76.28 -30.89 57.97 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 10.0 109.183 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 18.9 mt -60.75 -33.26 72.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.194 0.521 . . . . 10.0 110.31 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -71.15 -24.23 62.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.394 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.17 -15.76 56.34 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 120.922 0.391 . . . . 10.0 111.44 -179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD22 ' H23' ' A' ' 201' ' ' GCH . 11.4 mt -96.67 8.6 43.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.958 -0.564 . . . . 10.0 110.004 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 56.18 40.71 29.99 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 114.952 -1.022 . . . . 10.0 110.617 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.701 ' CD1' H151 ' A' ' 202' ' ' CHO . 61.0 mt -80.95 159.03 69.51 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.368 -0.833 . . . . 10.0 110.627 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 28' ' ' ILE . 17.9 Cg_endo -63.11 125.72 16.42 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.224 1.949 . . . . 10.0 111.885 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -53.05 -32.38 46.58 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.894 0.746 . . . . 10.0 111.585 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.8 -52.72 33.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.505 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -65.4 -29.26 69.95 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.496 -0.32 . . . . 10.0 111.793 -178.064 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.624 HG23 HD12 ' A' ' 18' ' ' LEU . 96.8 mt -62.61 -22.28 29.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.971 0.415 . . . . 10.0 110.61 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.83 -27.0 27.07 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.542 0.687 . . . . 10.0 109.812 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.585 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.5 mpp? -84.93 -53.43 5.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.388 -0.823 . . . . 10.0 110.816 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -22.01 62.3 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.004 0.742 . . . . 10.0 113.004 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 14' ' ' TYR . 26.3 ptt180 -72.91 -9.91 59.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.971 0.415 . . . . 10.0 110.499 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -115.38 -30.31 6.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.404 0.621 . . . . 10.0 109.33 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 30' ' ' MET . 41.6 mt -78.56 101.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.827 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -127.1 88.72 53.65 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.669 -0.696 . . . . 10.0 110.08 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.99 -177.28 3.62 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.304 2.003 . . . . 10.0 112.309 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.565 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -91.91 146.48 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.18 -0.464 . . . . 10.0 110.346 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.5 t -97.17 107.16 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.909 0.385 . . . . 10.0 110.898 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 5' ' ' THR . 2.3 mt-10 -90.85 123.09 34.11 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.582 -0.525 . . . . 10.0 109.582 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.26 134.98 63.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.196 0.522 . . . . 10.0 111.23 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -117.6 145.83 44.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.832 -0.622 . . . . 10.0 110.054 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 3' ' ' SER . 5.8 tt0 -133.88 143.74 48.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.935 0.398 . . . . 10.0 111.17 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -144.48 77.25 1.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.659 -0.701 . . . . 10.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -103.92 2.82 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.73 -0.748 . . . . 10.0 111.349 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -107.09 -16.96 14.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.711 0.291 . . . . 10.0 110.241 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -88.61 133.65 34.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.27 -0.423 . . . . 10.0 110.895 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -120.13 148.39 43.69 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.879 -0.6 . . . . 10.0 109.786 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.6 t -132.05 99.19 3.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 109.112 -0.699 . . . . 10.0 109.112 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.795 HG21 ' H11' ' A' ' 201' ' ' GCH . 23.8 t -92.29 126.98 44.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.959 -0.564 . . . . 10.0 110.472 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.0 m -107.34 104.66 14.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.25 -0.886 . . . . 10.0 110.262 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -95.89 116.48 28.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.11 -0.495 . . . . 10.0 110.13 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -84.38 145.9 27.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.129 -0.487 . . . . 10.0 111.236 -178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' H232 ' A' ' 202' ' ' CHO . 15.8 p -135.01 176.45 2.87 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.309 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HD2' H232 ' A' ' 202' ' ' CHO . 3.5 Cg_exo -76.6 6.3 4.17 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.108 2.539 . . . . 10.0 112.833 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.831 ' HB2' H261 ' A' ' 202' ' ' CHO . 1.6 ttt180 -136.0 -59.08 0.75 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 122.376 -0.202 . . . . 10.0 111.093 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -152.35 133.83 14.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.542 0.211 . . . . 10.0 110.922 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 9.7 t -76.05 136.84 39.92 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 10.0 110.434 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.2 153.01 4.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.18 -0.463 . . . . 10.0 110.723 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 31.5 m -111.36 116.23 30.62 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.06 -0.518 . . . . 10.0 110.894 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.531 ' ND2' ' H33' ' A' ' 201' ' ' GCH . 65.9 m-20 -111.85 120.23 41.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.08 150.88 42.59 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 122.165 -0.334 . . . . 10.0 111.587 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.79 179.43 8.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.362 -0.381 . . . . 10.0 110.573 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.4 m -131.93 141.01 49.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.211 -0.45 . . . . 10.0 109.924 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.4 mt -58.98 117.91 5.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.304 -0.407 . . . . 10.0 112.03 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.26 21.79 69.45 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.947 -0.57 . . . . 10.0 112.13 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mtpt -136.29 147.66 47.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.924 0.392 . . . . 10.0 110.77 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -82.87 125.4 31.3 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.27 148.78 51.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.065 0.459 . . . . 10.0 111.6 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.31 122.09 32.22 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 10.0 109.341 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.755 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.2 pp -128.62 163.11 34.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.025 -0.534 . . . . 10.0 110.326 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.9 m -112.48 143.88 42.88 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.325 0.583 . . . . 10.0 112.298 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.691 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 7.4 t -107.0 161.69 14.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.704 -0.68 . . . . 10.0 109.521 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.564 ' HG2' H213 ' A' ' 202' ' ' CHO . 1.3 mpp? -66.65 -19.89 65.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.899 0.333 . . . . 10.0 111.899 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 14.4 t70 -74.24 -23.49 59.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 10.0 110.537 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.86 39.8 4.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.699 . . . . 10.0 111.878 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 19.3 mttp -121.29 152.77 38.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.674 0.273 . . . . 10.0 110.435 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -91.71 118.35 30.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.007 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 11.0 mt -131.23 150.91 51.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.252 0.549 . . . . 10.0 110.589 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -119.56 117.6 28.8 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.582 -0.736 . . . . 10.0 109.284 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.698 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.6 OUTLIER -107.65 111.08 23.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.039 0.447 . . . . 10.0 110.959 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 m -84.55 78.86 9.76 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.863 -0.792 . . . . 10.0 108.863 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.492 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 t -82.82 145.47 8.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.398 -0.819 . . . . 10.0 111.891 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -149.25 147.98 29.03 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.205 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.5 tp -94.61 106.65 18.64 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.988 -0.375 . . . . 10.0 109.988 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -113.49 119.47 37.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.811 -0.631 . . . . 10.0 110.814 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 59.88 25.42 14.54 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.976 -0.557 . . . . 10.0 111.232 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.95 80.12 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.358 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 9.2 mptt -107.34 145.66 32.57 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 89' ' ' LEU . 7.5 tp -94.48 122.78 37.42 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.969 -0.382 . . . . 10.0 109.969 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.59 135.61 62.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.455 -0.338 . . . . 10.0 111.622 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 38.0 t -133.25 102.48 5.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.184 -1.043 . . . . 10.0 108.184 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -107.54 145.55 33.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.067 0.46 . . . . 10.0 111.153 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.08 -177.8 3.22 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.536 -0.757 . . . . 10.0 109.332 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.27 28.04 2.33 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.164 0.507 . . . . 10.0 110.154 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -163.17 -33.97 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.267 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.78 -178.15 4.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.314 -0.403 . . . . 10.0 111.011 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -155.21 129.7 9.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.995 -0.548 . . . . 10.0 111.012 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.602 ' CE1' ' H42' ' A' ' 201' ' ' GCH . 3.9 t-160 -118.13 125.77 50.9 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -127.63 140.44 52.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.542 0.571 . . . . 10.0 112.542 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 70.5 mt-30 -136.73 124.42 22.42 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.385 -0.825 . . . . 10.0 110.311 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -126.31 130.64 51.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.858 0.361 . . . . 10.0 110.979 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.7 122.06 49.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.86 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -115.03 77.78 1.1 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.222 -0.445 . . . . 10.0 110.844 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.52 -88.55 1.03 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.966 -0.635 . . . . 10.0 112.954 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -123.03 21.38 9.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.253 0.549 . . . . 10.0 110.465 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -141.17 158.14 44.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.684 -0.689 . . . . 10.0 110.258 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.0 ttp -135.7 120.64 18.66 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.003 0.43 . . . . 10.0 110.049 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.16 123.54 60.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.39 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.603 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 0.2 OUTLIER -121.66 143.46 49.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.143 0.497 . . . . 10.0 111.36 -179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 m -137.9 107.97 6.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.372 -0.831 . . . . 10.0 109.281 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.51 170.45 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.007 -0.542 . . . . 10.0 110.533 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.6 m -152.01 111.1 3.87 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.881 -0.414 . . . . 10.0 109.881 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 13.7 m-85 -143.14 146.88 34.13 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.55 24.33 56.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.074 -0.584 . . . . 10.0 112.791 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.62 13.3 81.77 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.835 -0.697 . . . . 10.0 112.803 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 17' ' ' PHE . 45.0 t -122.36 124.01 69.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.998 0.399 . . . . 10.0 110.8 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 86.1 m -92.37 88.57 6.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.151 -0.477 . . . . 10.0 109.776 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.816 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.5 tp -76.83 124.01 27.07 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.462 0.649 . . . . 10.0 110.814 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 mt -108.88 116.05 50.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.023 -0.989 . . . . 10.0 111.157 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 38.5 mtp180 -120.75 146.76 46.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.33 -0.395 . . . . 10.0 110.562 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 mmp_? -115.69 148.88 39.23 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.834 -0.802 . . . . 10.0 108.834 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -140.71 139.68 34.75 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.306 0.574 . . . . 10.0 111.203 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -116.85 136.05 53.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.241 -0.891 . . . . 10.0 109.346 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -73.76 146.92 43.95 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.712 -0.395 . . . . 10.0 110.23 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.423 -0.798 . . . . 10.0 110.79 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.795 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.831 H261 ' HB2' ' A' ' 55' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 110.365 -0.235 . . . . 10.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -73.18 -28.8 62.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.412 -0.358 . . . . 10.0 110.609 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.3 p -59.36 104.43 0.26 Allowed 'General case' 0 C--N 1.33 -0.246 0 O-C-N 123.3 0.375 . . . . 10.0 110.187 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.37 -153.8 15.2 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.614 -0.803 . . . . 10.0 112.1 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -135.62 118.36 16.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.719 0.295 . . . . 10.0 110.437 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -120.38 129.05 53.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.296 0.48 . . . . 10.0 112.296 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.9 118.81 31.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.685 -0.857 . . . . 10.0 108.685 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.3 t -85.48 141.26 14.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 113.281 0.845 . . . . 10.0 113.281 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -145.03 130.38 18.69 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.56 ' HA ' HH21 ' A' ' 121' ' ' ARG . . . -164.06 150.63 11.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.29 0.566 . . . . 10.0 112.502 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -136.31 39.48 2.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.984 -1.007 . . . . 10.0 109.183 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 74.6 mm-40 -98.75 -156.3 0.54 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.794 -0.639 . . . . 10.0 110.594 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.4 78.16 1.02 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.446 0.641 . . . . 10.0 109.547 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 45.3 t80 -96.32 -62.59 1.25 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.151 -0.931 . . . . 10.0 111.236 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.8 pm0 -60.99 -32.41 71.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.289 -0.414 . . . . 10.0 111.9 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tp10 -70.66 -41.38 72.18 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -63.55 -33.78 76.34 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.11 -0.7 . . . . 10.0 109.11 178.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.727 HD12 HG23 ' A' ' 28' ' ' ILE . 40.2 mt -57.32 -38.87 74.73 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 121.238 0.542 . . . . 10.0 110.306 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE2' HG21 ' A' ' 28' ' ' ILE . 3.7 mmtt -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.852 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.811 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.85 -29.37 61.02 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.163 0.431 . . . . 10.0 112.163 -178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.764 HD23 ' H23' ' A' ' 201' ' ' GCH . 0.9 OUTLIER -89.48 9.95 24.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.218 -0.446 . . . . 10.0 110.732 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.83 45.62 12.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.436 -0.802 . . . . 10.0 110.15 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.824 ' CD1' H151 ' A' ' 202' ' ' CHO . 58.7 mt -83.36 162.01 55.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.074 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' O ' HG13 ' A' ' 28' ' ' ILE . 7.5 Cg_exo -71.25 128.41 14.64 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.815 2.343 . . . . 10.0 112.187 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.542 ' HA ' HD12 ' A' ' 28' ' ' ILE . 17.9 mm-40 -49.92 -34.05 19.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.822 -0.626 . . . . 10.0 112.389 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -66.67 -52.58 43.17 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.753 -0.203 . . . . 10.0 110.616 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' HA ' ' CE ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -66.82 -25.88 66.66 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.624 -0.262 . . . . 10.0 111.435 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.727 HG23 HD12 ' A' ' 18' ' ' LEU . 87.6 mt -63.6 -22.23 30.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.942 0.401 . . . . 10.0 109.946 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -85.96 -20.93 28.2 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.101 0.477 . . . . 10.0 109.822 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.657 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.6 mpp? -92.53 -39.29 11.45 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.056 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.525 ' HA ' HD12 ' A' ' 34' ' ' ILE . . . -59.3 -33.38 71.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.756 -0.656 . . . . 10.0 111.464 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.31 -14.0 23.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.892 0.377 . . . . 10.0 111.355 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.3 -13.55 11.06 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.151 -0.477 . . . . 10.0 111.041 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.657 HG13 ' O ' ' A' ' 30' ' ' MET . 66.4 mt -70.7 98.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.741 0.305 . . . . 10.0 110.289 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -126.41 75.03 73.85 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.527 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -88.17 -172.37 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.972 2.448 . . . . 10.0 112.212 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.48 142.47 18.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.948 -0.569 . . . . 10.0 109.668 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.3 t -95.79 108.23 20.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.908 0.385 . . . . 10.0 110.437 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.29 121.38 32.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.754 -0.657 . . . . 10.0 109.767 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.46 123.39 46.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.312 0.577 . . . . 10.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -124.01 145.15 49.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.819 -0.628 . . . . 10.0 109.483 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -128.8 168.54 15.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.383 0.611 . . . . 10.0 111.477 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -147.73 78.57 1.46 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.715 -1.129 . . . . 10.0 108.382 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 -99.84 2.16 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 110.41 -1.076 . . . . 10.0 110.41 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 29.3 m-20 -109.0 -17.54 13.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.837 0.351 . . . . 10.0 110.563 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.26 133.05 34.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.44 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.1 m-85 -121.03 151.53 39.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.971 -0.559 . . . . 10.0 110.847 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.6 t -135.69 104.49 4.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.64 -0.709 . . . . 10.0 109.263 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.757 HG21 ' H11' ' A' ' 201' ' ' GCH . 14.8 t -97.01 134.11 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.959 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 87.3 m -118.23 118.23 31.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.582 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -104.23 126.3 51.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.26 -0.427 . . . . 10.0 109.908 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -92.11 131.8 37.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.219 0.451 . . . . 10.0 112.219 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.645 ' HB ' H232 ' A' ' 202' ' ' CHO . 3.9 p -136.54 155.97 76.62 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.942 -0.572 . . . . 10.0 109.548 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' C23' ' A' ' 202' ' ' CHO . 49.8 Cg_exo -58.6 -17.77 36.68 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 123.354 2.703 . . . . 10.0 113.272 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.647 ' HG3' H262 ' A' ' 202' ' ' CHO . 2.6 mtm180 -99.72 -61.89 1.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.628 0.251 . . . . 10.0 111.212 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -155.68 143.43 19.69 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 10.0 111.484 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.98 123.08 25.81 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.709 -0.678 . . . . 10.0 110.115 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.15 152.46 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.004 0.43 . . . . 10.0 110.849 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.64 135.31 54.98 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.723 -0.671 . . . . 10.0 111.68 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.63 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 37.3 m-80 -129.25 124.58 34.83 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 m -126.48 146.06 50.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 118.036 0.38 . . . . 10.0 110.932 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 25.8 p90 -155.17 170.68 21.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.661 0.267 . . . . 10.0 111.355 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -123.26 127.1 48.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.85 -0.613 . . . . 10.0 109.554 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 45' ' ' ASP . 67.0 mt -56.27 122.7 12.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.941 0.4 . . . . 10.0 111.737 -179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.34 -7.36 72.04 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.766 -0.652 . . . . 10.0 113.142 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 160.08 29.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.996 0.427 . . . . 10.0 110.917 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.79 134.33 34.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.39 148.05 49.67 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.528 -0.469 . . . . 10.0 111.634 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.05 101.15 13.69 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.72 -0.673 . . . . 10.0 109.707 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.63 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -110.31 164.08 6.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.837 -0.62 . . . . 10.0 110.008 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 m -132.11 126.26 33.31 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 119.864 -0.734 . . . . 10.0 112.45 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.582 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 9.0 t -76.65 156.12 32.89 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.866 -0.606 . . . . 10.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.811 ' SD ' ' H17' ' A' ' 202' ' ' CHO . 15.6 ptp -68.44 -14.6 63.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.837 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.469 ' OD2' ' HG3' ' A' ' 76' ' ' LYS . 5.5 t70 -71.86 -24.5 61.69 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.157 0.503 . . . . 10.0 110.261 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.55 22.01 7.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 10.0 112.97 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.469 ' HG3' ' OD2' ' A' ' 74' ' ' ASP . 31.9 mttp -106.86 153.18 22.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.763 0.316 . . . . 10.0 110.59 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.16 117.28 33.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.795 -0.639 . . . . 10.0 109.481 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD21 ' H24' ' A' ' 201' ' ' GCH . 0.5 OUTLIER -134.7 143.48 47.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.041 0.448 . . . . 10.0 110.588 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -108.36 116.14 31.41 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 1.4 t -108.18 129.82 55.16 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.97 0.414 . . . . 10.0 110.787 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -96.07 85.61 4.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.16 -0.681 . . . . 10.0 109.16 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' SG ' ' A' ' 91' ' ' CYS . 0.3 OUTLIER -84.38 141.02 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.737 -0.665 . . . . 10.0 111.808 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -153.06 145.16 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.666 -0.697 . . . . 10.0 109.782 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.0 109.75 20.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.156 -0.474 . . . . 10.0 109.844 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -120.55 109.56 15.41 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.304 -0.407 . . . . 10.0 111.009 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 65.48 35.42 7.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.716 -0.675 . . . . 10.0 111.262 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.17 5.52 85.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.66 -0.781 . . . . 10.0 112.132 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -114.88 126.3 54.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 8.2 tp -81.38 125.04 29.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.212 0.529 . . . . 10.0 109.681 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 37.5 t -115.59 126.88 73.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.271 -0.422 . . . . 10.0 112.112 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.78 ' SG ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -127.09 78.66 1.83 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 177.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 32.8 ttpt -95.85 139.27 32.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.732 -0.667 . . . . 10.0 111.076 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.7 -163.49 0.92 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.636 -0.711 . . . . 10.0 109.605 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.23 -38.39 24.58 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.923 0.392 . . . . 10.0 110.675 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -113.21 -16.74 12.5 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.381 0.511 . . . . 10.0 112.381 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.27 177.97 6.78 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.617 0.246 . . . . 10.0 110.449 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 12.9 t -160.64 133.36 6.35 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.142 0.496 . . . . 10.0 110.455 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.708 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.6 t-160 -102.4 125.7 49.2 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.467 -0.788 . . . . 10.0 109.188 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -101.96 122.74 44.62 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.721 -0.391 . . . . 10.0 111.466 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 38.5 mt-30 -122.31 106.23 10.91 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.532 0.52 . . . . 10.0 109.645 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -125.81 126.94 45.33 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.951 0.405 . . . . 10.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 96.8 t -109.44 118.17 56.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.129 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -115.33 104.15 11.51 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.789 -0.642 . . . . 10.0 109.825 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.5 -105.81 1.69 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.518 -0.849 . . . . 10.0 111.393 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -120.45 14.4 11.96 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 10.0 109.804 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -121.41 123.26 41.67 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.364 -0.834 . . . . 10.0 110.776 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 51.7 ttp -101.89 125.2 48.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 121' ' ' ARG . 0.5 OUTLIER -118.29 124.37 73.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.241 0.543 . . . . 10.0 110.902 -179.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 100' ' ' GLN . 12.5 mt-10 -119.67 151.93 37.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.583 0.706 . . . . 10.0 111.403 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.2 m -137.69 102.48 4.76 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.622 -1.172 . . . . 10.0 108.561 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.454 HD11 HH11 ' A' ' 120' ' ' ARG . 1.0 OUTLIER -110.46 158.61 10.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.372 -0.376 . . . . 10.0 110.165 -178.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 29.0 m -148.15 107.51 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.0 0.429 . . . . 10.0 111.603 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 17' ' ' PHE . 57.7 m-85 -139.81 147.87 41.37 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 107.98 -1.119 . . . . 10.0 107.98 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.811 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 68.27 13.6 65.15 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.07 -1.062 . . . . 10.0 112.189 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 11.83 82.31 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.407 -0.425 . . . . 10.0 112.719 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.573 HG21 ' HA ' ' A' ' 17' ' ' PHE . 2.1 t -115.46 138.71 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 117.353 0.577 . . . . 10.0 110.207 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.4 m -102.69 97.4 7.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.099 0.476 . . . . 10.0 110.523 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 H192 ' A' ' 202' ' ' CHO . 11.4 tp -93.2 101.83 14.11 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.942 -0.572 . . . . 10.0 110.784 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.463 ' HB ' ' HG3' ' A' ' 12' ' ' GLU . 3.0 mt -85.9 135.71 24.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.915 -0.772 . . . . 10.0 108.915 178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.454 HH11 HD11 ' A' ' 111' ' ' ILE . 14.5 mtp-105 -132.39 149.05 52.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.068 0.461 . . . . 10.0 111.526 -178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.56 HH21 ' HA ' ' A' ' 10' ' ' ALA . 9.9 mtm180 -128.51 135.61 49.67 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 108.245 -1.021 . . . . 10.0 108.245 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.34 126.49 33.4 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.739 -0.664 . . . . 10.0 111.018 -178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -97.21 140.53 31.56 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.314 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -70.86 145.98 49.92 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.001 -0.37 . . . . 10.0 110.001 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.408 -0.806 . . . . 10.0 110.695 -178.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.766 ' H21' ' O3 ' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.824 H151 ' CD1' ' A' ' 23' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.796 0.332 . . . . 10.0 110.263 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 6.9 m-85 -82.56 -27.11 31.82 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.271 -0.422 . . . . 10.0 110.704 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -51.13 113.61 0.98 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.574 0.546 . . . . 10.0 111.071 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.29 -150.93 20.66 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.361 -0.836 . . . . 10.0 111.733 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' HB ' HD11 ' A' ' 37' ' ' ILE . 1.2 p -137.87 118.68 14.15 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.924 0.392 . . . . 10.0 110.14 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -116.7 127.43 54.39 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.302 -0.408 . . . . 10.0 111.328 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -91.82 126.63 36.98 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.027 -0.731 . . . . 10.0 109.027 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.4 t -93.05 143.67 10.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.649 0.738 . . . . 10.0 112.798 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CE2' ' HG3' ' A' ' 121' ' ' ARG . 42.3 p90 -149.09 142.06 24.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.769 -1.105 . . . . 10.0 108.163 178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.78 -178.33 1.27 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.237 0.471 . . . . 10.0 111.898 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -155.76 44.06 0.44 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.94 . . . . 10.0 110.232 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -102.85 -156.77 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.924 -0.58 . . . . 10.0 110.937 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.88 73.73 1.62 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.195 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.42 ' CE2' H193 ' A' ' 202' ' ' CHO . 58.1 t80 -87.86 -64.43 1.15 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.768 -0.651 . . . . 10.0 111.833 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.89 -29.25 70.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.592 -0.276 . . . . 10.0 111.335 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -71.04 -33.59 70.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.409 -0.36 . . . . 10.0 110.292 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HD2' HD22 ' A' ' 118' ' ' LEU . 14.9 t80 -70.07 -37.09 75.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.23 -0.441 . . . . 10.0 110.219 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' HA ' HD12 ' A' ' 21' ' ' LEU . 13.5 mt -60.16 -32.4 71.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 10.0 110.32 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HG2' HD13 ' A' ' 28' ' ' ILE . 14.2 mttt -71.99 -20.13 61.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.966 -0.561 . . . . 10.0 110.784 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -89.36 4.02 50.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.297 -0.41 . . . . 10.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 18' ' ' LEU . 15.8 mt -113.63 15.87 18.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.153 -0.476 . . . . 10.0 110.719 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.1 40.96 24.7 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.523 -0.762 . . . . 10.0 111.02 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.489 HD13 H151 ' A' ' 202' ' ' CHO . 79.1 mt -96.49 158.6 33.5 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.915 -0.584 . . . . 10.0 110.61 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -73.6 136.63 23.84 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.689 2.26 . . . . 10.0 112.739 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 3.2 tp10 -55.9 -42.43 75.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.595 -0.73 . . . . 10.0 111.776 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -64.62 -37.25 86.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.416 -0.356 . . . . 10.0 111.001 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.588 ' HG ' ' C23' ' A' ' 202' ' ' CHO . 3.3 tp -71.34 -38.26 71.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.244 0.545 . . . . 10.0 109.98 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.486 HG23 HD12 ' A' ' 18' ' ' LEU . 93.5 mt -61.82 -30.98 49.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.43 -0.805 . . . . 10.0 110.824 179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 91.3 mttt -67.73 -24.83 65.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.138 -0.483 . . . . 10.0 111.451 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB2' ' C24' ' A' ' 202' ' ' CHO . 10.8 mtt -84.78 -43.37 14.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.224 0.535 . . . . 10.0 110.081 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.786 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.72 -28.77 61.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.755 -1.111 . . . . 10.0 113.751 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -59.03 -16.82 20.43 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.388 0.514 . . . . 10.0 112.388 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -121.29 17.94 11.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 10.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 HD11 H261 ' A' ' 202' ' ' CHO . 1.3 mt -117.81 115.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.477 0.656 . . . . 10.0 111.833 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.26 82.12 38.06 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.173 -0.921 . . . . 10.0 109.211 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.8 142.8 40.1 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.624 2.216 . . . . 10.0 111.948 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -76.09 138.22 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 109.119 -0.696 . . . . 10.0 109.119 178.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.8 t -95.18 110.39 23.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 10.0 110.641 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.59 128.45 35.58 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.961 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.23 128.53 45.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.131 0.491 . . . . 10.0 110.547 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -129.35 140.16 51.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.904 -0.589 . . . . 10.0 109.981 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 13.6 pt20 -129.75 178.44 6.5 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 121.01 -0.276 . . . . 10.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -152.93 36.49 0.49 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.908 0.861 . . . . 10.0 109.127 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.77 -93.67 0.51 Allowed Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 110.674 -0.971 . . . . 10.0 110.674 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -107.39 -21.04 13.07 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.901 -0.407 . . . . 10.0 109.901 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.29 134.4 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.955 -0.566 . . . . 10.0 110.288 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.2 m-85 -125.29 153.11 43.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.666 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -133.88 105.49 7.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.016 -0.735 . . . . 10.0 109.016 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.851 HG21 ' H11' ' A' ' 201' ' ' GCH . 18.7 t -98.13 128.64 49.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.15 0.5 . . . . 10.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 97.5 m -114.5 117.6 31.42 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.535 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.0 m -111.71 116.12 30.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.868 -0.606 . . . . 10.0 109.804 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -92.9 130.74 38.39 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.297 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 p -130.78 159.19 72.37 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 116.382 -0.372 . . . . 10.0 110.356 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.569 ' HG2' ' C24' ' A' ' 202' ' ' CHO . 25.2 Cg_exo -70.67 8.01 1.09 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.434 2.756 . . . . 10.0 112.814 178.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.496 ' NH2' ' HA ' ' A' ' 74' ' ' ASP . 6.8 ptm180 -125.94 -53.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.488 -0.324 . . . . 10.0 111.138 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -160.13 127.5 4.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.836 0.35 . . . . 10.0 110.746 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.4 m -79.38 119.02 21.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.13 -0.486 . . . . 10.0 110.322 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.78 142.23 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.143 0.497 . . . . 10.0 111.669 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.1 m -110.55 125.49 53.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.235 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.694 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 26.6 m-80 -115.74 124.81 51.73 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.07 147.94 48.75 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 121.158 -0.217 . . . . 10.0 110.872 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.9 p90 -159.22 172.87 17.27 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-O 120.936 0.398 . . . . 10.0 111.807 -178.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.0 m -129.57 134.71 47.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.604 -0.725 . . . . 10.0 109.584 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.5 mt -55.2 110.85 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.339 0.866 . . . . 10.0 113.339 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.31 7.97 63.22 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.792 -0.64 . . . . 10.0 113.438 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -128.93 140.78 51.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 117.125 0.462 . . . . 10.0 110.624 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -65.21 131.78 47.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.471 -0.566 . . . . 10.0 109.471 179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.85 130.77 50.87 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.859 0.361 . . . . 10.0 111.936 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -80.8 112.07 17.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.893 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -121.02 168.07 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.859 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.5 m -135.74 138.94 43.2 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.245 -0.582 . . . . 10.0 111.126 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.517 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 15.1 t -84.42 164.93 18.57 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.954 -0.387 . . . . 10.0 109.954 178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.438 ' SD ' ' H14' ' A' ' 202' ' ' CHO . 9.7 ptp -61.82 -23.57 66.32 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.258 0.836 . . . . 10.0 113.258 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' HA ' ' NH2' ' A' ' 55' ' ' ARG . 31.3 t70 -85.43 -10.56 56.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.431 -0.508 . . . . 10.0 111.868 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.83 35.98 4.92 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 119.964 -1.112 . . . . 10.0 113.852 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -113.63 132.98 55.56 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.441 -0.447 . . . . 10.0 110.009 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -81.83 121.8 26.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.523 -0.308 . . . . 10.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' H29' ' A' ' 201' ' ' GCH . 2.9 mt -133.56 151.1 51.66 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 10.0 109.834 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -116.29 117.34 29.72 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.786 -0.449 . . . . 10.0 109.786 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.85 106.19 11.05 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.909 -0.317 . . . . 10.0 110.399 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.7 m -78.02 85.03 4.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.793 -0.818 . . . . 10.0 108.793 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.8 t -76.31 131.65 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 115.591 -0.731 . . . . 10.0 111.787 -178.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.44 151.55 39.38 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 114.97 -1.014 . . . . 10.0 109.683 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.603 HD13 ' N ' ' A' ' 85' ' ' ALA . 2.7 tm? -88.58 135.08 33.67 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 108.115 -1.069 . . . . 10.0 108.115 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.603 ' N ' HD13 ' A' ' 84' ' ' LEU . . . -141.76 110.71 6.23 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 114.967 -1.015 . . . . 10.0 111.414 -178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 57.22 25.82 11.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.99 -0.55 . . . . 10.0 111.824 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' CD1' ' A' ' 84' ' ' LEU . . . 95.03 -1.17 64.86 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.636 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -111.01 141.39 44.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 -179.353 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 5.0 tp -92.88 128.05 38.61 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.826 0.346 . . . . 10.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 92' ' ' LYS . 4.6 t -134.9 138.28 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.236 -0.438 . . . . 10.0 111.885 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.877 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 12.3 p -130.83 32.96 4.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.694 0.759 . . . . 10.0 109.232 177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.535 ' H ' HG12 ' A' ' 90' ' ' VAL . 20.9 ttmm -47.21 134.99 10.61 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.405 -1.27 . . . . 10.0 112.665 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.04 -168.14 1.46 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.171 -0.922 . . . . 10.0 109.08 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.83 -22.08 29.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.976 0.417 . . . . 10.0 111.046 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -114.48 -29.29 6.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.185 -0.461 . . . . 10.0 111.86 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -125.81 178.77 5.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.677 -0.409 . . . . 10.0 111.062 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.3 t -155.66 141.65 18.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.985 0.422 . . . . 10.0 111.217 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.847 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.5 t-160 -125.9 125.67 43.16 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -119.59 128.76 54.2 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.087 0.402 . . . . 10.0 112.087 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.475 ' HG2' ' HB2' ' A' ' 109' ' ' GLU . 63.5 mt-30 -125.41 116.97 22.69 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.463 -0.335 . . . . 10.0 110.365 178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -122.61 131.61 53.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.814 0.34 . . . . 10.0 111.571 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 55.6 t -108.59 122.86 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.122 0.487 . . . . 10.0 110.451 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.65 68.7 0.68 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.796 -0.446 . . . . 10.0 109.796 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.02 -96.26 2.09 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.872 -0.68 . . . . 10.0 112.567 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 124' ' ' ARG . 10.8 t-20 -106.07 -6.06 18.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.278 0.561 . . . . 10.0 110.548 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -113.59 155.41 25.49 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.279 -0.419 . . . . 10.0 110.915 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 52.4 ttp -133.89 124.56 26.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.376 -0.374 . . . . 10.0 110.544 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.7 p -114.43 114.06 45.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 109.362 -0.607 . . . . 10.0 109.362 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 4.2 pt-20 -114.33 144.62 42.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.551 0.691 . . . . 10.0 111.706 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.609 HG23 HG12 ' A' ' 119' ' ' ILE . 1.3 m -124.63 115.24 20.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.827 -1.079 . . . . 10.0 110.132 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.7 152.79 18.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 109.655 -0.498 . . . . 10.0 109.655 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 20.5 m -141.76 112.28 7.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.708 0.29 . . . . 10.0 110.838 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -147.61 146.18 29.27 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.818 -0.438 . . . . 10.0 109.818 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 65.94 16.33 63.88 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.17 -0.538 . . . . 10.0 112.156 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.03 17.02 70.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 121.189 -0.529 . . . . 10.0 111.965 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.9 t -122.58 128.44 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 121.023 0.439 . . . . 10.0 110.815 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 3.1 m -93.62 96.25 9.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.209 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD22 ' HD2' ' A' ' 17' ' ' PHE . 14.6 tp -88.15 102.12 14.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 10.0 110.544 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.65 129.9 49.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.875 -0.602 . . . . 10.0 110.347 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.6 mtp-105 -138.51 159.83 41.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.017 0.437 . . . . 10.0 111.017 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.669 ' HG3' ' CE2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -121.43 143.6 49.14 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.162 -1.051 . . . . 10.0 108.162 178.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.07 150.19 52.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.893 0.377 . . . . 10.0 111.157 -179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.6 pttt -122.51 141.45 51.65 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.783 -0.644 . . . . 10.0 109.678 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 105' ' ' ASN . 16.2 ttp180 -69.47 146.09 52.22 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.987 0.423 . . . . 10.0 110.414 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.482 -0.771 . . . . 10.0 110.372 -179.74 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.893 ' H34' HD13 ' A' ' 70' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 1.117 H211 ' O24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.565 0.221 . . . . 10.0 110.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.0 m-85 -76.38 -29.92 57.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.466 -0.333 . . . . 10.0 110.22 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.464 ' OG ' ' HG2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -59.27 101.81 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.711 -0.677 . . . . 10.0 111.424 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.22 -162.3 31.84 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.707 -0.557 . . . . 10.0 111.707 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.665 ' HB ' HD11 ' A' ' 37' ' ' ILE . 16.4 p -124.52 115.95 21.69 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.913 -0.403 . . . . 10.0 109.913 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -115.13 122.37 45.88 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.925 -0.31 . . . . 10.0 111.826 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -92.79 103.66 15.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.072 -1.084 . . . . 10.0 108.072 178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.2 p -72.06 137.48 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.317 -0.856 . . . . 10.0 113.239 -177.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -141.06 134.54 29.91 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.148 -0.933 . . . . 10.0 109.146 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.85 161.16 1.56 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.624 0.249 . . . . 10.0 110.467 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -136.3 34.11 2.79 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.19 -0.459 . . . . 10.0 110.942 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -121.36 141.13 51.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.158 -0.474 . . . . 10.0 110.386 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 27.14 45.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 O-C-N 125.674 1.859 . . . . 10.0 113.551 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.479 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 90.0 t80 -95.16 -58.73 2.07 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.696 0.284 . . . . 10.0 110.886 -178.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.86 -30.13 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 10.0 111.22 -178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -76.27 -33.25 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.891 0.377 . . . . 10.0 110.104 179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' CD2' H192 ' A' ' 202' ' ' CHO . 28.8 t80 -69.45 -35.52 75.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.971 -0.558 . . . . 10.0 109.761 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD12 HG23 ' A' ' 28' ' ' ILE . 17.0 mt -58.19 -34.35 70.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 10.0 110.618 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.1 mttp -77.56 -18.5 56.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.483 . . . . 10.0 110.834 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 -22.87 42.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.049 0.452 . . . . 10.0 111.073 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD13 ' H62' ' A' ' 202' ' ' CHO . 1.2 mt -87.36 6.13 35.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.868 -0.606 . . . . 10.0 110.152 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.61 39.68 21.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.593 -0.73 . . . . 10.0 109.812 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 HD13 H152 ' A' ' 202' ' ' CHO . 71.1 mt -84.43 165.66 36.97 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.058 -0.974 . . . . 10.0 110.811 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' O ' HG13 ' A' ' 28' ' ' ILE . 6.9 Cg_exo -70.76 128.9 15.71 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.905 2.403 . . . . 10.0 111.505 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.661 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.5 mp0 -54.65 -36.21 64.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.497 -0.774 . . . . 10.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -64.91 -40.23 94.75 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.019 -0.537 . . . . 10.0 110.939 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.841 HD11 H222 ' A' ' 202' ' ' CHO . 4.7 tt -69.28 -35.27 75.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.464 . . . . 10.0 110.026 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 25' ' ' GLU . 73.4 mt -61.97 -26.02 38.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 10.0 110.554 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 74.9 mttt -76.49 -24.01 53.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.928 -0.578 . . . . 10.0 110.732 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.483 ' O ' HG13 ' A' ' 34' ' ' ILE . 9.8 mmt -92.95 -46.69 7.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.207 0.527 . . . . 10.0 110.354 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.13 -28.29 57.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.245 -0.889 . . . . 10.0 112.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -59.12 -29.12 67.15 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.817 0.341 . . . . 10.0 110.956 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -101.57 -36.17 8.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 10.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.739 HD12 H232 ' A' ' 202' ' ' CHO . 47.1 mt -63.54 131.4 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 10.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -127.04 83.55 65.72 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.38 -0.6 . . . . 10.0 109.38 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -70.56 157.98 57.26 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.786 2.324 . . . . 10.0 112.576 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.665 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -100.77 142.82 15.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.839 -0.618 . . . . 10.0 110.084 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG21 HH22 ' A' ' 120' ' ' ARG . 35.6 t -96.55 111.58 26.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.475 -0.33 . . . . 10.0 110.301 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.84 120.63 32.03 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.948 -0.39 . . . . 10.0 109.948 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -133.25 131.55 58.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.557 0.694 . . . . 10.0 110.614 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -133.89 142.32 47.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.441 -0.8 . . . . 10.0 109.119 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG2' ' OG ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -121.09 -179.89 4.18 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.198 0.523 . . . . 10.0 111.9 -179.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -166.92 96.53 0.52 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.947 -1.024 . . . . 10.0 108.557 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.75 -89.31 0.95 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.482 -0.866 . . . . 10.0 111.02 -178.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -134.95 -6.34 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.605 0.241 . . . . 10.0 110.428 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.18 127.5 43.2 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.941 0.4 . . . . 10.0 110.201 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.467 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.1 m-85 -112.17 150.56 30.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 10.0 111.937 -177.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.13 104.3 9.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.146 -0.934 . . . . 10.0 108.669 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' H11' ' A' ' 201' ' ' GCH . 54.6 t -95.48 126.21 48.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.717 -0.674 . . . . 10.0 110.746 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.3 m -107.99 112.24 24.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.632 -0.713 . . . . 10.0 110.78 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' THR . 3.8 m -96.71 93.76 6.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.243 0.544 . . . . 10.0 110.15 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -85.73 120.17 26.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.35 -0.841 . . . . 10.0 109.995 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.695 HG21 ' SD ' ' A' ' 73' ' ' MET . 9.0 p -136.36 167.98 19.19 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.654 -0.248 . . . . 10.0 110.755 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.881 ' HD2' H221 ' A' ' 202' ' ' CHO . 4.7 Cg_exo -77.69 12.7 1.85 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.284 2.656 . . . . 10.0 112.756 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.59 ' HG2' H262 ' A' ' 202' ' ' CHO . 0.0 OUTLIER -132.63 -55.42 0.95 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.855 0.359 . . . . 10.0 111.381 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -151.87 125.23 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.995 0.426 . . . . 10.0 111.191 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 51' ' ' SER . 95.7 m -90.26 106.03 18.21 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.736 -0.666 . . . . 10.0 109.481 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 51' ' ' SER . 13.5 m -97.88 150.62 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 120.547 -0.461 . . . . 10.0 111.131 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 42.2 m -118.93 126.91 52.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.227 -0.442 . . . . 10.0 110.167 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.639 ' OD1' ' H16' ' A' ' 201' ' ' GCH . 1.4 m-80 -117.92 127.84 54.23 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.448 -0.575 . . . . 10.0 109.448 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.44 148.36 45.21 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.677 -0.409 . . . . 10.0 110.43 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -164.63 162.85 21.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.641 0.258 . . . . 10.0 110.724 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m -120.2 134.22 55.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.137 -0.483 . . . . 10.0 109.934 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 HD11 ' A' ' 89' ' ' LEU . 46.5 mt -57.81 109.42 0.72 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.876 -0.602 . . . . 10.0 112.044 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.92 8.64 53.87 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.443 -0.884 . . . . 10.0 113.377 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -138.28 151.65 47.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 10.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -80.82 129.95 34.8 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.498 -0.556 . . . . 10.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 146.59 51.97 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.124 0.487 . . . . 10.0 111.355 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.54 125.29 30.33 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.11 -0.95 . . . . 10.0 109.871 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.5 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.5 pp -133.47 170.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.906 -0.588 . . . . 10.0 110.346 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 m -132.57 140.44 48.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.14 0.495 . . . . 10.0 112.216 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.523 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 5.8 t -94.09 164.14 13.19 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.694 -0.685 . . . . 10.0 110.284 178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.695 ' SD ' HG21 ' A' ' 53' ' ' THR . 6.7 ttm -70.78 -22.98 62.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.908 -0.587 . . . . 10.0 112.38 -178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -81.97 -1.41 48.0 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.81 0.338 . . . . 10.0 111.422 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.68 57.26 2.93 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.673 -0.775 . . . . 10.0 113.789 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 10.9 mttp -134.67 151.9 51.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.648 -0.501 . . . . 10.0 109.648 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -94.89 122.37 37.46 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.238 -0.437 . . . . 10.0 109.994 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.6 mt -138.63 151.64 47.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.872 0.367 . . . . 10.0 111.121 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 mttm -130.35 119.18 22.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.168 -0.469 . . . . 10.0 109.883 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.5 t -114.6 147.66 39.19 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.699 -0.4 . . . . 10.0 111.527 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 t -107.88 57.27 0.62 Allowed 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.908 0.861 . . . . 10.0 109.705 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 2.9 t -53.97 137.08 15.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 114.821 -1.081 . . . . 10.0 111.715 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -152.77 152.73 31.99 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.032 -0.531 . . . . 10.0 110.431 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.58 105.88 18.07 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.328 -0.396 . . . . 10.0 110.49 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.98 118.7 27.61 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.881 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 m-80 63.53 37.57 10.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.537 -0.756 . . . . 10.0 111.305 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.68 9.92 75.33 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.948 -0.644 . . . . 10.0 112.675 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.96 140.68 52.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.345 -0.613 . . . . 10.0 109.345 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 1.5 tp -89.3 119.94 30.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 39.9 t -105.41 117.56 51.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.821 -0.627 . . . . 10.0 110.904 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.823 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 38.8 t -122.26 83.51 2.12 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.594 -0.891 . . . . 10.0 108.594 178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 23.4 ttpp -100.11 142.96 30.88 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.436 0.636 . . . . 10.0 111.313 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.83 -165.79 1.19 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.277 -0.874 . . . . 10.0 109.017 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.5 -26.52 32.47 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.599 -0.441 . . . . 10.0 110.625 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -121.54 -21.54 6.19 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.333 0.494 . . . . 10.0 112.333 -178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.88 -174.35 3.07 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.373 -0.204 . . . . 10.0 111.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 9.1 t -162.87 141.78 8.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.168 0.508 . . . . 10.0 111.003 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.843 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.1 t-160 -119.35 121.66 40.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -115.81 130.03 56.68 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.855 -0.338 . . . . 10.0 111.009 -179.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.56 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 3.1 pt20 -144.99 130.36 18.71 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.972 0.415 . . . . 10.0 111.038 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -130.11 136.75 49.66 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.969 0.414 . . . . 10.0 110.803 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.9 t -98.59 114.81 37.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.804 -0.635 . . . . 10.0 110.17 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -115.11 89.21 3.04 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.055 -0.52 . . . . 10.0 109.831 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.41 -98.55 1.39 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.811 -0.709 . . . . 10.0 112.669 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -120.08 7.83 10.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.102 0.477 . . . . 10.0 110.656 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -126.04 133.17 51.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.988 -0.551 . . . . 10.0 111.242 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -109.62 116.01 30.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.668 -0.696 . . . . 10.0 109.374 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.5 m -104.51 117.17 49.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.887 -0.597 . . . . 10.0 110.206 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 8.6 pt-20 -132.36 150.5 52.14 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.874 0.845 . . . . 10.0 112.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.597 HG23 HG13 ' A' ' 119' ' ' ILE . 96.2 m -135.3 124.34 24.29 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.787 -1.097 . . . . 10.0 108.808 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -118.23 159.89 18.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 116.142 -0.481 . . . . 10.0 110.483 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.7 m -141.95 111.65 6.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.146 -0.316 . . . . 10.0 110.146 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CD1' ' H19' ' A' ' 201' ' ' GCH . 7.2 m-85 -147.01 145.46 29.73 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.286 0.366 . . . . 10.0 110.44 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.63 17.87 63.0 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.104 -0.569 . . . . 10.0 112.827 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.69 15.18 68.64 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 121.202 -0.523 . . . . 10.0 112.269 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.07 127.51 72.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.882 0.372 . . . . 10.0 110.541 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.29 96.34 10.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 10.0 109.77 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.3 tp -85.89 103.03 14.25 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.211 0.529 . . . . 10.0 111.635 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 110' ' ' THR . 3.2 mp -90.75 122.85 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.322 177.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.446 HH22 HG21 ' A' ' 38' ' ' VAL . 2.0 ptm180 -138.14 159.29 42.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.276 0.56 . . . . 10.0 111.888 -178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.489 ' NH2' HG22 ' A' ' 119' ' ' ILE . 0.5 OUTLIER -124.8 127.95 47.96 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.517 -0.919 . . . . 10.0 108.517 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.8 m -121.28 108.79 14.16 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.468 0.652 . . . . 10.0 111.41 -179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.85 149.38 24.16 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.22 -0.9 . . . . 10.0 110.067 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 ttp85 -80.31 164.66 22.99 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.889 -0.325 . . . . 10.0 110.498 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--O 1.25 1.102 0 O-C-N 124.925 1.391 . . . . 10.0 113.517 179.279 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.843 ' H42' ' ND1' ' A' ' 98' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.881 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.076 0 N-CA-C 110.111 -0.329 . . . . 10.0 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 27.7 m-85 -75.49 -32.31 60.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.247 -0.433 . . . . 10.0 110.856 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.98 97.42 0.08 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.308 -0.405 . . . . 10.0 110.553 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.87 -153.96 12.74 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.828 -0.701 . . . . 10.0 112.576 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 37' ' ' ILE . 5.2 p -128.48 118.57 23.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.707 0.289 . . . . 10.0 111.006 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -118.26 128.22 54.48 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.259 0.466 . . . . 10.0 112.259 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -100.87 111.98 24.31 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.282 -0.636 . . . . 10.0 109.282 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 3.0 t -79.26 140.66 16.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.181 0.808 . . . . 10.0 113.181 -178.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -146.88 137.14 23.54 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.504 -0.771 . . . . 10.0 109.33 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . 179.88 160.52 0.85 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.776 0.322 . . . . 10.0 111.4 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -132.14 33.3 3.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 10.0 109.776 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' C ' ' H ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -86.73 -156.88 0.34 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.424 -0.807 . . . . 10.0 111.066 -179.367 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.894 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 5.3 p30 -61.5 29.85 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.968 1.307 . . . . 10.0 113.56 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.505 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 55.5 t80 -57.05 -63.89 1.06 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 122.506 0.323 . . . . 10.0 111.836 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.21 -25.29 66.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.598 0.221 . . . . 10.0 111.598 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -72.38 -43.0 64.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 10.0 110.035 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.692 ' HE2' ' H5 ' ' A' ' 202' ' ' CHO . 15.9 t80 -66.76 -32.99 74.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.83 -0.623 . . . . 10.0 110.066 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD21 H182 ' A' ' 202' ' ' CHO . 10.3 mt -58.8 -35.41 72.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.974 0.416 . . . . 10.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -69.6 -23.25 63.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.172 -0.467 . . . . 10.0 111.641 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.23 -21.18 50.34 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.131 0.491 . . . . 10.0 111.316 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' CD1' ' H62' ' A' ' 202' ' ' CHO . 1.0 OUTLIER -91.89 7.53 41.6 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.922 -0.581 . . . . 10.0 110.572 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 59.54 40.26 20.6 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.625 -0.716 . . . . 10.0 109.841 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD13 H152 ' A' ' 202' ' ' CHO . 43.3 mt -81.46 156.61 70.93 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.014 -0.993 . . . . 10.0 110.698 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 28' ' ' ILE . 33.5 Cg_endo -66.81 127.44 17.04 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.359 2.039 . . . . 10.0 112.399 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -53.56 -35.08 60.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.494 -0.776 . . . . 10.0 111.408 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.26 -45.98 91.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 10.0 110.494 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD21 H162 ' A' ' 202' ' ' CHO . 1.4 tt -69.08 -39.54 79.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.932 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 24' ' ' PRO . 56.6 mt -61.42 -21.87 26.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.32 -0.4 . . . . 10.0 110.708 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -82.4 -26.27 32.97 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.345 -0.222 . . . . 10.0 111.573 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.522 ' O ' HG13 ' A' ' 34' ' ' ILE . 10.1 ptt? -101.67 -42.87 6.05 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.77 -0.372 . . . . 10.0 111.036 -179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.829 ' HB2' H232 ' A' ' 202' ' ' CHO . . . -60.51 -23.02 64.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.939 0.4 . . . . 10.0 111.618 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -61.93 -27.29 68.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.938 -0.574 . . . . 10.0 110.453 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.02 -30.24 8.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.355 -0.384 . . . . 10.0 110.76 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 59.8 mt -68.71 126.37 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.78 -0.452 . . . . 10.0 109.78 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' HE3' ' O ' ' A' ' 34' ' ' ILE . 7.0 mmpp? -118.18 87.57 29.76 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 10.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' HB3' H262 ' A' ' 202' ' ' CHO . 35.8 Cg_endo -67.29 147.91 79.11 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.487 2.125 . . . . 10.0 112.162 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.502 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -89.91 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.88 -0.6 . . . . 10.0 109.67 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -95.33 102.01 13.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 120.977 0.418 . . . . 10.0 110.848 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.95 118.41 29.5 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.204 -0.665 . . . . 10.0 109.204 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.454 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.09 129.69 65.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 10.0 111.05 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -131.98 134.59 45.78 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.66 -0.7 . . . . 10.0 110.386 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -125.94 -165.1 1.38 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.046 0.45 . . . . 10.0 111.378 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -171.78 68.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.297 -0.865 . . . . 10.0 110.246 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.69 -73.8 0.87 Allowed Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.05 -0.595 . . . . 10.0 112.478 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -131.14 -28.75 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.757 0.313 . . . . 10.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -83.37 123.14 29.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.835 0.35 . . . . 10.0 111.125 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 40' ' ' ILE . 4.6 m-85 -112.01 151.59 29.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.914 -0.585 . . . . 10.0 111.148 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -136.28 106.02 5.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 108.682 -0.858 . . . . 10.0 108.682 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG21 ' H11' ' A' ' 201' ' ' GCH . 11.3 t -98.83 129.45 49.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.191 -0.458 . . . . 10.0 110.883 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 63.1 m -112.3 120.64 42.43 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.783 -0.644 . . . . 10.0 110.8 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.7 m -105.2 138.18 41.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.776 0.322 . . . . 10.0 110.737 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 57' ' ' THR . 1.3 mptm? -102.28 134.12 46.07 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.333 -0.394 . . . . 10.0 110.94 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.593 ' HA ' ' HN ' ' A' ' 202' ' ' CHO . 7.5 p -146.78 160.99 39.3 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.728 ' HD3' ' N25' ' A' ' 202' ' ' CHO . 77.6 Cg_endo -77.66 -3.4 13.54 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.698 2.265 . . . . 10.0 110.042 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -95.83 -76.27 0.5 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 113.71 -1.586 . . . . 10.0 110.687 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -158.39 137.03 11.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.957 -1.019 . . . . 10.0 109.601 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 52' ' ' LYS . 3.9 p -76.94 118.63 19.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.72 0.295 . . . . 10.0 111.075 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.3 m -96.68 149.4 4.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.137 0.494 . . . . 10.0 111.052 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -119.75 124.54 46.43 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.734 -0.666 . . . . 10.0 110.648 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.645 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 38.1 m-80 -113.75 126.94 55.78 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.991 -0.744 . . . . 10.0 108.991 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.1 p -127.17 144.45 51.03 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.978 -0.289 . . . . 10.0 111.187 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 10.6 p90 -157.47 171.64 20.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.741 0.305 . . . . 10.0 111.234 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.1 m -124.14 127.23 47.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.051 -0.522 . . . . 10.0 109.717 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.9 mt -55.04 122.3 10.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.969 0.414 . . . . 10.0 111.841 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.9 3.35 68.27 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.879 -0.677 . . . . 10.0 113.199 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -136.37 147.81 47.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.94 0.4 . . . . 10.0 110.706 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 4.1 tt0 -81.06 124.43 29.19 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.65 152.1 40.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.779 0.323 . . . . 10.0 111.133 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -86.47 122.32 30.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.542 -0.753 . . . . 10.0 110.038 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.645 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.6 pp -126.23 164.71 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.778 -0.646 . . . . 10.0 109.81 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 m -130.38 133.28 46.27 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.189 -0.604 . . . . 10.0 112.446 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.588 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 10.0 t -88.33 156.83 18.96 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.133 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.12 -17.17 64.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.887 0.375 . . . . 10.0 111.1 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.18 -24.52 64.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.256 -0.429 . . . . 10.0 109.859 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.54 22.83 9.96 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.825 -0.702 . . . . 10.0 113.096 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -112.65 149.44 32.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.765 0.316 . . . . 10.0 110.711 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -93.77 122.7 36.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.258 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' H26' ' A' ' 201' ' ' GCH . 3.1 mt -129.95 170.36 14.05 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.464 -0.569 . . . . 10.0 109.464 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 20.8 pttt -143.06 124.94 15.11 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.086 0.47 . . . . 10.0 110.357 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -120.62 115.93 24.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.76 -0.655 . . . . 10.0 110.748 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 4.0 t -80.47 62.62 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 122.27 1.033 . . . . 10.0 109.523 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.599 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.1 t -60.45 130.51 24.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.556 -1.202 . . . . 10.0 112.648 -178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -147.98 144.19 27.81 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.039 -0.982 . . . . 10.0 109.211 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.2 tp -84.42 108.86 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.988 0.423 . . . . 10.0 110.043 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.14 115.76 22.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.781 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 63.37 36.65 11.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.79 -0.641 . . . . 10.0 110.992 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.56 4.74 76.19 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.987 -0.625 . . . . 10.0 112.675 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -116.72 143.47 45.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.011 -0.366 . . . . 10.0 110.011 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.599 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 3.7 tp -87.94 126.44 35.06 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.697 -0.483 . . . . 10.0 109.697 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 88.3 t -130.33 129.26 64.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.936 -0.574 . . . . 10.0 111.381 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.588 ' HB3' HG22 ' A' ' 82' ' ' VAL . 11.5 p -132.78 32.37 3.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.417 0.627 . . . . 10.0 109.684 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 36.0 ttpt -45.42 135.33 6.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.51 -1.223 . . . . 10.0 111.857 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -100.78 -169.65 1.74 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.231 -0.895 . . . . 10.0 110.21 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -71.37 -38.81 71.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.974 0.416 . . . . 10.0 110.997 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -113.91 -20.63 10.99 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.385 0.883 . . . . 10.0 113.385 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.08 178.89 4.88 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.531 -0.468 . . . . 10.0 111.325 -177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 1.2 p -156.17 145.79 20.97 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.112 -0.494 . . . . 10.0 110.791 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.768 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.1 t-160 -130.17 112.88 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -97.02 134.07 40.87 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.908 -0.587 . . . . 10.0 111.46 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -132.32 103.95 6.48 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.241 -0.436 . . . . 10.0 109.961 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -112.61 126.59 55.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 10.0 111.565 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 53.6 t -109.12 119.89 59.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.249 -0.432 . . . . 10.0 110.045 178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -114.98 74.17 0.87 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.205 -0.665 . . . . 10.0 109.205 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.93 -113.13 3.6 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.616 -0.72 . . . . 10.0 112.451 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -94.03 7.41 45.21 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.172 0.511 . . . . 10.0 110.439 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -124.57 136.53 54.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.05 -0.523 . . . . 10.0 110.587 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 58.3 ttp -127.19 135.07 50.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.8 124.37 61.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 109.669 -0.493 . . . . 10.0 109.669 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' CD ' ' HE ' ' A' ' 120' ' ' ARG . 0.1 OUTLIER -116.26 144.93 43.58 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.374 0.607 . . . . 10.0 110.466 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.516 HG23 HG12 ' A' ' 119' ' ' ILE . 2.4 m -130.93 112.39 12.92 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.183 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.9 OUTLIER -115.05 159.24 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.62 -0.264 . . . . 10.0 110.6 -178.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -139.45 111.42 7.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.419 0.152 . . . . 10.0 110.796 178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.62 ' CD1' ' H23' ' A' ' 201' ' ' GCH . 25.4 m-85 -145.99 146.14 30.88 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.137 -0.32 . . . . 10.0 110.137 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.97 56.09 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.301 -0.476 . . . . 10.0 113.069 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.34 16.42 66.74 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.774 -0.727 . . . . 10.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.8 t -127.19 124.37 64.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-O 120.756 0.313 . . . . 10.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' ILE . 86.8 m -95.39 87.33 4.76 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.262 0.553 . . . . 10.0 109.724 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.894 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 20.8 tp -69.67 121.2 16.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.489 -0.778 . . . . 10.0 111.055 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.516 HG12 HG23 ' A' ' 110' ' ' THR . 3.2 mt -115.75 130.0 71.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.007 -0.997 . . . . 10.0 110.642 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HE ' ' CD ' ' A' ' 109' ' ' GLU . 0.3 OUTLIER -151.43 161.03 43.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.275 0.56 . . . . 10.0 110.084 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.01 156.5 28.46 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.025 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 5.0 t -137.92 140.01 40.1 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.2 0.524 . . . . 10.0 110.801 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -115.61 133.44 56.03 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.545 -0.752 . . . . 10.0 109.192 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -68.1 142.27 55.86 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.495 -0.482 . . . . 10.0 109.705 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.793 -0.623 . . . . 10.0 111.032 -178.672 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.768 ' H10' ' O1 ' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.896 H211 ' C24' ' A' ' 202' ' ' CHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.299 -0.26 . . . . 10.0 110.299 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.56 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 28.9 m-85 -67.77 -29.66 68.92 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.309 0.38 . . . . 10.0 110.369 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.75 109.71 1.51 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.991 -0.549 . . . . 10.0 110.32 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.36 -150.62 18.58 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.71 -0.757 . . . . 10.0 112.334 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.429 ' HB ' HD11 ' A' ' 37' ' ' ILE . 3.0 p -129.66 120.06 24.58 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 10.0 110.623 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.513 ' HB3' ' OG ' ' A' ' 122' ' ' SER . 10.9 m95 -118.4 126.42 52.05 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.116 -0.493 . . . . 10.0 111.694 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 126.34 38.71 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 120' ' ' ARG . 21.7 t -96.57 145.83 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 112.897 0.703 . . . . 10.0 112.897 -177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' HE1' ' HG2' ' A' ' 123' ' ' LYS . 44.3 p90 -149.91 138.77 20.97 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.914 -0.772 . . . . 10.0 108.914 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -174.03 163.11 3.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.652 0.263 . . . . 10.0 110.968 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -138.58 32.09 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.417 0.627 . . . . 10.0 110.338 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -85.97 -155.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.403 -0.817 . . . . 10.0 110.448 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.32 61.38 0.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.577 . . . . 10.0 109.744 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.528 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 43.9 t80 -75.51 -65.89 0.84 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.312 -0.858 . . . . 10.0 111.238 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -26.89 68.63 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.817 0.341 . . . . 10.0 110.685 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.01 -38.89 79.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.05 -0.523 . . . . 10.0 109.69 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.542 ' CE2' H192 ' A' ' 202' ' ' CHO . 26.9 t80 -70.21 -33.61 71.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 10.0 110.02 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.647 HD12 HG23 ' A' ' 28' ' ' ILE . 31.4 mt -58.55 -30.2 66.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 10.0 110.632 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HE3' HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -71.95 -24.03 61.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 10.0 110.518 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.44 -18.27 52.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 10.0 111.576 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.748 HD13 ' H62' ' A' ' 202' ' ' CHO . 1.4 mt -92.83 6.1 48.85 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.263 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 63.73 31.74 14.1 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.691 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.0 mt -78.73 162.22 66.16 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.851 -0.613 . . . . 10.0 110.405 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -73.22 124.9 9.83 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.111 1.874 . . . . 10.0 111.979 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HA ' HD12 ' A' ' 28' ' ' ILE . 2.0 mp0 -52.33 -33.93 44.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.035 -0.53 . . . . 10.0 111.548 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -48.88 77.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.304 -0.407 . . . . 10.0 110.3 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.614 HD21 H222 ' A' ' 202' ' ' CHO . 3.7 tp -70.78 -32.0 68.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.384 -0.371 . . . . 10.0 110.487 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.647 HG23 HD12 ' A' ' 18' ' ' LEU . 70.3 mt -56.55 -44.51 80.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.644 . . . . 10.0 111.636 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HD3' ' O ' ' A' ' 25' ' ' GLU . 2.0 mptp? -65.85 -27.12 67.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 10.0 111.175 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 34' ' ' ILE . 31.8 mtt -82.48 -43.41 17.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 10.0 109.546 179.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' ' H20' ' A' ' 202' ' ' CHO . . . -56.95 -33.22 66.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.099 -0.955 . . . . 10.0 112.534 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 7.5 ptm180 -70.1 -3.68 17.7 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 111.926 0.343 . . . . 10.0 111.926 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -117.88 8.64 12.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.73 0.776 . . . . 10.0 109.288 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.706 HD12 H232 ' A' ' 202' ' ' CHO . 7.6 mt -113.81 138.2 44.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.301 -0.863 . . . . 10.0 111.147 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -116.59 81.3 11.27 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -63.03 134.82 48.05 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.052 1.834 . . . . 10.0 112.338 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -87.24 142.8 12.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.744 -0.662 . . . . 10.0 109.89 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -100.23 105.08 17.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.196 -0.456 . . . . 10.0 110.957 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.84 109.7 20.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.732 -0.84 . . . . 10.0 108.732 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 115.604 -0.726 . . . . 10.0 111.393 -178.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -131.17 142.33 50.19 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.352 -0.61 . . . . 10.0 109.352 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -123.71 -176.64 3.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.994 0.426 . . . . 10.0 111.218 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -161.63 61.39 0.26 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.042 -0.981 . . . . 10.0 109.65 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.76 -83.25 0.69 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.858 -0.61 . . . . 10.0 111.905 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -123.1 -18.96 6.19 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.937 -0.394 . . . . 10.0 109.937 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -87.07 134.17 33.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 10.0 110.02 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 40' ' ' ILE . 3.4 m-85 -123.2 148.73 45.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.014 -0.539 . . . . 10.0 110.99 -179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.8 t -130.3 100.5 5.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.865 HG21 ' H11' ' A' ' 201' ' ' GCH . 40.8 t -92.65 113.57 27.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.631 -0.713 . . . . 10.0 110.918 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 46.8 m -99.93 105.98 17.74 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.644 -0.707 . . . . 10.0 110.688 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB2' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -94.61 99.29 11.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.844 -0.616 . . . . 10.0 109.503 179.427 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -89.26 128.18 35.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.257 -0.883 . . . . 10.0 111.237 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.708 HG21 ' SD ' ' A' ' 73' ' ' MET . 14.0 p -134.06 165.56 35.78 Favored Pre-proline 0 N--CA 1.444 -0.742 0 CA-C-N 115.69 -0.687 . . . . 10.0 109.699 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.845 ' HD2' H221 ' A' ' 202' ' ' CHO . 12.0 Cg_exo -73.49 21.56 0.35 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.135 2.556 . . . . 10.0 113.291 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -152.21 -46.04 0.1 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 112.131 0.419 . . . . 10.0 112.131 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -147.1 118.02 7.66 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.897 0.38 . . . . 10.0 111.434 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 t -95.12 108.05 20.14 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.207 -0.664 . . . . 10.0 109.207 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 51' ' ' SER . 33.0 m -91.06 158.74 2.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.19 0.519 . . . . 10.0 112.016 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.2 m -127.7 109.99 12.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.591 -0.731 . . . . 10.0 110.047 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 48.9 m-80 -107.25 126.03 51.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 4.6 m -124.46 143.2 50.78 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.557 -0.457 . . . . 10.0 110.48 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -154.41 170.09 22.2 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.464 -0.334 . . . . 10.0 110.805 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -121.55 132.97 55.0 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 46.3 mt -59.86 115.57 3.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.232 0.539 . . . . 10.0 111.929 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.54 9.23 56.78 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.421 -0.809 . . . . 10.0 113.068 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -136.05 160.02 39.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.975 0.417 . . . . 10.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 43.2 tt0 -91.49 115.84 28.37 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.403 -0.962 . . . . 10.0 108.403 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.5 143.06 45.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.197 0.522 . . . . 10.0 111.87 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.76 123.55 27.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.996 -1.002 . . . . 10.0 109.314 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.558 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.4 pp -129.78 163.6 34.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 116.114 -0.494 . . . . 10.0 110.264 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.3 m -125.24 129.54 50.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.139 0.495 . . . . 10.0 111.515 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.7 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 6.2 t -78.76 -177.65 5.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.745 -0.662 . . . . 10.0 110.863 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.708 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.8 ttm -85.75 -22.05 27.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.891 -0.595 . . . . 10.0 111.582 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.16 -3.2 58.91 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.253 0.464 . . . . 10.0 112.253 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.82 44.39 6.08 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.532 -0.842 . . . . 10.0 114.52 178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' H ' ' CG2' ' A' ' 72' ' ' THR . 10.1 mttp -124.48 156.4 37.32 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -104.74 116.71 32.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.118 0.485 . . . . 10.0 111.275 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.558 HD11 ' H26' ' A' ' 201' ' ' GCH . 7.8 mt -129.89 162.13 29.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.861 -0.608 . . . . 10.0 109.899 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt -131.49 115.85 16.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.817 0.342 . . . . 10.0 110.911 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -108.52 113.78 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.235 -0.438 . . . . 10.0 109.999 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 3.9 t -82.41 62.81 6.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.366 1.079 . . . . 10.0 109.822 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 ' HB3' ' A' ' 91' ' ' CYS . 2.4 t -59.23 127.29 18.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.349 -1.296 . . . . 10.0 112.836 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -142.14 149.58 39.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.939 -1.028 . . . . 10.0 109.279 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -88.52 110.44 20.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 10.0 110.565 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.94 119.98 33.1 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.516 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 60.39 34.96 20.58 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.689 0.618 . . . . 10.0 111.0 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.5 12.05 80.21 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.75 -0.738 . . . . 10.0 112.141 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 100' ' ' GLN . 21.5 mmtp -118.69 160.71 21.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.111 -0.7 . . . . 10.0 109.111 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.605 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 2.9 tp -104.76 129.49 52.99 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.692 -0.403 . . . . 10.0 110.918 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 92' ' ' LYS . 42.2 t -135.65 129.21 48.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.126 -0.488 . . . . 10.0 111.591 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.773 ' HB3' HG22 ' A' ' 82' ' ' VAL . 14.6 p -129.0 34.16 4.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.657 0.742 . . . . 10.0 109.43 177.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' H ' HG12 ' A' ' 90' ' ' VAL . 34.9 ttpt -49.28 133.77 19.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.485 -1.234 . . . . 10.0 111.782 -178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -107.21 -174.96 2.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.063 -0.971 . . . . 10.0 109.921 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -78.08 -23.62 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.519 0.2 . . . . 10.0 111.45 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 96' ' ' PHE . 80.5 tttt -113.24 -27.58 7.93 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 112.006 0.372 . . . . 10.0 112.006 -179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 95' ' ' LYS . 3.3 m-85 -126.48 176.77 6.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.722 0.296 . . . . 10.0 111.139 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.8 p -156.27 132.06 9.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.076 -0.511 . . . . 10.0 111.027 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.833 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.3 t-160 -118.51 118.53 31.96 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.964 -0.754 . . . . 10.0 108.964 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -103.24 131.94 49.89 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.798 -0.637 . . . . 10.0 110.812 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.523 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 30.3 mt-30 -135.34 121.49 20.14 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 110.236 -0.283 . . . . 10.0 110.236 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -125.96 122.14 35.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 10.0 112.013 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 66.9 t -101.27 116.81 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.714 -0.847 . . . . 10.0 108.714 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -120.19 93.42 4.04 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.691 -0.686 . . . . 10.0 110.905 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.97 -95.18 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.645 -0.788 . . . . 10.0 112.842 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -118.45 11.66 13.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.019 0.438 . . . . 10.0 111.101 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -126.78 153.72 45.19 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.459 -0.337 . . . . 10.0 110.852 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 65.4 ttp -137.28 108.02 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.02 -0.536 . . . . 10.0 109.845 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 34.2 m -102.73 132.46 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.11 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.59 ' OE2' ' HD3' ' A' ' 120' ' ' ARG . 11.1 pt-20 -128.59 149.27 50.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.541 0.686 . . . . 10.0 111.731 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 119' ' ' ILE . 5.9 m -128.13 107.64 9.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.196 -0.911 . . . . 10.0 108.995 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.4 mt -110.97 155.67 12.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 120.625 -0.43 . . . . 10.0 110.857 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.9 m -143.52 110.78 5.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.758 -0.46 . . . . 10.0 109.758 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.708 ' CD1' ' H22' ' A' ' 201' ' ' GCH . 5.9 m-85 -146.64 148.34 31.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.455 -0.339 . . . . 10.0 110.317 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.05 18.66 60.44 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 121.077 -0.582 . . . . 10.0 112.908 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.74 19.0 66.66 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.166 -0.54 . . . . 10.0 112.459 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.4 135.06 63.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.715 0.293 . . . . 10.0 110.334 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 24.0 m -99.25 99.27 10.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.221 0.534 . . . . 10.0 110.689 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.1 tp -95.76 101.82 13.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.119 -0.491 . . . . 10.0 110.652 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 110' ' ' THR . 3.8 mt -91.69 115.13 30.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.635 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' OE2' ' A' ' 109' ' ' GLU . 32.2 mtp180 -115.25 142.72 46.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.598 0.713 . . . . 10.0 112.361 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtm180 -113.59 137.15 51.99 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.254 -0.885 . . . . 10.0 109.038 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 6' ' ' TRP . 46.7 t -132.02 147.37 52.45 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.487 0.66 . . . . 10.0 111.894 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.456 ' HG2' ' HE1' ' A' ' 9' ' ' TYR . 13.3 mmtt -119.93 136.08 54.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.605 -1.179 . . . . 10.0 108.645 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.4 ttp180 -66.69 141.93 57.6 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.821 -0.352 . . . . 10.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.312 -0.852 . . . . 10.0 111.036 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.865 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.845 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 110.356 -0.238 . . . . 10.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.4 m-85 -88.06 -31.92 19.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.165 -0.471 . . . . 10.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 t -63.03 105.84 0.75 Allowed 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.821 -0.437 . . . . 10.0 109.821 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.71 -164.96 37.27 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 121.073 -0.584 . . . . 10.0 111.693 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.579 ' HB ' HD11 ' A' ' 37' ' ' ILE . 9.6 p -119.4 118.59 31.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.651 0.263 . . . . 10.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -115.66 127.88 55.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.28 0.562 . . . . 10.0 111.94 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -96.84 106.06 18.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.335 -0.987 . . . . 10.0 108.335 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 5.6 p -80.37 139.5 18.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.276 -0.874 . . . . 10.0 112.688 -178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.491 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 4.2 p90 -150.76 135.98 17.72 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.016 -0.993 . . . . 10.0 109.369 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -177.22 166.1 2.32 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.603 0.239 . . . . 10.0 110.998 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.56 32.62 2.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.34 0.59 . . . . 10.0 111.406 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.5 148.14 36.57 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.532 -0.758 . . . . 10.0 109.256 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 14.72 59.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 125.534 1.771 . . . . 10.0 113.559 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 57.9 t80 -102.46 -61.55 1.38 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.201 -0.454 . . . . 10.0 111.551 -178.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.74 -34.34 74.28 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.299 -0.41 . . . . 10.0 110.854 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -73.35 -29.91 62.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.352 -0.386 . . . . 10.0 110.949 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 113' ' ' PHE . 17.7 t80 -73.37 -34.55 65.63 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.64 HD12 HG23 ' A' ' 28' ' ' ILE . 20.4 mt -60.39 -38.4 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.802 -0.635 . . . . 10.0 110.086 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -68.68 -33.99 74.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.943 -0.571 . . . . 10.0 110.303 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -74.29 -11.69 60.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 10.0 111.469 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD11 ' CE2' ' A' ' 17' ' ' PHE . 41.0 mt -96.93 4.44 51.58 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.18 34.39 18.87 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.077 -0.965 . . . . 10.0 110.451 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.871 HD13 H151 ' A' ' 202' ' ' CHO . 61.8 mt -80.15 164.98 49.74 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.267 -0.879 . . . . 10.0 110.505 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.481 ' O ' HG13 ' A' ' 28' ' ' ILE . 14.1 Cg_exo -66.34 126.58 15.87 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.643 2.229 . . . . 10.0 112.13 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' HD12 ' A' ' 28' ' ' ILE . 49.8 mm-40 -52.94 -33.02 49.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.831 -0.622 . . . . 10.0 111.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.72 -48.78 29.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.276 -0.42 . . . . 10.0 110.27 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.903 HD21 H222 ' A' ' 202' ' ' CHO . 1.6 tp -60.39 -29.88 69.24 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-O 120.985 0.421 . . . . 10.0 110.978 -179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.64 HG23 HD12 ' A' ' 18' ' ' LEU . 96.0 mt -63.31 -23.81 34.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.758 -0.655 . . . . 10.0 111.602 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -82.73 -22.79 34.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.111 0.481 . . . . 10.0 110.342 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.536 ' O ' HG13 ' A' ' 34' ' ' ILE . 1.8 mpp? -93.48 -36.84 12.25 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 116.216 -0.447 . . . . 10.0 110.864 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.686 ' HB1' H181 ' A' ' 202' ' ' CHO . . . -62.19 -25.07 67.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.244 -0.434 . . . . 10.0 111.376 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -68.74 -14.7 63.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.892 0.377 . . . . 10.0 110.229 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -109.1 -38.29 5.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.087 -0.506 . . . . 10.0 109.944 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 30' ' ' MET . 2.7 mt -72.39 120.78 21.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.909 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -116.83 83.32 14.17 Favored Pre-proline 0 C--N 1.32 -0.685 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.14 141.04 74.57 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 C-N-CA 122.412 2.075 . . . . 10.0 112.325 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -82.62 138.0 20.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 121.224 0.535 . . . . 10.0 109.598 179.278 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -91.97 102.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.051 -0.522 . . . . 10.0 110.292 -179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -89.69 111.52 22.51 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.661 -0.496 . . . . 10.0 109.661 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' CD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -124.6 125.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.393 0.616 . . . . 10.0 110.668 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -131.73 141.06 49.44 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.82 -0.807 . . . . 10.0 108.82 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -138.63 -168.79 2.47 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.101 -0.64 . . . . 10.0 112.041 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -123.85 -74.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.05 -0.977 . . . . 10.0 109.18 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.3 -54.89 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 N-CA-C 111.267 -0.733 . . . . 10.0 111.267 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.36 -21.55 4.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.702 0.286 . . . . 10.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -93.82 121.83 35.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.241 -0.436 . . . . 10.0 110.203 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.432 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 3.2 m-85 -107.39 149.69 27.59 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.901 -0.591 . . . . 10.0 111.485 -178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.0 t -128.06 99.58 5.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.969 -0.752 . . . . 10.0 108.969 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.949 HG21 ' H11' ' A' ' 201' ' ' GCH . 22.8 t -92.62 121.22 43.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.609 -0.723 . . . . 10.0 110.444 -179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.6 m -105.95 106.65 17.25 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.013 -0.54 . . . . 10.0 111.232 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.1 m -92.39 110.47 21.87 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.284 -0.635 . . . . 10.0 109.284 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 mtpt -88.49 125.64 34.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.075 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.472 HG21 ' SD ' ' A' ' 73' ' ' MET . 8.8 p -140.46 150.06 59.56 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.622 -0.263 . . . . 10.0 110.889 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.747 ' HD2' H231 ' A' ' 202' ' ' CHO . 56.4 Cg_exo -57.47 -26.57 72.17 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.0 2.467 . . . . 10.0 112.643 178.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -79.6 -60.53 2.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.948 -0.569 . . . . 10.0 110.661 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -168.91 125.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.061 -0.518 . . . . 10.0 110.199 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.9 t -76.21 128.03 34.1 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.814 0.34 . . . . 10.0 110.332 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.9 m -105.67 160.34 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.925 0.393 . . . . 10.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -125.82 117.56 23.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.745 -0.661 . . . . 10.0 110.377 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -109.8 125.56 52.85 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.766 -0.652 . . . . 10.0 109.971 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' PHE . 1.2 p -121.85 143.16 49.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.738 0.304 . . . . 10.0 111.043 -179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.59 ' CD1' HG11 ' A' ' 82' ' ' VAL . 22.8 p90 -157.4 160.63 38.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.581 -0.281 . . . . 10.0 110.946 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m -116.65 129.02 55.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.796 -0.638 . . . . 10.0 110.868 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD13 ' HB2' ' A' ' 84' ' ' LEU . 47.0 mt -60.32 124.82 21.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.008 -0.542 . . . . 10.0 111.493 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.88 -6.04 64.18 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.77 -0.728 . . . . 10.0 112.102 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -124.22 177.24 5.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.085 0.469 . . . . 10.0 111.036 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -109.84 128.38 55.29 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.03 -1.1 . . . . 10.0 108.03 178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.19 136.19 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.369 . . . . 10.0 111.48 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.47 117.51 21.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.747 -0.661 . . . . 10.0 109.33 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.657 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.0 pp -118.76 177.3 2.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.841 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.8 m -124.99 141.05 52.38 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.887 -0.725 . . . . 10.0 112.466 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 76' ' ' LYS . 9.2 t -88.25 -178.88 6.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.676 -0.693 . . . . 10.0 109.61 178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' HG21 ' A' ' 53' ' ' THR . 20.4 tpp -86.82 -22.68 25.68 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 111.921 0.341 . . . . 10.0 111.921 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -85.34 -11.43 54.63 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.06 55.23 1.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.423 -0.894 . . . . 10.0 114.668 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 72' ' ' THR . 31.3 mttt -138.28 152.44 48.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.062 -0.718 . . . . 10.0 109.062 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -102.02 120.93 41.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.058 0.456 . . . . 10.0 110.27 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.4 151.14 51.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.054 -0.521 . . . . 10.0 110.094 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -106.87 119.63 39.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.86 0.362 . . . . 10.0 110.653 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.424 ' SG ' ' HB ' ' A' ' 82' ' ' VAL . 23.7 t -93.94 110.36 22.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 10.0 111.539 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -93.98 84.9 4.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.97 -1.122 . . . . 10.0 107.97 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.59 HG11 ' CD1' ' A' ' 62' ' ' PHE . 10.8 p -109.52 158.68 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.599 -0.728 . . . . 10.0 112.51 -177.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -163.91 157.97 19.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.195 -0.912 . . . . 10.0 108.867 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' HB2' HD13 ' A' ' 64' ' ' LEU . 6.8 tp -95.2 113.54 25.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.988 0.423 . . . . 10.0 109.992 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.52 120.83 30.65 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.894 -0.594 . . . . 10.0 110.432 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 63.28 24.83 14.46 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.095 -0.502 . . . . 10.0 110.965 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.11 -3.19 87.0 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.817 -0.706 . . . . 10.0 111.725 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -104.13 162.49 13.13 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.908 -0.404 . . . . 10.0 109.908 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 2.6 tp -110.4 124.61 52.05 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.729 -0.471 . . . . 10.0 109.729 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 14.5 t -118.46 101.02 11.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.593 -0.443 . . . . 10.0 112.062 -178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.4 t -101.29 97.69 8.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.446 -1.316 . . . . 10.0 107.446 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -108.12 142.67 37.99 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.245 0.545 . . . . 10.0 110.96 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.06 -174.55 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.613 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.18 -26.21 47.5 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.455 . . . . 10.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -120.34 -18.0 8.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.221 0.452 . . . . 10.0 112.221 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -130.65 173.93 10.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.815 0.34 . . . . 10.0 111.679 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 130.54 12.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.049 -0.523 . . . . 10.0 110.167 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.871 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.4 t-160 -111.55 126.09 54.61 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.97 0.414 . . . . 10.0 109.906 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.37 122.86 43.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.655 -0.702 . . . . 10.0 110.543 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.567 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 7.9 mm100 -126.42 124.41 40.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.464 -0.335 . . . . 10.0 110.61 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -146.54 138.85 25.0 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.645 0.259 . . . . 10.0 110.9 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 79.5 t -114.81 123.29 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.342 -0.39 . . . . 10.0 110.463 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -113.42 82.17 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.53 -0.544 . . . . 10.0 109.53 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.07 -99.04 1.77 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.721 -0.672 . . . . 10.0 112.435 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -110.08 -1.41 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.664 0.268 . . . . 10.0 111.205 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -120.52 137.68 54.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.304 0.573 . . . . 10.0 111.932 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.411 ' SD ' ' NE2' ' A' ' 100' ' ' GLN . 49.1 ttp -109.02 113.23 25.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.304 -0.862 . . . . 10.0 109.501 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -105.33 106.88 21.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.219 0.533 . . . . 10.0 110.186 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.75 158.34 21.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.754 0.787 . . . . 10.0 112.128 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.762 HG23 HG12 ' A' ' 119' ' ' ILE . 3.2 m -138.06 115.57 11.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.869 -1.059 . . . . 10.0 109.267 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.17 162.52 13.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 121.106 -0.238 . . . . 10.0 111.083 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.8 m -149.69 109.43 4.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.578 -0.283 . . . . 10.0 110.579 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.5 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 25.0 m-85 -143.83 144.5 31.8 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 63.19 23.91 66.68 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.887 -0.673 . . . . 10.0 112.859 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.24 13.3 83.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.348 -0.453 . . . . 10.0 113.045 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.1 t -119.68 127.79 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-O 120.909 0.385 . . . . 10.0 110.629 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 21.4 m -96.13 90.8 5.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.128 -0.487 . . . . 10.0 110.13 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.2 tp -79.95 109.7 14.63 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.427 0.632 . . . . 10.0 110.74 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.762 HG12 HG23 ' A' ' 110' ' ' THR . 5.5 mt -99.78 114.56 38.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.187 -0.915 . . . . 10.0 109.47 178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -125.89 166.71 16.39 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.341 0.591 . . . . 10.0 111.963 -178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.37 125.14 40.17 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.164 -0.926 . . . . 10.0 108.952 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 1.5 m -122.22 101.75 7.71 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.49 0.662 . . . . 10.0 111.922 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.491 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -87.87 142.44 27.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.68 -0.691 . . . . 10.0 110.364 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -69.79 160.07 32.42 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.956 -0.298 . . . . 10.0 110.62 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.25 1.108 0 CA-C-N 115.304 -0.862 . . . . 10.0 111.475 178.832 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.949 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.903 H222 HD21 ' A' ' 27' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.312 -0.255 . . . . 10.0 110.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 20.1 m-85 -74.77 -30.35 61.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.585 -0.28 . . . . 10.0 110.651 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.97 111.06 1.99 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.968 0.413 . . . . 10.0 110.045 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.05 -156.76 26.21 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.883 -0.675 . . . . 10.0 111.481 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.593 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.9 p -131.17 117.8 19.56 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.66 0.267 . . . . 10.0 110.532 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.409 ' O ' HG12 ' A' ' 37' ' ' ILE . 5.4 m95 -116.86 126.23 52.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.971 0.415 . . . . 10.0 112.066 -178.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -89.27 105.43 17.79 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.213 -1.032 . . . . 10.0 108.213 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 13.8 p -81.5 141.52 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.459 0.647 . . . . 10.0 112.546 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -144.5 136.49 26.07 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.85 -1.167 . . . . 10.0 107.85 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 120' ' ' ARG . . . -158.38 156.42 30.46 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.663 -0.415 . . . . 10.0 111.438 -178.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -144.29 22.13 1.7 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.421 0.629 . . . . 10.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -122.08 138.15 54.55 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.177 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 29.13 50.39 0.05 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.235 1.585 . . . . 10.0 112.203 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.508 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 70.6 t80 -93.94 -62.77 1.29 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 10.0 110.914 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 1.6 pm0 -63.42 -29.49 70.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.661 -0.7 . . . . 10.0 111.074 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.87 -35.29 62.31 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.422 -0.354 . . . . 10.0 110.277 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.719 ' CD2' H192 ' A' ' 202' ' ' CHO . 24.9 t80 -71.37 -34.96 70.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.385 -0.371 . . . . 10.0 110.125 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.611 HD12 HG23 ' A' ' 28' ' ' ILE . 15.2 mt -58.92 -35.67 73.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.27 0.557 . . . . 10.0 110.064 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -71.98 -25.22 61.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.731 -0.668 . . . . 10.0 111.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.19 -12.17 59.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.06 0.457 . . . . 10.0 111.507 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.927 HD13 ' H62' ' A' ' 202' ' ' CHO . 2.0 mt -101.84 9.44 40.73 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.079 -0.509 . . . . 10.0 109.822 179.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 58.8 33.58 23.15 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.335 -0.848 . . . . 10.0 110.167 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 ' HG ' ' HB2' ' A' ' 21' ' ' LEU . 80.5 mt -74.69 156.67 86.56 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.353 -0.839 . . . . 10.0 110.991 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.515 ' O ' HG13 ' A' ' 28' ' ' ILE . 44.8 Cg_endo -68.37 132.55 25.95 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.467 2.111 . . . . 10.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 4.1 tp10 -51.31 -42.49 61.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.883 -0.599 . . . . 10.0 111.696 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.12 -47.37 78.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.978 -0.555 . . . . 10.0 111.548 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -38.72 81.45 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.518 -0.31 . . . . 10.0 110.814 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 18' ' ' LEU . 81.3 mt -58.9 -41.32 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.967 -0.561 . . . . 10.0 110.981 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 50.8 mtpt -67.46 -31.75 72.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.999 -0.546 . . . . 10.0 111.955 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.511 ' O ' HG13 ' A' ' 34' ' ' ILE . 21.5 ptp -89.71 -37.11 14.8 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.514 -0.474 . . . . 10.0 111.784 -178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.37 -19.14 61.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 10.0 111.675 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.05 -21.6 65.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.181 -0.463 . . . . 10.0 110.86 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -106.16 -38.45 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 10.0 109.906 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.638 HD13 ' HN ' ' A' ' 202' ' ' CHO . 26.8 mt -65.26 132.04 31.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 10.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -132.72 80.71 60.84 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-N 115.928 -0.578 . . . . 10.0 109.761 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.96 147.47 61.64 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.606 2.204 . . . . 10.0 111.626 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -83.34 136.57 22.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.063 0.458 . . . . 10.0 110.018 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.87 111.42 22.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.796 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -91.19 124.82 35.7 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.625 -0.509 . . . . 10.0 109.625 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.32 129.17 46.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.403 0.621 . . . . 10.0 110.321 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -127.88 147.62 50.46 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.743 -0.662 . . . . 10.0 109.939 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -133.29 168.62 18.24 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.145 -0.479 . . . . 10.0 110.31 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -147.44 48.25 1.11 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.843 0.83 . . . . 10.0 109.057 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.86 -109.44 2.35 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-N 114.928 -1.033 . . . . 10.0 111.026 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.81 -25.81 17.97 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.913 0.387 . . . . 10.0 109.965 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.93 136.39 33.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.256 0.551 . . . . 10.0 110.78 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.8 m-85 -122.67 155.25 36.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.654 -0.703 . . . . 10.0 110.621 -179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -134.99 104.44 5.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.739 -0.838 . . . . 10.0 108.739 178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' H11' ' A' ' 201' ' ' GCH . 11.0 t -95.06 131.12 42.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 116.076 -0.511 . . . . 10.0 110.173 -179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 28.7 m -123.35 125.9 45.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.14 0.495 . . . . 10.0 111.618 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.5 m -110.27 138.59 46.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.113 -0.494 . . . . 10.0 110.101 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.89 137.74 41.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.894 0.378 . . . . 10.0 111.096 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 8.4 p -141.48 168.6 13.48 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.811 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.759 ' HB3' H262 ' A' ' 202' ' ' CHO . 59.3 Cg_endo -80.84 11.18 3.06 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 10.0 111.767 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.406 HH12 ' HG3' ' A' ' 24' ' ' PRO . 10.1 mtp180 -131.4 -62.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.105 -0.498 . . . . 10.0 112.021 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -151.27 132.8 14.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.77 0.319 . . . . 10.0 111.459 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.3 t -86.58 125.38 33.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.06 -0.518 . . . . 10.0 109.939 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.0 m -98.4 150.71 4.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 120.89 -0.324 . . . . 10.0 110.696 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -124.65 116.07 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.892 -0.594 . . . . 10.0 111.19 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.682 ' OD1' ' H33' ' A' ' 201' ' ' GCH . 13.2 m120 -107.2 132.61 52.86 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.057 -0.719 . . . . 10.0 109.057 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 m -130.08 147.33 51.81 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.896 -0.503 . . . . 10.0 110.95 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 28.7 p90 -158.2 -179.28 7.96 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 110.477 -0.194 . . . . 10.0 110.477 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 66' ' ' LYS . 13.0 m -131.83 136.94 47.87 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.356 -0.609 . . . . 10.0 109.356 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 mt -56.59 112.05 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.274 0.472 . . . . 10.0 112.274 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.22 10.09 58.7 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.022 -0.609 . . . . 10.0 112.887 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.418 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 22.4 mtpp -132.09 143.17 49.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.833 0.349 . . . . 10.0 111.04 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 29.1 tt0 -84.59 118.51 24.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.643 -0.708 . . . . 10.0 109.388 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.48 139.63 53.66 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.013 0.435 . . . . 10.0 111.338 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 121.43 22.35 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.238 -0.892 . . . . 10.0 109.389 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -122.75 165.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.286 -0.87 . . . . 10.0 109.816 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.5 m -129.06 128.23 43.14 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 119.462 -0.895 . . . . 10.0 112.813 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.52 ' HB ' ' H32' ' A' ' 201' ' ' GCH . 3.8 t -88.38 155.18 19.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.569 -0.742 . . . . 10.0 110.113 179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.523 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -66.61 -13.06 60.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.614 0.245 . . . . 10.0 111.373 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -76.97 -11.89 59.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.171 0.51 . . . . 10.0 110.193 179.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.88 34.32 13.45 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.789 -0.642 . . . . 10.0 113.571 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' HB2' ' OD2' ' A' ' 74' ' ' ASP . 17.9 mtmm -116.51 145.77 43.08 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.88 0.371 . . . . 10.0 110.143 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 77' ' ' LYS . 5.8 mmpt? -93.32 109.79 21.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.394 0.616 . . . . 10.0 110.883 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD11 ' H26' ' A' ' 201' ' ' GCH . 24.3 mt -124.03 158.69 31.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.288 -0.869 . . . . 10.0 110.065 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -139.87 122.33 16.14 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.713 -0.477 . . . . 10.0 109.713 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -117.77 143.02 46.62 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 119.75 -0.78 . . . . 10.0 112.114 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 2.8 t -100.76 57.36 0.89 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.779 -1.1 . . . . 10.0 109.022 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 4.0 t -56.97 134.36 21.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.523 -1.217 . . . . 10.0 111.302 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -150.61 148.78 29.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.713 -0.676 . . . . 10.0 109.373 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 tt -94.54 117.03 29.5 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.069 0.461 . . . . 10.0 109.958 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 86' ' ' ASN . . . -135.56 142.88 45.42 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 108.986 -0.746 . . . . 10.0 108.986 -179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.517 ' HB3' ' O ' ' A' ' 85' ' ' ALA . 7.3 t30 66.49 9.46 6.55 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 122.024 0.916 . . . . 10.0 110.619 176.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 89.59 0.16 79.48 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.351 -0.841 . . . . 10.0 111.16 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -115.53 175.21 5.62 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.192 -0.299 . . . . 10.0 110.192 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HB2' ' CE2' ' A' ' 2' ' ' PHE . 7.2 tp -106.56 126.99 52.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.037 0.446 . . . . 10.0 110.873 -179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 82' ' ' VAL . 45.5 t -110.85 120.3 61.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.058 -0.519 . . . . 10.0 111.204 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.853 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 44.2 t -128.87 79.93 1.94 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.553 -0.906 . . . . 10.0 108.553 178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 40.2 ttpt -104.92 146.08 29.52 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.878 -0.601 . . . . 10.0 111.868 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.4 m -112.93 -168.4 1.32 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.152 -0.931 . . . . 10.0 109.078 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.12 -31.34 34.28 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.883 0.373 . . . . 10.0 111.327 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -113.85 -21.43 10.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.129 0.418 . . . . 10.0 112.129 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -130.23 179.14 6.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.93 -0.308 . . . . 10.0 111.027 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 23.1 t -159.08 133.36 7.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.258 -0.428 . . . . 10.0 110.582 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.733 ' CE1' ' H3 ' ' A' ' 201' ' ' GCH . 3.6 t-160 -107.29 125.91 51.77 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.164 -0.68 . . . . 10.0 109.164 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 109' ' ' GLU . 4.7 tp10 -99.33 140.64 33.2 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.093 -0.503 . . . . 10.0 110.682 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -143.9 98.4 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 10.0 110.608 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -117.4 125.95 51.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.82 0.343 . . . . 10.0 111.066 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 91.2 t -104.23 122.41 57.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.08 0.467 . . . . 10.0 110.204 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -120.3 99.76 6.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.943 -0.571 . . . . 10.0 109.869 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 67.01 -102.17 0.75 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.929 -0.578 . . . . 10.0 112.154 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -117.14 14.7 14.95 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.084 0.469 . . . . 10.0 110.336 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.1 136.31 51.96 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.073 0.463 . . . . 10.0 110.895 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -111.66 116.33 30.59 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.946 -0.57 . . . . 10.0 110.081 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.57 106.6 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.069 -0.514 . . . . 10.0 110.268 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 99' ' ' GLU . 5.1 pt-20 -111.92 152.88 27.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.404 0.621 . . . . 10.0 111.343 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 73.8 m -138.2 121.18 16.65 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.576 -0.738 . . . . 10.0 109.327 179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.58 157.68 20.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.799 0.333 . . . . 10.0 110.495 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 24.3 m -146.8 109.73 4.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.762 0.315 . . . . 10.0 110.502 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.564 ' HB3' ' H23' ' A' ' 201' ' ' GCH . 27.7 m-85 -144.82 146.97 32.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.47 -0.567 . . . . 10.0 109.47 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.09 21.3 63.67 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 121.108 -0.567 . . . . 10.0 112.77 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.32 15.63 78.01 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 121.045 -0.598 . . . . 10.0 112.346 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 3.7 t -123.15 127.44 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.76 0.314 . . . . 10.0 110.334 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.6 m -96.8 88.18 4.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.958 0.408 . . . . 10.0 110.476 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 14' ' ' TYR . 10.1 tp -77.26 111.37 12.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.258 0.551 . . . . 10.0 110.265 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.46 119.9 44.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.954 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.556 ' HA ' ' HB2' ' A' ' 10' ' ' ALA . 25.5 mtm180 -121.67 153.29 38.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.234 0.54 . . . . 10.0 111.348 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.43 127.06 32.55 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.096 -1.075 . . . . 10.0 108.096 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 2.0 m -119.79 144.36 47.34 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.376 -0.529 . . . . 10.0 111.045 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -120.47 137.21 54.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.951 -0.568 . . . . 10.0 109.774 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -73.85 148.58 42.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.7 -0.667 . . . . 10.0 111.055 -179.098 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.853 ' H6 ' ' SG ' ' A' ' 91' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.927 ' H62' HD13 ' A' ' 21' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 121.011 0.434 . . . . 10.0 110.891 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 20.4 m-85 -81.93 -27.49 33.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.873 -0.603 . . . . 10.0 110.667 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.434 ' HB2' ' OE1' ' A' ' 42' ' ' GLN . 0.8 OUTLIER -58.74 105.22 0.28 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.136 0.493 . . . . 10.0 110.356 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.23 -150.34 12.83 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.882 -0.675 . . . . 10.0 112.184 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.586 ' HB ' HD11 ' A' ' 37' ' ' ILE . 10.4 p -133.48 119.35 19.45 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 120.823 0.344 . . . . 10.0 110.593 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . . . . . . . . . 5.7 m95 -119.86 127.59 52.88 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.904 -0.589 . . . . 10.0 111.463 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.11 108.18 20.26 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.568 -0.53 . . . . 10.0 109.568 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -75.58 141.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 10.0 112.377 -178.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.25 121.05 5.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.399 -0.819 . . . . 10.0 108.797 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -175.11 139.78 0.49 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.156 -0.34 . . . . 10.0 111.717 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -101.8 87.62 3.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.477 0.656 . . . . 10.0 109.86 178.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -130.85 -144.83 0.26 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.82 0.819 . . . . 10.0 109.815 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.919 ' OD1' ' HA ' ' A' ' 118' ' ' LEU . 3.3 p30 -78.95 26.77 0.24 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.04 -1.436 . . . . 10.0 111.343 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.539 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 61.3 t80 -57.79 -61.16 2.72 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.023 -0.535 . . . . 10.0 112.21 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -62.94 -27.19 69.22 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.074 0.398 . . . . 10.0 112.074 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -77.05 -37.78 54.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.845 0.355 . . . . 10.0 110.178 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' CE2' HD11 ' A' ' 21' ' ' LEU . 27.2 t80 -65.49 -36.32 83.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 10.0 110.345 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.551 HD12 HG23 ' A' ' 28' ' ' ILE . 17.7 mt -57.97 -32.4 67.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.005 -0.543 . . . . 10.0 110.55 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HG2' HD13 ' A' ' 28' ' ' ILE . 44.1 mttt -75.68 -17.95 59.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.737 -0.665 . . . . 10.0 110.949 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.89 -18.65 39.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.158 0.504 . . . . 10.0 110.639 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 18' ' ' LEU . 1.2 mt -93.12 9.96 33.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.895 -0.593 . . . . 10.0 110.811 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 61.55 40.34 13.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.429 -0.805 . . . . 10.0 111.002 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.3 mt -91.8 155.37 43.55 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.663 -0.699 . . . . 10.0 110.263 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.34 126.31 14.78 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.302 2.001 . . . . 10.0 111.884 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.579 ' HA ' HD12 ' A' ' 28' ' ' ILE . 24.9 tt0 -54.24 -37.4 64.59 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.018 -0.537 . . . . 10.0 111.46 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -57.38 -43.89 84.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.457 -0.338 . . . . 10.0 110.718 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.763 HD21 H222 ' A' ' 202' ' ' CHO . 1.0 OUTLIER -71.64 -34.87 70.14 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.221 0.534 . . . . 10.0 110.127 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.711 HD13 ' HG2' ' A' ' 19' ' ' LYS . 96.8 mt -61.59 -36.88 76.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.243 -0.89 . . . . 10.0 110.48 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -66.44 -23.52 66.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 10.0 111.09 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.48 ' O ' HG13 ' A' ' 34' ' ' ILE . 6.8 mmt -93.12 -40.74 10.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.228 0.537 . . . . 10.0 109.906 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB1' H183 ' A' ' 202' ' ' CHO . . . -57.92 -28.52 64.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.135 -0.939 . . . . 10.0 112.462 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.9 ptt180 -64.22 -22.46 66.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.792 0.329 . . . . 10.0 111.225 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -103.44 -22.92 13.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.179 0.514 . . . . 10.0 110.218 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.568 HD12 H232 ' A' ' 202' ' ' CHO . 22.3 mt -79.86 123.62 36.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 10.0 110.74 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -113.26 85.58 8.64 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.186 -0.672 . . . . 10.0 109.186 179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.76 146.32 38.04 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.324 2.016 . . . . 10.0 111.85 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.586 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -95.26 136.96 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.13 109.73 22.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.947 -0.57 . . . . 10.0 111.13 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -88.26 118.13 27.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.944 -0.571 . . . . 10.0 109.786 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.34 127.18 68.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.234 0.54 . . . . 10.0 110.385 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -129.16 140.46 51.51 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.956 -0.565 . . . . 10.0 109.628 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 3' ' ' SER . 9.3 pt20 -117.18 168.88 9.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.368 0.604 . . . . 10.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -147.78 71.12 1.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.883 -1.053 . . . . 10.0 108.452 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.65 -95.74 2.13 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.314 -1.114 . . . . 10.0 110.314 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.17 -14.55 11.74 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -87.66 134.27 33.68 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.012 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.448 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 2.7 m-85 -118.31 147.87 43.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.015 -0.539 . . . . 10.0 110.503 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.9 t -130.82 101.37 5.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 115.436 -0.802 . . . . 10.0 109.396 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.732 HG11 ' H11' ' A' ' 201' ' ' GCH . 48.4 t -92.58 113.89 28.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 115.543 -0.753 . . . . 10.0 110.493 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.1 m -95.04 97.12 9.72 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.525 -0.761 . . . . 10.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.63 104.92 15.03 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.844 -0.617 . . . . 10.0 109.399 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -97.2 122.0 39.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.798 -0.637 . . . . 10.0 111.542 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.4 p -133.56 152.6 79.37 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.453 -0.573 . . . . 10.0 109.453 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.81 ' HD2' H221 ' A' ' 202' ' ' CHO . 12.3 Cg_exo -68.38 -2.21 8.69 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.049 2.5 . . . . 10.0 113.612 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 56' ' ' GLN . 0.6 OUTLIER -117.81 -41.25 2.93 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 122.236 -0.29 . . . . 10.0 111.693 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' N ' ' HG3' ' A' ' 55' ' ' ARG . 7.4 tp60 -161.25 112.52 1.77 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.715 0.293 . . . . 10.0 110.937 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.8 t -93.87 124.69 38.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.5 m -117.89 158.07 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.947 0.403 . . . . 10.0 111.965 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 m -112.28 121.87 46.13 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.672 -0.695 . . . . 10.0 109.828 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.577 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 54.0 m-80 -116.18 119.81 36.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.441 -0.577 . . . . 10.0 109.441 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.1 m -121.64 152.63 39.1 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.832 -0.347 . . . . 10.0 111.703 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 47' ' ' PHE . 21.6 p90 -161.21 176.7 10.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.536 -0.302 . . . . 10.0 110.693 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 m -126.57 136.83 53.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.007 -0.368 . . . . 10.0 110.007 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 29.8 mt -57.6 108.68 0.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 10.0 111.99 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.39 10.88 55.34 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.809 -0.632 . . . . 10.0 113.604 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -137.68 148.55 45.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 117.102 0.451 . . . . 10.0 111.297 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 41.4 tt0 -81.77 125.07 30.21 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.709 -0.678 . . . . 10.0 109.691 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.93 140.44 52.0 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.012 0.434 . . . . 10.0 110.931 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -74.55 127.66 33.63 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.485 -0.78 . . . . 10.0 109.587 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.577 ' HB ' ' OD1' ' A' ' 60' ' ' ASN . 2.3 pp -130.41 162.8 37.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.507 -0.553 . . . . 10.0 109.507 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 m -125.09 117.78 24.7 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 119.937 -0.705 . . . . 10.0 112.001 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.623 ' OG1' ' H28' ' A' ' 201' ' ' GCH . 2.8 t -73.79 156.46 37.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.328 -0.851 . . . . 10.0 110.031 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.443 ' SD ' ' O7 ' ' A' ' 202' ' ' CHO . 0.0 OUTLIER -70.79 -8.01 49.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.071 -0.513 . . . . 10.0 111.979 -179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' OD2' ' H25' ' A' ' 201' ' ' GCH . 1.1 p30 -89.41 -3.96 58.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.136 0.494 . . . . 10.0 110.693 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.56 42.12 7.49 Favored Glycine 0 CA--C 1.518 0.232 0 CA-C-N 115.883 -0.599 . . . . 10.0 114.06 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.503 ' O ' HG22 ' A' ' 72' ' ' THR . 20.5 mtmm -126.98 146.19 50.43 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.976 0.417 . . . . 10.0 110.196 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -93.65 116.08 28.57 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.953 -0.567 . . . . 10.0 110.188 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD11 ' H26' ' A' ' 201' ' ' GCH . 19.0 mt -130.8 153.42 49.09 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.293 -0.632 . . . . 10.0 109.293 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -119.25 123.48 44.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.826 0.346 . . . . 10.0 110.365 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.635 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 0.1 OUTLIER -105.12 123.29 47.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.084 -0.507 . . . . 10.0 110.82 -179.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 8.5 t -98.75 44.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.988 0.899 . . . . 10.0 109.389 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.49 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 2.4 t -51.84 131.91 13.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.498 -1.228 . . . . 10.0 112.71 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -142.24 145.55 34.2 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.486 -0.779 . . . . 10.0 110.448 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 23.8 tp -88.2 119.52 28.67 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.659 . . . . 10.0 109.969 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -128.99 107.35 9.54 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.144 -0.48 . . . . 10.0 110.807 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 63.02 33.86 14.4 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.453 0.471 . . . . 10.0 111.184 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.82 -3.57 85.08 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.732 -0.747 . . . . 10.0 112.223 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.37 141.85 33.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 6.1 tp -98.35 123.78 42.64 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.018 0.437 . . . . 10.0 109.968 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.07 132.92 70.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 112.197 0.443 . . . . 10.0 112.197 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.45 ' HB2' HG22 ' A' ' 82' ' ' VAL . 41.8 t -135.56 88.86 2.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.05 -1.092 . . . . 10.0 108.05 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 33.4 ttmt -105.36 138.63 41.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.899 -0.591 . . . . 10.0 110.574 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 -167.03 1.33 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.804 -0.635 . . . . 10.0 109.562 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' OE2' ' HB2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -81.66 -10.03 59.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.422 . . . . 10.0 110.558 179.816 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HB2' ' OE2' ' A' ' 94' ' ' GLU . 2.2 ttmp? -131.85 -30.73 1.58 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.42 0.526 . . . . 10.0 112.42 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -119.31 178.06 4.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.61 0.243 . . . . 10.0 111.235 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -155.23 129.51 8.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 10.0 111.267 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 3.8 t-160 -112.5 116.23 29.92 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 109' ' ' GLU . 13.9 mm-40 -110.51 94.83 5.21 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.72 0.637 . . . . 10.0 112.72 -178.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -100.9 114.01 27.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.772 0.32 . . . . 10.0 110.527 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -121.42 140.19 52.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.959 0.409 . . . . 10.0 111.012 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.64 120.97 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.001 -0.545 . . . . 10.0 110.315 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.7 mttp -126.91 98.9 5.52 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.259 -0.428 . . . . 10.0 109.939 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.57 -111.14 3.29 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.752 -0.737 . . . . 10.0 111.567 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -112.56 17.92 18.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.873 0.368 . . . . 10.0 110.032 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -128.57 125.08 37.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.06 -0.518 . . . . 10.0 111.623 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 55.1 ttp -112.2 114.37 27.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.355 -0.98 . . . . 10.0 108.355 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.3 m -122.79 131.53 73.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 120.843 0.354 . . . . 10.0 111.036 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLU . 1.2 pt-20 -128.97 156.82 43.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.912 0.863 . . . . 10.0 111.905 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.6 m -129.79 99.12 5.01 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.248 -1.342 . . . . 10.0 108.052 178.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 117' ' ' THR . 0.5 OUTLIER -102.28 174.01 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.27 -0.641 . . . . 10.0 109.27 -178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 117' ' ' THR . 28.3 m -157.57 106.89 2.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.529 -0.545 . . . . 10.0 109.529 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HB3' ' H23' ' A' ' 201' ' ' GCH . 15.4 m-85 -139.48 143.75 37.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.837 -0.431 . . . . 10.0 109.837 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.46 20.76 61.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.143 -0.551 . . . . 10.0 112.15 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.13 3.81 78.77 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 121.217 -0.516 . . . . 10.0 112.284 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 112' ' ' THR . 4.4 t -115.56 123.42 70.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 CA-C-O 121.44 0.638 . . . . 10.0 111.431 -179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 112' ' ' THR . 1.6 t -90.07 71.0 7.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.111 -0.949 . . . . 10.0 110.811 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.919 ' HA ' ' OD1' ' A' ' 13' ' ' ASN . 12.9 tp -60.68 118.91 7.17 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.386 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 5.5 mt -106.05 117.04 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.347 -0.842 . . . . 10.0 109.557 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -113.33 143.66 44.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.624 0.726 . . . . 10.0 111.946 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -121.68 122.03 38.66 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.375 -1.284 . . . . 10.0 108.206 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -121.16 144.07 48.77 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.348 0.594 . . . . 10.0 111.352 -179.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.34 138.52 54.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.546 -0.752 . . . . 10.0 110.406 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 -78.69 146.65 33.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.783 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.543 -0.741 . . . . 10.0 110.358 -179.434 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.768 ' O2 ' ' H19' ' A' ' 201' ' ' GCH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.81 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.563 0.22 . . . . 10.0 110.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 14.7 m-85 -67.84 -22.96 65.11 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.309 -0.405 . . . . 10.0 110.768 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.97 100.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.221 -0.445 . . . . 10.0 110.279 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.8 -159.66 30.33 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.595 -0.812 . . . . 10.0 112.583 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.538 ' HB ' HD11 ' A' ' 37' ' ' ILE . 2.4 p -124.73 118.46 26.49 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.682 0.277 . . . . 10.0 110.619 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TRP . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' ILE . 7.7 m95 -116.49 121.72 42.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.353 0.597 . . . . 10.0 112.56 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.78 108.81 20.27 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 122' ' ' SER . 4.4 p -85.47 138.98 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 113.03 0.752 . . . . 10.0 113.03 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CE1' ' HG2' ' A' ' 123' ' ' LYS . 7.5 p90 -150.39 132.72 15.53 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.301 -0.863 . . . . 10.0 109.086 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -176.52 157.58 1.66 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.579 0.228 . . . . 10.0 110.994 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -123.68 65.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.593 0.711 . . . . 10.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.43 ' HG3' ' HB ' ' A' ' 119' ' ' ILE . 25.4 mm-40 -109.76 -159.07 0.67 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.244 -0.889 . . . . 10.0 109.254 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -71.51 58.67 0.29 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.293 0.568 . . . . 10.0 110.314 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.468 ' O ' ' HG ' ' A' ' 18' ' ' LEU . 50.5 t80 -70.6 -64.62 0.86 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.598 -0.728 . . . . 10.0 111.625 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -58.02 -35.71 71.66 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.284 0.475 . . . . 10.0 112.284 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -68.38 -39.39 81.76 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.737 0.303 . . . . 10.0 110.538 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.471 ' CE2' HD11 ' A' ' 21' ' ' LEU . 17.9 t80 -65.31 -36.42 84.02 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.062 -0.517 . . . . 10.0 110.228 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 14' ' ' TYR . 13.9 mt -60.62 -37.48 81.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.092 -0.504 . . . . 10.0 110.24 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.672 ' HG2' HD13 ' A' ' 28' ' ' ILE . 16.6 mttt -68.64 -30.17 68.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 10.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' HB1' ' HA3' ' A' ' 114' ' ' GLY . . . -79.1 -6.94 57.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 10.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.822 HD13 ' H62' ' A' ' 202' ' ' CHO . 41.7 mt -104.58 11.31 34.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.877 -0.602 . . . . 10.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 62.45 29.85 17.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.111 -0.95 . . . . 10.0 111.235 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD13 H152 ' A' ' 202' ' ' CHO . 91.2 mt -84.2 161.3 55.23 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.292 -0.413 . . . . 10.0 110.163 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' O ' HG13 ' A' ' 28' ' ' ILE . 4.0 Cg_exo -72.72 122.65 8.38 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.635 2.224 . . . . 10.0 112.054 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.755 ' HA ' HD12 ' A' ' 28' ' ' ILE . 3.1 mp0 -54.96 -31.54 60.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 10.0 111.439 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -65.89 -37.26 85.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.427 -0.351 . . . . 10.0 110.292 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.649 HD21 H222 ' A' ' 202' ' ' CHO . 4.4 tp -77.61 -32.08 53.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.193 0.52 . . . . 10.0 109.703 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.755 HD12 ' HA ' ' A' ' 25' ' ' GLU . 96.6 mt -59.28 -34.61 54.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.149 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 58.0 mtpt -70.9 -22.65 62.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 10.0 111.282 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.494 ' O ' HG13 ' A' ' 34' ' ' ILE . 76.2 mtm -95.93 -38.46 10.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.045 0.45 . . . . 10.0 110.722 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.2 -27.76 64.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.589 -0.732 . . . . 10.0 112.184 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 29' ' ' LYS . 1.3 ptt180 -58.81 -32.81 69.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.204 -0.453 . . . . 10.0 111.998 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.77 0.22 38.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.982 0.42 . . . . 10.0 111.115 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.57 HD12 H232 ' A' ' 202' ' ' CHO . 8.5 mt -98.54 127.08 51.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.1 -0.5 . . . . 10.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -120.64 85.46 38.64 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.721 -0.672 . . . . 10.0 109.954 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.11 127.79 10.18 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.85 2.367 . . . . 10.0 111.489 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER -75.47 135.34 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 120.155 -0.618 . . . . 10.0 109.639 179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.7 t -89.03 110.63 21.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.987 -0.551 . . . . 10.0 110.963 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -89.47 119.4 29.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.057 0.456 . . . . 10.0 109.889 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.525 HD11 ' HD2' ' A' ' 47' ' ' PHE . 0.0 OUTLIER -130.61 130.05 64.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-O 121.392 0.615 . . . . 10.0 110.549 -179.517 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 145.39 49.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.005 -0.543 . . . . 10.0 109.825 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -134.73 -165.79 1.72 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.156 0.503 . . . . 10.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -175.76 68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.216 -0.902 . . . . 10.0 110.098 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.29 -90.89 0.69 Allowed Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.722 -0.751 . . . . 10.0 112.134 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -123.39 -24.29 4.65 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.834 0.35 . . . . 10.0 110.505 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -86.61 130.5 34.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 10.0 110.442 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.525 ' HD2' HD11 ' A' ' 40' ' ' ILE . 2.9 m-85 -117.84 151.54 37.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.02 -0.536 . . . . 10.0 110.73 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 77.7 t -131.45 101.95 5.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.426 -0.806 . . . . 10.0 109.196 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.903 HG21 ' H11' ' A' ' 201' ' ' GCH . 32.2 t -90.08 118.68 35.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.688 -0.687 . . . . 10.0 110.183 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.445 HG22 ' HG3' ' A' ' 52' ' ' LYS . 61.5 m -102.33 103.33 13.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.526 -0.761 . . . . 10.0 110.606 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -93.25 100.33 12.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.403 -0.592 . . . . 10.0 109.403 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HG3' HG22 ' A' ' 50' ' ' THR . 43.8 mtpt -97.38 113.78 25.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.667 -0.697 . . . . 10.0 111.086 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.7 HG21 ' SD ' ' A' ' 73' ' ' MET . 1.1 p -120.3 164.96 19.73 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.718 -0.674 . . . . 10.0 110.072 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.848 ' HD2' H221 ' A' ' 202' ' ' CHO . 15.1 Cg_exo -69.38 -3.55 11.99 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.992 2.461 . . . . 10.0 112.224 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -108.61 -62.04 1.52 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.126 -0.488 . . . . 10.0 110.558 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.15 150.21 35.46 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.264 -0.425 . . . . 10.0 110.531 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 99.8 m -108.12 112.1 24.46 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.613 -0.514 . . . . 10.0 109.613 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -103.6 151.03 6.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.216 0.531 . . . . 10.0 111.37 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 m -118.34 114.96 23.74 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.55 -0.75 . . . . 10.0 110.553 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' OD1' ' HB ' ' A' ' 70' ' ' ILE . 45.6 m-80 -106.93 122.89 47.31 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.63 -0.878 . . . . 10.0 108.63 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.34 150.97 41.66 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 121.171 -0.211 . . . . 10.0 111.289 -178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -167.45 169.12 12.46 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.694 -0.23 . . . . 10.0 110.393 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -122.64 132.61 54.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 50.8 mt -48.87 112.46 0.62 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.759 0.652 . . . . 10.0 112.759 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 83' ' ' HIS . . . 94.34 -8.81 72.22 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.005 -0.617 . . . . 10.0 113.746 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.37 148.99 40.09 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.126 0.463 . . . . 10.0 111.0 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' THR . 32.5 tt0 -81.27 129.63 34.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.644 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.68 154.7 47.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.837 0.351 . . . . 10.0 110.794 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -85.03 120.42 26.53 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.696 -0.684 . . . . 10.0 109.92 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.784 HD13 ' H34' ' A' ' 201' ' ' GCH . 2.6 pp -126.27 166.31 22.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.581 -0.736 . . . . 10.0 109.4 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.4 m -140.25 131.23 26.17 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.152 -0.619 . . . . 10.0 112.212 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.755 ' HB ' ' H28' ' A' ' 201' ' ' GCH . 9.7 t -77.73 162.62 26.82 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.648 -0.706 . . . . 10.0 109.391 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.7 ' SD ' HG21 ' A' ' 53' ' ' THR . 15.6 ptp -74.73 -4.69 38.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.807 0.337 . . . . 10.0 111.596 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -37.84 28.83 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.262 -0.426 . . . . 10.0 110.488 178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.96 12.48 4.87 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.847 -0.692 . . . . 10.0 112.428 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -95.43 142.69 27.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 10.0 110.815 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -96.68 118.43 33.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.223 -0.444 . . . . 10.0 110.166 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.49 149.63 50.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.177 -0.465 . . . . 10.0 110.153 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.0 mttm -124.37 127.14 47.13 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.963 -0.384 . . . . 10.0 109.963 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.8 t -120.44 149.34 42.53 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.183 -0.607 . . . . 10.0 111.259 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 5.1 t -107.39 43.99 1.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.471 -0.786 . . . . 10.0 109.733 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.6 t -40.95 126.74 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 114.643 -1.162 . . . . 10.0 111.74 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.46 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 9.8 p80 -140.99 145.69 36.3 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.966 -179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.3 tp -91.68 112.21 24.04 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.779 -0.646 . . . . 10.0 110.257 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -123.51 117.89 26.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.846 -0.616 . . . . 10.0 110.596 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 61.27 34.01 18.81 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.503 0.502 . . . . 10.0 110.98 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.18 7.71 87.64 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.856 -0.688 . . . . 10.0 112.182 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -111.69 139.85 46.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 122.528 0.331 . . . . 10.0 110.399 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 2' ' ' PHE . 8.2 tp -93.86 118.68 31.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.523 -0.547 . . . . 10.0 109.523 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.71 120.15 61.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.724 -0.671 . . . . 10.0 111.504 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.718 ' SG ' ' H6 ' ' A' ' 201' ' ' GCH . 37.8 t -122.62 86.93 2.66 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.753 -0.832 . . . . 10.0 108.753 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 3.2 tmmt? -106.83 132.91 52.25 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.068 -0.515 . . . . 10.0 110.491 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -176.05 2.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.335 -0.393 . . . . 10.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -76.8 -9.34 58.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.008 0.432 . . . . 10.0 111.365 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 45.3 tttm -133.49 -21.02 2.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.305 0.483 . . . . 10.0 112.305 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -131.1 -179.41 5.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 10.0 111.779 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 92' ' ' LYS . 0.3 OUTLIER -155.46 120.7 4.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.988 -0.551 . . . . 10.0 110.932 179.539 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.85 ' ND1' ' H42' ' A' ' 201' ' ' GCH . 2.8 t-160 -103.89 124.61 49.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.886 -0.597 . . . . 10.0 109.565 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -109.11 124.63 51.1 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.042 -0.526 . . . . 10.0 110.535 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.615 ' NE2' ' H2 ' ' A' ' 201' ' ' GCH . 1.2 tt0 -130.58 121.37 25.54 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.802 -0.444 . . . . 10.0 109.802 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 107' ' ' MET . 26.5 tt0 -124.34 126.7 46.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.658 0.266 . . . . 10.0 111.485 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 88.3 t -106.94 115.55 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.6 mtpp -116.83 95.12 4.87 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.409 -0.589 . . . . 10.0 109.409 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.61 -101.95 1.46 Allowed Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.599 -0.81 . . . . 10.0 111.507 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -119.77 12.13 12.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.993 0.425 . . . . 10.0 109.951 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -122.9 137.96 54.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.097 -0.501 . . . . 10.0 110.37 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.439 ' HA ' ' O ' ' A' ' 101' ' ' GLU . 58.1 ttp -122.79 106.84 11.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.826 0.345 . . . . 10.0 110.832 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -97.52 122.72 49.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.233 -0.654 . . . . 10.0 109.233 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -122.87 154.82 37.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.733 0.778 . . . . 10.0 112.019 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.462 HG23 HG12 ' A' ' 119' ' ' ILE . 96.9 m -133.77 110.88 10.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.529 -1.214 . . . . 10.0 109.151 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.3 mt -117.37 137.96 49.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.359 -0.382 . . . . 10.0 110.469 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 42.4 m -127.01 104.79 8.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.948 0.404 . . . . 10.0 110.103 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.427 ' HB2' ' CE1' ' A' ' 17' ' ' PHE . 3.0 m-85 -134.36 143.17 47.49 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.147 -0.686 . . . . 10.0 109.147 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' HB1' ' A' ' 20' ' ' ALA . . . 65.86 15.62 62.65 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.603 -0.808 . . . . 10.0 112.3 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.29 11.55 75.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 121.266 -0.493 . . . . 10.0 112.711 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.82 122.73 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 117.077 0.438 . . . . 10.0 110.757 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 93.7 m -91.78 97.01 10.73 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.998 -0.547 . . . . 10.0 110.192 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.2 tp -92.86 109.54 20.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.93 -0.577 . . . . 10.0 110.467 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 110' ' ' THR . 53.9 mt -97.08 117.34 41.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.885 -0.598 . . . . 10.0 109.534 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' CZ ' ' H22' ' A' ' 202' ' ' CHO . 28.9 mtm180 -121.21 151.33 40.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.166 0.507 . . . . 10.0 111.77 -178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.37 127.05 54.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.507 -0.769 . . . . 10.0 110.031 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.4 OUTLIER -117.07 145.8 43.51 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.16 0.505 . . . . 10.0 110.839 179.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HG2' ' CE1' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -127.68 134.56 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.431 -0.804 . . . . 10.0 108.929 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 -63.99 147.23 52.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.067 0.46 . . . . 10.0 111.243 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.249 1.075 0 CA-C-N 115.484 -0.78 . . . . 10.0 110.193 -179.705 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GCH . . . . . 0.903 ' H11' HG21 ' A' ' 49' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' CHO . . . . . 0.848 H221 ' HD2' ' A' ' 54' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_